Compounds > nevirapine

nevirapine and zidovudine

nevirapine has been researched along with zidovudine in 645 studies

Research

Studies (645)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's127 (19.69)18.2507
2000's234 (36.28)29.6817
2010's260 (40.31)24.3611
2020's24 (3.72)2.80

Authors

AuthorsStudies
Bamberger, DL; Fisher, TE; Goldman, ME; Hoffman, JM; Jones, JH; Rooney, CS; Saari, WS; Smith, AM; Thomas, CM; Wai, JS1
Behnke, ML; Cullen, E; Fuchs, VU; Grozinger, KG; Hargrave, KD; Kapadia, SR; Mauldin, SC; Patel, UR; Proudfoot, JR; Vitous, J1
Bethell, RC; Cammack, N; Green, DV; Hancock, AP; Hann, MM; Lamont, RB; Livermore, DG; Noble, SA; Orr, DC; Payne, JJ1
Alvarez, R; Aquaro, S; Balzarini, J; Camarasa, MJ; De Clercq, E; Karlsson, A; Perno, CF; San-Félix, A; Velázquez, S1
Fujiwara, M; Hanasaki, Y; Ijichi, K; Katsuura, K; Konno, K; Sakai, S; Shirakawa, S; Takayama, H; Watanabe, H; Yamaguchi, K1
Artico, M; La Colla, P; Loi, AG; Mai, A; Massa, S; Sbardella, G; Scano, P; Tramontano, E1
Balani, SK; Ciccarone, TM; Condra, JH; Emini, EA; Goldman, ME; Greenlee, WJ; Kauffman, LR; MacTough, SC; Rooney, CS; Williams, TM1
Althaus, IW; Biles, C; Busso, M; Genin, MJ; Morge, RA; Resnick, L; Reusser, F; Romero, DL; Tarpley, WG; Thomas, RC1
Bell, FW; Cantrell, AS; Högberg, M; Jaskunas, SR; Johansson, NG; Jordan, CL; Kinnick, MD; Lind, P; Morin, JM; Noréen, R1
Artico, M; Corrias, S; La Colla, P; Loi, AG; Massa, S; Piras, G; Silvestri, R1
Altamura, S; Campiani, G; De Filippis, MP; Di Renzo, L; Fiorini, I; Garofalo, A; Greco, G; Nacci, V; Novellino, E1
Artico, M; De Montis, A; La Colla, P; Loi, AG; Mai, A; Massa, S; Putzolu, M; Quartarone, S; Sbardella, G; Scintu, F1
Arranz, E; Balzarini, J; De Clercq, E; Díaz, JA; Ingate, ST; Pannecouque, C; Vega, S; Witvrouw, M1
Mao, C; Sudbeck, EA; Uckun, FM; Venkatachalam, TK1
Maher, D; Mao, C; Pendergrass, S; Tuel-Ahlgren, L; Uckun, FM; Venkatachalam, TK; Zhu, D2
Topliss, JG; Yoshida, F1
Andreola, ML; Aubertin, AM; Bisagni, E; Dollé, V; Kirn, A; Legraverend, M; Nguyen, CH; Tarrago-Litvak, L; Ventura, M1
Aiello, F; Armaroli, S; Bergamini, A; Bolacchi, F; Bongiovanni, B; Caccia, S; Campiani, G; Capozzi, M; Coletta, M; Fabbrini, M; Garofalo, A; Greco, G; Guiso, G; Maga, G; Marini, S; Morelli, E; Nacci, V; Novellino, E; Ramunno, A; Spadari, S; Ventura, L1
Buckheit, RW; Burrier, J; Cushman, M; Hartman, TL; Micklatcher, M; Osterling, MC; Silvestri, MA; Turpin, JA; Wargo, H; Xu, G1
Singh, SK; Yadav, A1
Bergamini, A; Butini, S; Campiani, G; Catalanotti, B; Coletta, M; De Angelis, M; Fattorusso, C; Fiorini, I; Gemma, S; Greco, G; Huleatt, P; Maga, G; Marini, S; Nacci, V; Novellino, E; Persico, M; Ramunno, A; Rodriquez, M; Spadari, S1
Alongi, M; Armand-Ugón, M; Bernardini, C; Botta, M; Cancio, R; Carmi, C; Clotet-Codina, I; Corelli, F; Crespan, E; Esté, JA; Maga, G; Manetti, F; Massa, S; Mugnaini, C; Petricci, E; Togninelli, A1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Botta, M; Cancio, R; Clotet-Codina, I; Corelli, F; Esté, JA; Maga, G; Manetti, F; Mugnaini, C1
Baba, M; De Clercq, E; Shi, M; Takao, S; Wang, X1
Baba, M; Cheng, YC; Dutschman, GE; Grill, SP; Hu, R; Lam, W; Paintsil, E; Tanaka, H1
Andricopulo, AD; Moda, TL; Montanari, CA1
De Clercq, E; Li, J; Lin, Y; Liu, X; Pannecouque, C; Witvrouw, M; Yan, R1
Alongi, M; Angeli, L; Armand-Ugón, M; Bellucci, L; Bernardini, C; Botta, M; Brizzi, A; Clotet-Codina, I; Corelli, F; Esté, JA; Facchini, M; Gevariya, H; Maga, G; Manetti, F; Massa, S; Mugnaini, C; Samuele, A; Tafi, A; Togninelli, A1
De Maeyer, M; Debyser, Z; Desadeleer, C; Hombrouck, A; Van Remoortel, B; Voet, A; Witvrouw, M1
Lombardo, F; Obach, RS; Waters, NJ1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Cao, Y; De Clercq, E; Liu, X; Pannecouque, C; Wang, Y; Zhan, P1
Cecchetti, V; Daelemans, D; Manfroni, G; Massari, S; Pannecouque, C; Sabatini, S; Tabarrini, O1
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E1
Bergamini, A; Borrelli, G; Brindisi, M; Butini, S; Campiani, G; Coccone, SS; Cosconati, S; Di Mattia, M; Galletti, B; Gemma, S; Giorgi, G; Lalli, S; Maga, G; Marinelli, L; Novellino, E; Ramunno, A; Samuele, A; Zanoli, S1
Bachmann, MH; Fessel, WJ; Kagan, RM; Mitsuya, Y; Shafer, RW; Shahriar, R; Varghese, V1
Chen, YC; Dumond, JB; Fiscus, SA; Horton, AL; Kashuba, AD; Patterson, KB; Rezk, NL; Tappouni, HL; Tien, HC; Vourvahis, M; Yeh, RF1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
De Clercq, E; Fang, Z; Li, Z; Liu, X; Pannecouque, C; Zhan, P1
Clercq, ED; Fang, Z; Li, Z; Liu, X; Pannecouque, C; Zhan, P; Zhu, J1
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Bharate, SB; Bhutani, KK; Chauthe, SK; Mitra, D; Sabde, S; Singh, IP1
Fransen, S; Gupta, S; Huang, W; Paxinos, EE; Petropoulos, CJ; Stawiski, E1
Asaftei, S; De Clercq, E1
Barbault, F; Chen, CH; Huang, L; Huang, R; Jiang, S; Jiang, X; Lee, KH; Lu, H; Qian, K; Qin, B; Tian, X; Xie, L1
Azas, N; Casano, G; Dumètre, A; Hutter, S; Pannecouque, C; Robin, M1
Corbau, R; Fishburn, L; Irving, S; Knöchel, T; Martin, A; Mori, J; Mowbray, C; Panton, W; Perros, M; Phillips, C; Ringrose, H; Smith-Burchnell, C; Thornberry, A; Westby, M; Wood, A1
Engelman, A; Haim, H; Koh, Y1
Cai, QQ; He, YP; Lai, CC; Li, C; Li, DX; Long, J; Wang, H; Zhang, CS; Zhang, DH; Zhang, SS; Zheng, YT1
Bhutani, KK; Bodiwala, HS; Mitra, D; Sabde, S; Singh, IP1
Balestrieri, E; Chiacchio, MA; Ferlazzo, A; Giofrè, SV; Iannazzo, D; Macchi, B; Mastino, A; Piperno, A; Pizzimenti, F; Romeo, R1
Coltart, DM; Garnsey, MR; Kwiek, JJ; Matous, JA1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
De Clercq, E; Ge, W; Jiang, Y; Li, Z; Liu, X; Pannecouque, C; Wu, J; Zhan, P; Zhang, J1
Balzarini, J; Chen, FE; De Clercq, E; Gu, SX; He, QQ; Ma, XD; Pannecouque, C; Yang, SQ1
Chen, W; Chen, X; De Clercq, E; Li, D; Li, X; Liu, X; Pannecouque, C; Tian, Y; Zhan, P1
Balzarini, J; Chen, FE; Clercq, ED; Dai, HF; Gu, SX; He, QQ; Ma, XD; Pannecouque, C; Yang, SQ1
Balzarini, J; Chen, X; De Clercq, E; Liu, X; Pannecouque, C; Zhan, P1
Balzarini, J; Chen, FE; De Clercq, E; Gu, SX; He, QQ; Li, ZM; Ma, XD; Pannecouque, C; Yang, SQ1
Chen, X; Cheng, Z; De Clercq, E; Liu, X; Meng, C; Pannecouque, C; Shao, S; Zhan, P1
Borrell, JI; Clotet, B; Esté, JA; Giménez, L; Gonzalo, E; Pascual, R; Pettersson, S; Puig-de-la-Bellacasa, R; Teixidó, J1
Brancale, A; Clotet, B; Coluccia, A; Cosconati, S; Esté, JA; Famiglini, V; Gonzalez, E; La Regina, G; Maga, G; Novellino, E; Piscitelli, F; Samuele, A; Schols, D; Silvestri, R1
Balzarini, J; Chen, X; De Clercq, E; Li, D; Li, X; Liu, H; Liu, X; Pannecouque, C; Wang, L; Zhan, P1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Chen, W; Chen, X; De Clercq, E; Li, X; Li, Z; Liu, X; Pannecouque, C; Tian, Y; Zhan, P1
Chen, W; Chen, X; Clercq, ED; Li, X; Li, Z; Liu, X; Pannecouque, C; Tian, Y; Zhan, P1
Briñón, MC; Daelemans, D; Dehaen, W; Leen, V; Madrid, M; Pannecouque, C; Ribone, SR1
Akkarawongsapat, R; Jariyawat, S; Kasisit, J; Kongkum, N; Napaswad, C; Piyachaturawat, P; Pohmakotr, M; Reutrakul, V; Suksen, K; Tuchinda, P1
Chen, FE; Daelemans, D; De Clercq, E; Liu, Y; Ma, XD; Pannecouque, C; Yang, S1
Asada, E; Baba, M; Demizu, Y; Hamasaki, T; Irie, K; Iwai, M; Kato, Y; Kurihara, M; Maruyama, T; Sakakibara, N1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Balzarini, J; Chen, FE; Chen, WX; Daelemans, D; De Clercq, E; He, QQ; Pannecouque, C; Wu, HQ; Yan, ZH1
Balzarini, J; Chen, X; De Clercq, E; Li, Z; Liu, H; Liu, X; Pannecouque, C; Xie, Z; Zhan, P; Zhang, L; Zhao, T1
Ba, M; Gu, Q; Guo, Y; Li, D; Li, G; Li, L; Ma, X; Zhu, T1
De Clercq, E; Li, Z; Liu, H; Liu, X; Pannecouque, C; Wang, J; Zhan, P1
Chen, FE; Chen, WX; De Clercq, E; He, QQ; Huang, XY; Pannecouque, C; Wu, HQ; Yan, ZH1
Badia, R; Brancale, A; Cirilli, R; Clotet, B; Coluccia, A; Crespan, E; Esté, JA; Famiglini, V; La Regina, G; Maga, G; Novellino, E; Pelliccia, S; Silvestri, R1
Chen, FE; Chen, WX; De Clercq, E; He, QQ; Pannecouque, C; Piao, HR; Wu, HQ; Wu, Y; Yan, ZH1
Collu, G; Giliberti, G; La Colla, P; Loddo, R; Loksha, YM; Pedersen, EB; Sanna, G1
Costa, J; Dumontet, V; Leyssen, P; Litaudon, M; Neyts, J; Nothias-Scaglia, LF; Pannecouque, C; Paolini, J; Retailleau, P; Roussi, F1
Balzarini, J; Chen, F; Chen, W; De Clercq, E; Liu, Y; Meng, G; Pannecouque, C; Zheng, A1
Ba, M; Cao, Y; Guo, C; Guo, Y; He, R; Li, Z; Liang, Y; Tang, C; Xu, Z; Yang, Y; Zhang, X; Zhou, H; Zhu, L1
Chen, W; De Clercq, E; Liu, X; Liu, Z; Pannecouque, C; Zhan, P1
Chen, FE; Chen, WX; Daelemans, D; De Clercq, E; He, QQ; Pannecouque, C; Wu, HQ; Yao, J1
Balzarini, J; Chen, W; De Clercq, E; Fu, L; Huang, B; Li, C; Liu, H; Liu, T; Liu, X; Pannecouque, C; Sun, Y; Yu, M; Zhan, P1
Ashok, P; Balzarini, J; Chander, S; Murugesan, S; Pannecouque, C1
Chen, W; De Clercq, E; Fu, L; Huang, B; Li, C; Li, X; Liang, X; Liu, H; Liu, T; Liu, X; Pannecouque, C; Sun, Y; Zhan, P1
Chen, FE; Chen, WX; Daelemans, D; De Clercq, E; He, QQ; Mao, TQ; Pannecouque, C; Tang, GF; Wan, ZY1
Girard-Valenciennes, E; Grondin, I; Leyssen, P; Litaudon, M; Neyts, J; Olivon, F; Palenzuela, H; Pannecouque, C; Roussi, F1
Bagnoli, L; Desantis, J; Iraci, N; Marini, F; Mariotti, A; Pannecouque, C; Sancineto, L; Santi, C; Tabarrini, O1
Chen, W; Daelemans, D; De Clercq, E; Huang, B; Kang, D; Li, X; Liu, X; Liu, Z; Lu, X; Pannecouque, C; Yang, J; Zhan, P1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Chen, X; Daelemans, D; De Clercq, E; Huang, B; Kang, D; Li, W; Liu, X; Meng, Q; Pannecouque, C; Zhan, P1
Bhatt, HG; Pannecouque, C; Patel, BD; Patel, SB1
Chizhov, AO; Geisman, AN; Khandazhinskaya, AL; Kochetkov, SN; Naesens, L; Novikov, MS; Ozerov, AA; Pannecouque, C; Seley-Radtke, KL; Valuev-Elliston, VT1
Bingöl Özakpınar, Ö; De Clercq, E; Küçükgüzel, İ; Kulabaş, N; Özsavcı, D; Pannecouque, C; Tatar, E1
Buckheit, RW; Cushman, M; Hartman, TL; Hoshi, A; Okazaki, M; Pannecouque, C; Sakamoto, T; Takayama, J; Xuan, M1
Chen, W; Daelemans, D; De Clercq, E; Huang, B; Liu, X; Pannecouque, C; Yang, J; Zhan, P1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y1
Daelemans, D; De Clercq, E; Ding, X; Fang, Z; Huang, B; Kang, D; Li, Z; Liu, X; Lu, X; Pannecouque, C; Xu, H; Zhan, P; Zhang, H; Zhou, Z1
Al-Masoudi, NA; Hamdy, AM; Hering-Junghans, C; Khaddour, Z; Langer, P; Rahman, Q; Villinger, A1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
De Clercq, E; Huo, Z; Kang, D; Liu, H; Liu, X; Pannecouque, C; Tian, Y; Zhan, P; Zhang, H; Zhou, Z1
Altieri, A; Belov, DS; Curreli, F; Debnath, AK; Kurkin, AV; Kwon, YD; Kwong, PD; Ramesh, RR1
Gu, SX; Ju, XL; Li, TT; Lu, HH; Pannecouque, C; Xiao, T; Xue, P; Zhang, X; Zheng, XJ; Zhu, YY1
Gu, SX; Ju, XL; Liu, GY; Lu, HH; Pannecouque, C; Xue, P; Zhang, XL; Zheng, XJ; Zhu, YY1
Cai, Z; Cosford, NDP; Heil, ML; Mattmann, ME; Pagano, N; Snyder, BA; Teriete, P; Yang, L1
Daelemans, D; De Clercq, E; Ding, X; Fang, Z; Huang, B; Huo, Z; Kang, D; Liu, X; Lu, X; Meng, Q; Pannecouque, C; Tian, Y; Wu, G; Xu, H; Yu, Z; Zhan, P; Zhang, H; Zhou, Z1
Cuong, NM; Fong, HHS; Guan, YF; Li, WF; Liu, KL; Nguyen, VH; Rong, L; Rumschlag-Booms, E; Soejarto, DD; Wang, DY; Zhang, HJ1
Badia, R; Brambilla, A; Brancale, A; Catalano, M; Cirilli, R; Coluccia, A; Crespan, E; Esté, JA; Famiglini, V; Formica, FR; La Regina, G; Limatola, C; Maga, G; Masci, D; Novellino, E; Riveira-Muñoz, E; Silvestri, R1
Daelemans, D; De Clercq, E; Huang, B; Kang, D; Liu, J; Liu, X; Liu, Z; Pannecouque, C; Tian, Y; Zhan, P1
Daelemans, D; De Clercq, E; Ding, X; Feng, D; Huo, Z; Kang, D; Liu, X; Pannecouque, C; Tian, Y; Wang, Z; Wu, G; Zhan, P; Zhao, T; Zhou, Z1
Chen, F; De Clercq, E; Jin, K; Meng, G; Pannecouque, C; Yin, H1
Daelemans, D; De Clercq, E; Gao, P; Kang, D; Liu, X; Lu, X; Pannecouque, C; Yang, J; Zhan, P1
Chen, CH; Daelemans, D; De Clercq, E; Huang, B; Kang, D; Lee, KH; Liu, J; Liu, X; Liu, Z; Pannecouque, C; Tian, Y; Zhan, P; Zhang, H1
Daelemans, D; De Clercq, E; Desta, S; Ding, X; Huo, Z; Jing, L; Kang, D; Liu, X; Pannecouque, C; Wang, Z; Wu, G; Zhan, P; Zhang, H; Zhou, Z; Zuo, X1
Clercq, E; Daelemans, D; Ding, X; Feng, D; Guma, S; Huang, B; Huo, Z; Jing, L; Kang, D; Liu, X; Luo, W; Pannecouque, C; Wang, Z; Wu, G; Zhan, P; Zhang, H; Zhang, J; Zhao, T; Zhou, Z; Zuo, X1
Byrareddy, SN; Kongsted, J; Kramer, VG; Kurup, S; Liu, X; Namasivayam, V; Vanangamudi, M; Zhan, P1
Abadi, LF; Bhutani, KK; Desai, D; Gaikwad, S; Gupta, S; Kulkarni, S; Kumar, S; Singh, IP1
Bal, C; Mitra, A; Mitra, D; Parveen, A; Rozy, F; Sharon, A; Trivedi, J1
Chen, FE; Gu, SX; Liu, GY; Meng, G; Pannecouque, C; Tang, JF; Wu, FS; Xiao, T; Xu, ZQ; Zhu, YY1
Armijos Rivera, JI; Badia, R; Brambilla, A; Catalano, M; Cinquina, E; Coluccia, A; Crespan, E; Esté, JA; Falasca, F; La Regina, G; Limatola, C; Maga, G; Masci, D; Nalli, M; Riveira-Muñoz, E; Silvestri, R; Turriziani, O1
Cherukupalli, S; De Clercq, E; Feng, D; Fu, Z; Jiang, X; Kang, D; Liu, X; Pannecouque, C; Wang, Z; Zhan, P1
De Clercq, E; Huang, B; Jiang, X; Kang, D; Li, J; Liu, X; Olotu, FA; Pannecouque, C; Soliman, MES; Wang, Z; Zhan, P1
Chen, CH; De Clercq, E; Feng, D; Jing, L; Kang, D; Lee, KH; Lin, H; Liu, X; Olotu, FA; Pannecouque, C; Soliman, M; Zhan, P; Zuo, X1
De Clercq, E; Gao, P; Liu, X; Pannecouque, C; Song, S; Sun, L; Wang, Z; Zhan, P; Zhang, J1
Cherukupalli, S; De Clercq, E; Fu, Z; Gao, S; Kang, D; Liu, X; Pannecouque, C; Sun, L; Zhan, P; Zhang, T; Zhou, Z1
Chen, FE; De Clercq, E; Jin, X; Pannecouque, C; Piao, HR; Zhuang, C1
Cheng, Y; De Clercq, E; Gao, P; Gao, S; Kang, D; Liu, X; Pannecouque, C; Song, L; Song, S; Sun, L; Xu, S; Zhan, P; Zhao, F1
Chen, FE; Clercq, E; Hao, QQ; Ling, X; Pannecouque, C1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Larder, BA1
Cheng, YC; Dutschman, GE; Im, GJ; Mellors, JW; Tramontano, E; Winkler, SR1
Cheng, YC; Tramontano, E1
Chou, TC; Eckner, RJ; Merluzzi, VJ; Richman, D; Rosenthal, AS; Sabo, JP; Skoog, M1
Barringer, K; Cheeseman, S; Corbeil, J; Havlir, D; Ignacio, C; Looney, D; Pauletti, D; Richman, DD; Spector, SA; Sullivan, J1
Connell, EV; Hsu, MC; Richman, DD1
Boone, LR; Borroto-Esoda, K1
Bakhanashvili, M; Boyer, PL; Hizi, A; Hughes, SH; Loya, S; Tal, R1
Cheeseman, SH; Greenough, TC; Hall, D; Hattox, SE; Havlir, D; McLaughlin, MM; Myers, M; Spector, SA; Stein, DS; Sullivan, JL1
López-Galíndez, C; Nájera, I; Nájera, R; Olivares, I; Peinado, MA; Perucho, M; Richman, DD; Rojas, JM1
Chavan, SJ; Prochaska, HJ1
Bader, JP; Boyer, PL; Buckheit, RW; Chu, SH; Fliakas-Boltz, V; Hughes, SH; Mayers, DL; Pan, BC; Weislow, O; Yeagy-Bargo, S1
Brennan, TM; Bridges, CG; Leyda, JP; Taylor, DL; Tyms, AS1
Barry, DW; Pennington, KN; Rooney, J; St Clair, MH1
Bechtel, LJ; Chow, YK; D'Aquila, RT; Eron, JJ; Hirsch, MS; Kaplan, JC; Merrill, DP1
Rennie, J1
Cohen, J3
Kellam, P; Kemp, SD; Larder, BA1
Brewster, F; Grob, P; Koup, RA; Sullivan, JL1
Richman, DD1
Boucher, CA; de Jong, MD; Hall, D; Imrie, A; Kauffmann, RH; Koster, R; Loewenthal, M; Schipper, P; van der Ende, I; Weigel, HM1
Jäger, H1
Arts, EJ; Gu, Z; Li, Z; Quan, Y; Wainberg, MA1
Basgoz, N; D'Aquila, RT; Fischl, MA; Hirsch, MS; Hughes, MD; Johnson, VA; Liou, SH; Myers, M; Niu, M; Sommadossi, JP; Timpone, J1
Gu, Z; Li, X; Parniak, MA; Quan, Y; Wainberg, MA1
Chou, TC; Polsky, B; Scarborough, A; Zhu, QY1
Boucher, CA; Carr, A; Cooper, DA; de Jong, MD; Imrie, A; Sorice, F; Vella, S1
Baba, M; Makino, M; Nakade, K; Okamoto, M; Yamada, K; Yuasa, S1
Anderson, B; Farley, M; Fox, C; Luzuriaga, K; Mueller, BU; Pizzo, PA; Schwartzentruber, DJ; Sei, S; Sullivan, JL; Tudor-Williams, G; Venzon, DJ1
Canon, J; Chen, IS; Krogstad, P; Rey, O1
Charpiot, B; Datema, R; Hincenbergs, M; Kaneshima, H; Linquist, V; McCune, JM; Moreno, MB; Rabin, L; Seifert, J; Warren, S1
Baba, M; Hashimoto, KI; Okamoto, M; Shigeta, S; Tsunoda, R1
Hirschel, B; Rutschmann, O1
Corbeil, J; Gervaix, A; Leoni, LM; Richman, DD; West, D; Wong-Staal, F1
Iversen, AK; Merigan, TC; Shafer, RW; Winters, MA1
Bryson, Y; Cort, S; Krogstad, P; Lamson, M; Luzuriaga, K; Robinson, J; Stechenberg, B; Sullivan, JL1
Beveridge, A; Cooper, DA; Genn, W; Imrie, A; Vizzard, J1
Basgoz, N; Bremer, JW; D'Aquila, RT; Elbeik, T; Erice, A; Fischl, MA; Hirsch, MS; Hughes, MD; Johnson, VA; Kuritzkes, DR; Scott, WA; Spector, SA1
Eisen, JA; Katzenstein, DA; Merigan, TC; Shafer, RW1
Collins, DO; Sakamoto, A1
Boucher, CA; de Boer, RJ; de Jong, MD; de Wolf, F; Foudraine, NA; Goudsmit, J; Lange, JM1
Danner, SA; de Jong, MD; Koot, M; Lange, JM; Miedema, F; Pakker, NG; Reiss, P; Roos, MT; Schellekens, PT; van Leeuwen, R1
Alaeus, A; Albert, J; Cox, S; Palmer, S1
Gómez-Cano, M; Soriano, V1
Balzarini, J; De Clercq, E; Kleim, JP; Pelemans, H; Riess, G; Roesner, M; Winkler, I1
Arranz, ME; Balzarini, J; De Clercq, E; Declercq, R; Desmyter, J; Diaz, JA; Esnouf, R; Ingate, ST; Jonckheere, H; Pannecouque, C; Schmit, JC; Van Meervelt, L; Vandamme, AM; Vega, S; Witvrouw, M1
Conway, B; Cooper, D; Hall, D; Harris, M; Lange, JM; Montaner, JS; Myers, M; Reiss, P; Robinson, P; Smith, D; Vella, S; Wainberg, MA1
Amacker, M; Hübscher, U1
Conway, B; Cooper, D; Dohnanyi, C; Hall, DB; Lange, J; Montaner, JG; Myers, M; Reiss, P; Vella, S1
Chen, IS; Grovit-Ferbas, K; Poon, B; Stewart, SA1
Danner, SA; de Wolf, F; Goudsmit, J; Hoetelmans, RM; Jurriaans, S; Lange, JM; Lukashov, VV; Notermans, DW; Prins, JM; Roos, M; Schuitemaker, H; Weverling, GJ1
Harrigan, PR; Harris, M; Mo, T; Montaner, JS1
Conway, B; Cooper, D; Hall, D; Harris, M; Lange, J; Montaner, JS; Myers, M; Raboud, JM; Rae, S; Reiss, P; Robinson, P; Vella, S; Wainberg, MA2
Saag, MS; Schooley, RT1
Chan, KC; Ho, TT; Lee, SS; Wong, KH1
Balfour, HH; Erice, A; Fischl, MA; Henry, K; Hirsch, MS; Kahn, JO; Kenton, A; Kmack, A; Liou, SH; Martinez, A; Phair, J; Tierney, C1
Brew, BJ; Markus, R1
D'Aquila, RT; Fischl, MA; Hirsch, MS; Hughes, MD; Johnson, VA; Myers, M; Sheiner, LB; Sommadossi, JP; Zhou, XJ1
Clay, PG; Rathbun, RC; Slater, LN1
Haubrich, R; Richman, D1
Amacker, M; Faraj, A; Gosselin, G; Hübscher, U; Imbach, JL; Maga, G; Mathé, C; Sommadossi, JP; Spadari, S1
Alberici, F; Andreotti, M; Bucciardini, R; Cargnel, A; De Rienzo, B; Fiaccadori, F; Floridia, M; Fragola, V; Francisci, D; Galluzzo, CM; Giannini, G; Grillone, W; Leoncini, F; Nigra, E; Ortona, L; Piazza, M; Pirillo, MF; Ricciardulli, D; Scalzini, A; Tomino, C; Tumietto, F; Vella, S; Weimer, LE1
Amacker, M; Hübscher, U; Tasara, T1
Bazmi, HZ; La Colla, P; Mellors, JW; Piras, G; Putzolu, M; Tramontano, E1
Baba, M; Okamoto, M; Okamoto, T1
Claessen, FA; Hall, D; Hamann, D; Kauffmann, RH; Koopmans, PP; Kroon, ED; Kroon, FP; Lange, JM; Miedema, F; Montaner, JS; Otto, SA; Pakker, NG; Reiss, P; Roos, MT; Schellekens, PT; Sprenger, HG; ten Napel, CH; van der Ende, ME; Weigel, HM; Wit, FW1
Liang, C; Quan, Y; Rong, L; Wainberg, MA1
Brown, AJ; D'Aquila, RT; Günthard, HF; Johnson, VA; Kuritzkes, DR; Richman, DD; Wong, JK1
Allen, M; Bagenda, D; Bakaki, P; Bray, D; Deseyve, M; Dransfield, K; Ducar, C; Emel, L; Fleming, T; Fowler, MG; Guay, LA; Jackson, JB; Miotti, P; Mirochnick, M; Mmiro, F; Mofenson, L; Musoke, P; Nakabiito, C; Sherman, J1
Simonds, RJ1
Lurie, P; Wolfe, SM1
Cherry, M2
Temesgen, Z; Wright, AJ1
Simon-Meyer, J1
D'Aquila, RT; Günthard, HF; Johnson, VA; Kuritzkes, DR; Leigh Brown, AJ; Precious, HM; Richman, DD; Wong, JK1
Arens, M; Heyden, NA; Pirounaki, M; Ratner, L1
Brown, AJ; D'Aquila, RT; Hanna, GJ; Hazelwood, JD; Johnson, VA; Kuritzkes, DR; Richman, DD; Savara, AV1
Howse, J1
Bucciardini, R; Fragola, V; Harrigan, PR; Montaner, JS; Raboud, JM; Rae, S; Ricciardulli, D; Vella, S1
Butler, KM; Clarke, SM; Condon, S; Healy, CM; Mulcahy, F1
Allende, MC; Belloso, WH; Benetucci, JA; Cahn, PE; Davey, RT; Emery, S; Lane, HC; Lasala, MC; Law, MG; Lopardo, G; Losso, MH; Nelson, E; Salomon, H; Saracco, M1
King, P; Masland, T1
Burger, DM; Hoetelmans, RM; Jurriaans, S; Lange, JM; Portegies, P; Prins, JM; Sommadossi, JP; Turner-Foisy, ML; van Praag, RM; Weverling, GJ; Zhou, XJ1
Hayashi, T1
Ahmed, PS; Bedard, J; Bowlin, TL; Chambers, P; Clarke, J; Kelly, LA; Rando, RF; Taylor, DL; Tyms, AS; Wood, LJ1
Andreotti, M; Binelli, A; Bucciardini, R; Floridia, M; Fragola, V; Galluzzo, MC; Giannini, G; Pirillo, MF; Ricciardulli, D; Tomino, C; Vella, S; Weimer, LE1
Chen, F; Pau, AK; Piscitelli, SC1
Cooper, PA; Gray, GE; Jivkov, BI; Lala, SG; Schorn, MC1
Badia, X; Benavides, A; Coma, A; López Lavid, C; Pinto, JL1
Bower, M; Gazzard, BG; Mandalia, S; Matthews, GV; Moyle, GJ; Nelson, M1
Escolano, C; Gregori, J; Gutiérrez, F; Moltó, J; Mora, A; Nogueira, E; Pasquau, F1
Andreotti, M; Bucciardini, R; Floridia, M; Fragola, V; Galluzzo, CM; Giannini, G; Marzi, M; Massella, M; Mirra, M; Pirillo, MF; Ricciardulli, D; Tomino, C; Vella, S; Weimer, LE; Wu, AW1
Mirochnick, M1
Fernandez, AD; McNeeley, DF1
Genka, I; Kikuchi, Y; Oka, S; Tachikawa, N; Teruya, K; Yamamoto, Y; Yasuoka, A; Yasuoka, C1
Babaki, P; Barré-Sinoussi, F; Charpak, N; de Thé, G; Dovie Akue, JP; Ferreira Rea, M; Huraux, C; Ndiaye, B; Pratomo, H; Samuel, NM; Wilfert, C; Zetterström, R1
Gosselin, G; Hübscher, U; Maga, G; Pregnolato, M; Spadari, S; Ubiali, D1
Gilden, D1
Benson, M; Shannon, M1
James, JS1
Mascolini, M1
Bowersox, J1
Doepel, L; Folkers, G1
MacDougall, DS2
Landry, S1
Wool, M1
Kasper, T1
Sax, PE1
Lindsay, MK1
Beijnen, JH; Cooper, DA; Hall, D; Hoetelmans, RM; Lange, JM; Montaner, JS; Reiss, P; Veldkamp, AI; Vella, S; Weverling, GJ1
Conway, B; Cooper, D; Curry, R; Hall, D; Harris, M; Lange, JM; Montaner, JS; Reiss, P; Robinson, P; Vella, S; Wainberg, MA1
Newell, ML1
Goldenberg, RL; Rouse, DJ; Sinkala, M; Stringer, JS; Vermund, SH1
Brocklehurst, P; Volmink, J2
Hudson, CP; Moodley, J; Smith, AN1
Broadhead, R; Fiscus, S; Gibbons, A; Hoover, D; Kumwenda, N; Lema, V; Liomba, G; Mukiibi, J; Taha, TE1
Delfraissy, JF; Glaziou, P; Kruy, LS; Leng, C; Min, DC; Rekacewicz, C; Saman, M1
de Wolf, F; Jurriaans, S; Lange, JM; Prins, JM; van Praag, RM; Wit, FW1
Nattrass, N; Skordis, J1
Fan, B; Stewart, JT2
Brenner, B; Detorio, M; Loemba, H; Ma'ayan, S; Moisi, D; Oliveira, M; Parniak, MA; Spira, B; Wainberg, MA1
Marchei, E; Pacifici, R; Pellegrini, M; Tossini, G; Valvo, L; Zuccaro, P1
Anderson, JR1
Flexner, C; Gandhi, R1
Gallant, JE1
Aranda, M; Badía, X; Barrufet, P; Cahn, P; Casado, A; Casiró, A; Consiglio, E; Estela, J; Ferrer, E; Gatell, JM; González, A; Llibre, JM; Lozano, L; Luna, E; Lupo, S; Maños, M; Martínez-Lacasa, J; Miró, JM; Ocaña, I; Pedrol, E; Perez, JL; Perez, P; Podzamczer, D1
Volmink, J2
Nachega, J1
Mandel, L; Surattanont, F1
Becker-Pergola, G; Eshleman, SH; Fleming, T; Guay, LA; Jackson, JB; Mmiro, F; Mracna, M; Musoke, P; Mwatha, A1
Almond, LM; Back, DJ; De Vries, C; Gould, J; Hoggard, PG; Kewn, S; Khoo, SH; Lou, Y; Maherbe, A; Sales, SD; Wood, R1
John-Stewart, GC; Kiarie, JN; Kreiss, JK; Richardson, BA1
Klosinski, L1
Baldanti, F; Galloni, D; Gerna, G; Lilleri, D; Piccinini, G; Seminari, E1
Boshoff, L; Coovadia, H; Gigliotti, M; Gray, G; Hall, D; Hofmyer, J; McIntyre, J; Moodley, D; Moodley, J; Nikodem, C; Robinson, P; Sullivan, JL1
Arnedo, M; Barberá, MJ; Ferrer, E; Fumero, E; Gatell, JM; Gudiol, F; McKenna, P; Pérez, JL; Podzamczer, D; Pumarola, T; Rinehart, A1
Baldanti, F; Blanca, G; Gerna, G; Hübscher, U; Maga, G; Paolucci, S; Skoblov, AY; Spadari, S; Victorova, L1
Everall, IP; Foster, R; Olajide, D1
Oka, S; Teruya, K1
Kahn, JG; Marseille, E1
Meldrum, J1
Das, P1
Avila-Figueroa, C; Bertozzi, SM; Guijarro, MT; Rely, K1
Andréola, M; Cruchaga, C; Dollé, V; Martínez-Irujo, JJ; Nguyen, CH; Odriozola, L; Pérez-Mediavilla, A; Tarrago-Litvak, L1
Bruun, JN1
Allen, M; Bagenda, D; Bakaki, P; Bray, D; Deseyve, M; Ducar, C; Duefield, C; Emel, L; Fleming, T; Fowler, MG; Gigliotti, M; Guay, LA; Jackson, JB; Miotti, P; Mirochnick, M; Mmiro, F; Mofenson, L; Musoke, P; Mwatha, A; Nakabiito, C; Owor, M; Sherman, J1
Bertolli, J; Hu, DJ; Macalalad, A; Nieburg, P; Simonds, RJ1
Broadhead, RL; Fiscus, S; Gibbons, A; Hoover, DR; Kumwenda, NI; Lema, V; Liomba, G; Miotti, PG; Nkhoma, C; Taha, TE1
Bethel, J; Fowler, MG; Harris, DR; Lambert, JS; Meyer, WA; Mofenson, LM; Moye, J; Stiehm, ER1
Danner, SA; Gruzdev, B; Jurriaans, S; Lange, JM; Peeters, M; Prins, JM; Rakhmanova, A; Sankatsing, SU; van't Klooster, G; Weverling, GJ1
Jackson, B; Mmiro, F1
Boyle, BA1
Gerntholtz, L1
Garry, RF; Jaspan, HB1
Smart, T1
Barberá, MJ; Barceló, JJ; Ferrer, E; Gallart, T; García, A; García, F; Gatell, JM; Lacarcel, M; Maleno, MJ; Martínez, C; Miró, JM; Plana, M; Podzamczer, D1
Becquet, R; Bequet, L; Dabis, F; Ekouevi, DK; Inwoley, A; Leroy, V; Rouet, F; Tonwe-Gold, B; Viho, I1
Beliaeva, VV; Bogoslovskaia, EV; Kravchenko, AV; Miroshnichenko, AV; Serebrovskaia, LV; Sitdykova, IuR1
Coovadia, H1
Jourdain, G; Kanshana, S; Koetsawang, S; Lallemant, M; Le Coeur, S; Mary, JY; McIntosh, K; Ngo-Giang-Huong, N; Thaineua, V1
Ariyadej, S; Bowonwatanuwong, C; Hammer, S; Jourdain, G; Kantipong, P; Lallemant, M; Le Coeur, S; Leechanachai, P; Leenasirimakul, P; Ngo-Giang-Huong, N1
Broadhead, RL; Chen, S; Fiscus, SA; Hoover, DR; Kafulafula, G; Kumwenda, NI; Liomba, G; Miotti, PG; Nkhoma, C; Nour, S; Taha, TE1
Beckerman, K; Chavers, S; Covington, DL; Dominguez, K; Garcia, P; Ross, B; Sacks, S; Scheuerle, A; Tilson, H; Watts, DH1
Herzmann, C; Karcher, H1
Feinberg, J1
Gerber, JG; Wyles, DL1
Byrne, CM; Coughlan, S; Hall, WW; Hopkins, SM; Lyons, FE; Mulcahy, FM1
Alexander, G; Christie, CD; Figueroa, JP; Harvey, KM; Johnson, N; McDonald, D; Mullings, AA; Palmer, P; Smikle, MF; Whorms, S; Williams, E1
Christie, CD; Evans-Gilbert, T; Figueroa, JP; Hambleton, I; Palmer, P; Pierre, R; Rodriquez, B; Smikle, MF; Steel-Duncan, JC; Whorms, S1
Hudson, CP1
Musoke, P1
Arts, EJ; Asiimwe, S; Bajunirwe, F; Kamya, MR; Massaquoi, I; Whalen, CC1
Becquet, R; Bequet, L; Dabis, F; Dequae-Merchadou, L; Ekouevi, DK; Fassinou, P; Horo, A; Leroy, V; Rouet, F; Rouzioux, C; Sakarovitch, C; Viho, I; Welffens-Ekra, C1
Broadhead, R; Chen, S; Chitale, R; Hoover, D; Kafulafula, G; Katundu, P; Kumwenda, J; Kumwenda, N; Mukiibi, J; Nkhoma, C; Taha, TE1
Capparelli, E; Cressey, TR; Jackson, JB; Jourdain, G; Kunkeaw, S; Lallemant, MJ; Mirochnick, M; Musoke, P1
Andréola, M; Cruchaga, C; Martínez-Irujo, JJ; Odriozola, L; Tarrago-Litvak, L1
Fleming, T; Jackson, B1
Andrieux-Meyer, I; Bourgeois, A; Calmy, A; Ciaffi, L; Delaporte, E; Lactuock, B; Laurent, C; Liégeois, F; Mougnutou, R; Mpoudi-Ngolé, E; Nkoué, N; Zekeng, L1
Qazi, S; Uckun, FM; Venkatachalam, TK1
Baker, SG; Fitzmaurice, GM; Freedman, LS; Kramer, BS1
Bonjoch, A; Clotet, B; De la Torre, J; Galvez, J; Martínez, E; Miralles, C; Miranda, J; Muñoz-Moreno, JA; Paredes, R; Prieto, A; Videla, S; Vilades, C1
Bolton, C; Chersich, MF; Gray, GE; McIntyre, JA; Stevens, W; Urban, M; van Niekerk, R; Violari, A1
Capparelli, E; Connor, JD; Essex, M; Holland, DT; Lockman, S; Mirochnick, M; Peter, T; Shapiro, RL; Stevens, L; Thior, I; Wester, C1
Chung, MH; John-Stewart, GC; Kiarie, JN; Lehman, DA; Overbaugh, J; Richardson, BA1
Mahlat, U; Volmink, J1
Eley, B1
Abdullah, F; Boulle, A; Coetzee, D; Draper, B; Goemaere, E; Hilderbrand, K1
Brown, CR; Hong-Brown, LQ; Lang, CH1
Billaud, E; Bugnon, F; Cua, E; Cuzin, L; Dellamonica, P; Delpierre, C; Massip, P; Pugliese, P; Raffi, F1
Nolan, D1
Girault, V1
Galeano, V; Galli, A; Gutiérrez, S; Lioni, M; Maturo, M; Quian, J; Serra, M; Visconti, A1
Balfour, HH; Brundage, RC; Cavert, W; Fox, K; Henry, K; Kurpad, AV; Raj, TD; Ravindran, GD; Vezina, HE; Weller, D1
Averitt, D; Kumar, PN; Pakes, GE; Pappa, KA; Rodriguez-French, A; Shaefer, MS; Tashima, KT; Thompson, MA; Wannamaker, PG; Williams, VC1
Chen, S; Eshleman, SH; Fiscus, SA; Hoover, DR; Hudelson, SE; Jackson, JB; Kumwenda, NI; Piwowar-Manning, E; Taha, TE1
Bequet, L; Chaix, ML; Dabis, F; Ekouevi, DK; Leroy, V; Menan, H; Peytavin, G; Rouet, F; Rouzioux, C; Tonwe-Gold, B; Toure, H; Viho, I1
Greiner, T1
Alexander, L; Collins, JA; Margolis, A; Paintsil, E1
Koh, MT1
Eilers, E; Feiterna-Sperling, C; Obladen, M; Schmitz, T; Weizsaecker, K1
Besser, M; Bulterys, M; Fowler, MG; Sansom, S; Soorapanth, S; Theron, G1
Hemanthkumar, AK; Kumaraswami, V; Ramachandran, G; Swaminathan, S1
Essex, M; Gaseitsiwe, S; Gilbert, PB; Heymann, SJ; Lagakos, S; Lockman, S; Makhema, J; Ndung'u, T; Novitsky, V; Shapiro, RL; Smeaton, LM; Stevens, L; Thior, I; Wester, C1
Acheampong, E; Argyris, EG; Dornadula, G; Mehlman, K; Nunnari, G; Pomerantz, RJ; Zhang, C; Zhang, H1
Dabis, F; Nightingale, S1
Arimi, P; Essex, M; Gilbert, PB; Heymann, SJ; Kebaabetswe, P; Kim, S; Lagakos, S; Lee, TH; Lockman, S; Makhema, J; Marlink, R; Mazonde, P; McIntosh, K; Moffat, C; Ndase, P; Novitsky, V; Peter, T; Shapiro, RL; Smeaton, LM; Stevens, L; Thior, I; van Widenfelt, E; Wester, C1
de Bethune, MP; Figueiredo, A; Mak, J; Moore, KL; Sluis-Cremer, N; Tachedjian, G1
Arbess, G; Boyle, E; Chipato, T; Chitsike, I; Glazier, RH; Gottesman, M; Pilon, R; Silverman, M; Simor, A; Spitzer, RF; Thistle, P1
Andreotti, M; Ceffa, S; Cusato, M; Germano, P; Giuliano, M; Guidotti, G; Liotta, G; Loureiro, S; Mancini, MG; Marazzi, MC; Palombi, L; Pirillo, MF; Regazzi, M; Vella, S; Villani, P1
Gu, SM1
Cecelia, AJ; Kumarasamy, N; Mayer, K; Saghayam, S; Solomon, S; Wanke, C1
Arimi, P; Asmelash, A; Chand, F; Essex, M; Lagakos, S; Lockman, S; Makhema, J; Mazhani, L; Moffat, C; Ndase, P; Novitsky, V; Shapiro, RL; Smeaton, LM; Stevens, L; Thior, I; van Widenfelt, E; Wester, C1
Becquet, R; Bedikou, G; Bequet, L; Dabis, F; Ekouevi, DK; Fassinou, P; Leroy, V; Sakarovitch, C; Timite-Konan, M; Viho, I1
Brocklehurst, P; Siegfried, NL; van der Merwe, L; Volmink, J1
Niamba, P; Taïeb, A; Traoré, A1
Gibb, DM; Grosskurth, H; Khoo, S; Kikaire, B; Mugyenyi, P; Munderi, P; Namale, L; Reid, A; Ssali, F; Walker, AS1
Chi, BH; Chintu, N; Lee, A; Sinkala, M; Stringer, EM; Stringer, JS1
Ket-Aim, S; Poolsup, N; Suksomboon, N1
Bethel, J; Dharmarajan, S; Jacob, SM; Junankar, V; Parameshwari, S; Read, JS; Samuel, NM; Stoszek, SK; Van Hook, HM; Xu, J1
Broadhead, RL; Chen, S; Fiscus, SA; Hoover, DR; Jackson, JB; Kafulafula, G; Kumwenda, NI; Miotti, PG; Nkhoma, C; Piwowar, E; Taha, TE1
Abdoulaye, D; André, C; André, E; Bernard, L; Sandrine, PF; Sylvie, A1
Baldanti, F; Belfiore, A; Campanini, G; Cancio, R; Gerna, G; Maga, G; Paolucci, S1
Abdel-Megeed, MF; Kashuba, AD; Rezk, NL1
Abrams, EJ; Amani-Bosse, C; Becquet, R; Coffie, PA; Dabis, F; Ekouevi, DK; El-Sadr, WM; Leroy, V; Rouet, F; Tonwe-Gold, B; Toure, S; Viho, I1
Adile, SL; Chandrakar, AK; Garg, ML; Pandey, N; Patel, S1
Dzombo, D; Essajee, S; Jelagat, J; Mandaliya, K; Mwalimu, M; Shikely, K; Song, R1
D'costa, GF; Khadke, K; Patil, YV1
Bharucha, KE; Bhosale, R; Bollinger, RC; Gupta, A; Gupte, N; Kulkarni, P; Nayak, U; Phadke, M; Sastry, J; Tripathy, S1
Dimarco, M; Dodard, C; Guilbaud, R; Marier, JF; Monif, T; Morelli, G; Singla, AK; Thudi, NR; Tippabhotla, SK1
Fahey, J; Harrigan, PR; Kuiper, M; Lima, VD; Sheen, CW; Sluis-Cremer, N; Tachedjian, G; Tyssen, D; Wynhoven, B; Yap, SH; Zanin, M1
Götte, M1
Chhum, V; Fleury, HJ; Glaziou, P; Koum, K; Kruy, LS; Ly, N; Min, DC; Phoung, V; Reynes, JM; Srey, C1
Abrams, EJ; Becquet, R; Chaix, ML; Clarisse, AB; Coffie, PA; Dabis, F; Ekouevi, DK; Leroy, V; N'dri-Yoman, T; Rouzioux, C; Tonwe-Gold, B; Viho, I1
Arts, EJ; Bajunirwe, F; Demers, KR; Fraundorf, E; Kyeyune, F; Lalonde, MS; Mugyenyi, P; Syed, A; Troyer, RM; Whalen, CC1
Becquet, R; Dabis, F; Dequae-Merchadou, L; Ekouevi, DK; Horo, A; Leroy, V; Rouet, F; Rouzioux, C; Sakarovitch, C; Timité-Konan, M; Tonwe-Gold, B; Viho, I1
Doerries, R; Drechsler, H; Gass, A; Hardmeier, M; Kuhle, J; Mehling, M; Ruegg, S1
Bourgeois, A; Calmy, A; Ciaffi, L; Delaporte, E; Kouanfack, C; Koulla-Shiro, S; Laurent, C; Mougnutou, R; Mpoudi-Ngolé, E; Nkoué, N1
Gomutbutra, V1
Cheng, J; Han, N; Liu, YN; Liu, ZY; Wei, HS; Zhang, FJ; Zhao, HX; Zhao, Y1
Anglaret, X; Dabis, F; Dakoury-Dogbo, N; Diakite, N; Duvignac, J; Grundmann, C; Karcher, S; Kouadio, B; Marlink, R; Seyler, C; Toure, S; Traore, M1
Claassen, M; Cotton, MF; Engelbrecht, S; Laten, JD; Preiser, W; Theron, GB; van Zyl, GU1
Bulterys, M; Fowler, MG; Hoover, DR; Kafulafula, G; Kumwenda, NI; Li, Q; Mebrahtu, T; Mipando, L; Mofenson, LM; Nkanaunena, K; Taha, TE; Thigpen, MC1
Gray, GE; Saloojee, H1
Basseila, GB; Bokilo, AD; Dokekias, AE; Galiba, FO; Malanda, F; Nsitou, MB; Ntsimba, P1
Chung, MH; John-Stewart, GC; Kiarie, J; Kinuthia, J; Lehman, DA; Overbaugh, J; Richardson, BA1
Aleyamma, TK; Buck, J; Chaguturu, S; Cu-Uvin, S; Gopalakrishnan, G; Lionel, J; Mayer, K; Varghese, L1
Bae, WH; Essex, M; Lockman, S; Onyait, K; Shapiro, RL; Smeaton, LM; Thior, I; Wester, C1
Abdullah, F; Draper, B1
Abrams, EJ; Becquet, R; Blanche, S; Coffie, PA; Dabis, F; Ekouevi, DK; Horo, A; Leroy, V; Thiebaut, R; Tonwe-Gold, B1
Chung, MH; John-Stewart, GC; Kiarie, JN; Kinuthia, J; Lehman, DA; Njiri, F; Overbaugh, J; Richardson, BA1
Mills, J1
Arimi, P; Asmelash, A; Essex, M; Leidner, J; Lockman, S; Makhema, J; Moffat, C; Ndase, P; Novitsky, V; Rossenkhan, R; Shapiro, RL; Smeaton, L; Stevens, L; Thior, I; Wester, C1
Capparelli, E; Fowler, MG; Holland, D; Masaba, R; Mirochnick, M; Odhiambo, P; Thigpen, MC; Thomas, T; Weidle, PJ; Zeh, C1
George, C; Jayakumar, B; Lal, L; Yesoda, A1
Patel, AK; Patel, JA; Patel, KK; Ranjan, RR; Sharma, R; Shukla, RK1
Allavena, C; Cahn, P; Clotet, B; Côté, H; Harris, M; Montaner, J; Negredo, E; Ochoa, C; Raffi, F; Singer, J; Thorne, A; Zala, C1
Barré-Sinoussi, F; Faye, A; Gomuthbutra, V; Lallemant, M; Le Coeur, S; Leechanachai, P; Limtrakul, A; Mary, JY; Matanasaravoot, W; Menu, E; Ngo-Giang-Huong, N; Pornprasert, S; Rugpao, S; Sirivatanapa, P1
Berzins, B; Evans, S; Forand, J; Hafner, R; Murphy, R; Owens, S; Shevitz, A; Tashima, K; Tebas, P; Yarasheski, K; Zhang, J1
Fang, L; Han, J; Jiang, Y; Wang, L; Wang, Q; Yao, J; Zhang, Q1
Black, V; Guidozzi, F1
Brinkman, K; Danner, SA; Geerlings, SE; Hassink, EA; Lips, P; Reiss, P; Ristola, M; Sutinen, J; van Agtmael, MA; van Vonderen, MG1
Foster, C; Gibb, DM; Lyall, H; Olmscheid, B; Pearce, G; Zhang, S1
Chung, MH; John-Stewart, GC; Kiarie, J; Kinuthia, J; Lehman, DA; Mabuka, JM; Overbaugh, J1
Ammann, AJ1
Asavapiriyanont, S; Chalermchockcharoenkit, A; Chotpitayasunondh, T; Culnane, M; Leelawiwat, W; McConnell, MS; McNicholl, JM; Mock, PA; Tappero, JW; Teeraratkul, A; Vanprapa, N1
Agmon-Levin, N; Asher, I; Chowers, M; Cohen, Y; Elbirt, D; Gottesman, G; Gradestein, S; Levi, I; Maayan, S; Risenberg, K; Sthoeger, Z; Torten, D; Turner, D; Werner, B1
Cao, YL; Chen, H; Guo, Y; Li, SX1
Christie, CD; Evans-Gilbert, T; Moore, J; Palmer, P; Pierre, RB; Rodriguez, B; Steel-Duncan, J; White, YR1
Aizire, J; Donnell, D; Eshleman, SH; Fowler, MG; Guay, LA; Jackson, JB; Mmiro, FA; Musoke, PM; Mwatha, AK; Nakabiito, C1
Averbuch, D; Engelhard, D; Jaouni, T; Pe'er, J1
Bisseye, C; Buelli, F; Castelli, F; Gnoula, C; Ilboudo, D; Karou, D; Nikiema, JB; Odolini, S; Ouermi, D; Pietra, V; Pignatelli, S; Sagna, T; Sanou, DS; Sia, DJ; Simpore, J1
Cole, SR; Fowler, MG; Hoover, DR; Kafulafula, G; Kumwenda, J; Kumwenda, NI; Li, Q; Mofenson, L; Taha, TE; Thigpen, MC1
Fowler, MG; Hoover, DR; Kafulafula, G; Kumwenda, NI; Li, Q; Mipando, L; Mofenson, LM; Nkanaunena, K; Taha, TE; Thigpen, M1
Eklund, M; Gray, GE; Hall, DB; Hopley, M; Martinson, NA; Mayers, D; McIntyre, JA; Moodley, D; Robinson, P1
John-Stewart, GC; Lehman, DA; Overbaugh, J1
Cheng, I; Kuritzkes, DR; Paredes, R; Tuomala, RE1
Burke, A; Dunn, DT; Gibb, DM; Gilks, CF; Goodall, RL; Kaleebu, P; Katundu, P; Kityo, C; Lyagoba, F; McCormick, A; Munderi, P; Ndembi, N; Pillay, D; Robertson, V; Walker, AS; Yirrell, DL1
Amuron, B; Birungi, J; Bunnell, R; Coutinho, A; Foster, S; Grosskurth, H; Jaffar, S; Kyomuhangi, R; Levin, J; Mermin, J; Nabiryo, C; Namara, G; Ndembi, N; Opio, A; Tappero, JW1
Asahchop, EL; Brenner, BG; Moisi, D; Ntemgwa, M; Toni, TA; Wainberg, MA1
Eshleman, SH; Fowler, MG; Hoover, DR; Kafulafula, G; Kumwenda, N; Li, Q; Lidström, J; Mofenson, LM; Taha, TE; Thigpen, MC1
Essex, M; Hagan, JE; Kim, S; Lockman, S; Makhema, J; Mitchell, R; Moyo, SM; Musonda, R; Ndung'u, T; Novitsky, V; Rossenkhan, R; Sebunya, TK; Shapiro, R; Thior, I; van Widenfelt, E1
Abaine, D; Aber, M; Ahimbisibwe, F; Akao, J; Akuma, S; Amuron, B; Amurwon, J; Angweng, E; Anywar, W; Atwiine, D; Atwiine, S; Awio, P; Babiker, A; Babiker, AG; Bafana, T; Bagaya, L; Bahendeka, S; Bakeinyaga, GT; Barungi, G; Bassett, M; Bohannon, J; Boocock, K; Borok, M; Bray, D; Breckenridge, A; Bulaya-Tembo, R; Buluma, E; Burke, A; Burke, C; Byakwaga, H; Byamukama, A; Byaruhanga, R; Chakonza, L; Chidziva, E; Chigwedere, E; Chimanzi, J; Chimbetete, C; Chirairo, H; Chirara, M; Chirema, O; Chitsungo, S; Chivhunga, T; Coutinho, A; Darbyshire, JH; Drasiku, A; Dunn, D; Enzama, R; Etukoit, B; Fadhiru, K; Ferrier, A; Florence, A; Foster, S; Gazzard, B; Generous, L; Gibb, DM; Gilks, C; Gilks, CF; Goodall, R; Grosskurth, H; Grundy, C; Haguma, W; Hakim, J; Hill, C; Hughes, P; Jamu, A; Jangano, M; Jones, S; Kabanda, J; Kabuye, G; Kagina, G; Kajungu, D; Kaleebu, P; Kambungu, A; Kankunda, R; Karungi, J; Kasirye, R; Katabira, E; Katabira, H; Katundu, P; Khauka, P; Kigozi, J; Kikaire, B; Kityo, C; Komugyena, J; Kulume, R; Kusiima, A; Kyomugisha, H; Labeja, O; Lara, AM; Latif, A; Levin, J; Lubwama, E; Lutwama, F; Lyagoba, F; Machingura, I; Machingura, J; Makota, S; Mambule, I; Mapinge, F; Mapuchere, C; Massa, R; Matenga, J; Matongo, M; Maweni, C; Mawora, A; McCormick, A; McLaren, A; Mdege, N; Moyo, K; Muchabaiwa, L; Mudzingwa, S; Mufuka-Kapuya, C; Muganzi, A; Mugisha, A; Mugurungi, O; Mugyenyi, P; Muhweezi, D; Muhwezi, A; Mukiibi, S; Mukose, A; Mulindwa, G; Mulindwa, M; Munderi, P; Murungi, S; Musana, H; Musoro, G; Mutowo, J; Mutsai, S; Muvirimi, C; Muyingo, S; Muzambi, M; Mwebesa, D; Mwesigwa, P; Nabankema, E; Nabongo, P; Naidoo, B; Nairuba, R; Nakahima, W; Nakazibwe, M; Nakiyingi, J; Nalumenya, R; Namale, L; Namara, W; Namata, I; Namazzi, A; Namuli, T; Namyalo, M; Nanfuka, A; Nanfuka, R; Nassuna, G; Ndembi, N; Newland, C; Ngorima, N; Nimwesiga, E; Nsibambi, D; Nyachwo, L; Nyiraguhirwa, D; Ochai, R; Ojiambo, H; Ojiambo, W; Oketta, F; Omony, W; Otim, T; Oyugi, J; Palfreeman, A; Pascoe, M; Pearce, G; Peto, L; Peto, T; Phiri, M; Pillay, D; Pozniak, A; Puddephatt, C; Rahim, S; Rauchenberger, M; Reid, A; Robertson, V; Ronald, A; Rooney, J; Ruberantwari, A; Rutikarayo, N; Sabiiti, J; Sadik, F; Sematala, F; Serwadda, D; Sheehan, S; Simango, M; Smith, M; Snowden, W; Spencer-Drake, C; Spyer, M; Ssali, F; Steens, JM; Svovanapasis, P; Takubwa, J; Taylor, K; Taziwa, F; Tinago, G; Todd, J; Tugume, S; Tukamushaba, J; Tumukunde, D; Tumusiime, C; Twijukye, C; Vere, L; Waita, R; Wakholi, BN; Walker, AS; Walusimbi, J; Wangati, K; Wanyama, J; Wapakhabulo, AC; Warambwa, C; Warara, R; Wavamunno, P; Weller, I; Whitworth, J; Wilkes, H; Winogron, D; Yirrell, D; Zalwango, A; Zalwango, E; Zawedde, C; Zengeza, E1
Battegay, M; Bernasconi, E; Cavassini, M; Elzi, L; Furrer, H; Hirschel, B; Ledergerber, B; Marzolini, C; Vernazza, P; Weber, R1
Hou, T; Liu, JS; Wang, W; Zhang, J1
Babiker, AG; Darbyshire, JH; Gibb, DM; Gilks, CF; Grosskurth, H; Kityo, C; Mugyenyi, P; Munderi, P; Reid, A; Ssali, F; Walker, AS1
Achalapong, J; Ariyadej, S; Chotivanich, N; Collins, IJ; Cressey, TR; Frenkel, LM; Hemvuttiphan, J; Jarupanich, T; Jourdain, G; Kanchana, S; Kanjanasing, A; Kengsakul, K; Koetsawang, S; Lallemant, M; Le Coeur, S; Liampongsabuddhi, P; McIntosh, K; Ngo-Giang-Huong, N; Pornkitprasarn, W; Ratanakosol, J; Sabsanong, P; Sittipiyasakul, V; Sukhumanant, T; Traisaithit, P; Van Dyke, RB; Wannapira, W; Winiyakul, N1
Cotton, MF; Rabie, H; van Zyl, GU1
Deshpande, A; Fleury, HJ; Jeannot, AC; Pinson, P; Schrive, MH; Wittkop, L1
Asboe, D; Dunn, D; Fearnhill, E; Gazzard, B; Pillay, D; Pozniak, A; Price, H1
Butini, L; Cirioni, O; Costantini, A; Giacometti, A; Montroni, M; Scalise, G1
Aparna, P; Badarinadh Gupta, P; Mukkanti, K; Narayan, GK; Rangarao, K; Rao, SV; Sandip, T; Thomas, KM; Upendra, K1
Bryan, G; Bweupe, M; Colebunders, R; Kabaso, M; Kasonde, P; Mukonka, V; Mwale, F; Torpey, K; Weaver, MA; Zimba, C1
Ahmed, YI; Chasela, CS; Chigwenembe, M; Ellington, SR; Fiscus, SA; Hoffman, IF; Hosseinipour, MC; Hudgens, MG; Jamieson, DJ; Kacheche, Z; Kamwendo, DD; Kayira, D; Kazembe, P; Knight, RJ; Kourtis, AP; Martinson, F; Mofolo, IA; Sichali, DS; Soko, A; Tegha, G; van der Horst, CM; Wiener, JB1
Akhtar, M; Asmelash, A; Essex, M; Handelsman, E; Hughes, MD; Jayeoba, O; Kitch, D; Leidner, J; Lockman, S; Lubega, E; Makhema, J; Martinez-Tristani, M; Mazhani, L; Mburu, K; McIntosh, K; Moffat, C; Moko, E; Moyo, S; Ogwu, A; Powis, K; Shapiro, RL; Sharma, U; Snowden, W; Souda, S; Thior, I; Tumbare, E; Tuomola, R; van Widenfelt, E; Wester, C; Zwerski, S1
Cisse, M; Doulougou, B; Kouanda, S; Ouedraogo, CM; Ouedraogo, G; Pietra, V; Simpore, J; Sondo, B; Soudre, R; Tougri, H1
Banda, HN; Chasela, C; Eron, JJ; Farr, SL; Fiscus, SA; Jamieson, DJ; Johnson, JA; Kashuba, AD; Kourtis, AP; Lipscomb, J; Matiki, C; Mpaso, M; Nelson, JA; Ng'ombe, TJ; Tegha, GL; van der Horst, C; Wiener, J1
Abrams, EJ; Amani-Bosse, C; Chaix, ML; Coffie, PA; Dabis, F; Ekouevi, DK; Leroy, V; Tonwe-Gold, B1
Bancheno, WM; Mareverwa, J; Mwanyumba, F1
Castelnuovo, B; Kamya, MR; Kiragga, A; Manabe, Y1
Bachani, D; Chan, PL; Deshpande, A; Rajasekaran, S; Rewari, BB; Srikantiah, P1
Rutherford, GW; Siegfried, N; Spaulding, A1
De Bruyn, G; Gray, GE; Harwell, JI; Lurie, MN; McGarvey, ST; Triche, EW; Venkatesh, KK1
Arrivé, E; Avit, D; Benaboud, S; Blanche, S; Dabis, F; Ekouévi, DK; Gray, G; Hirt, D; McIntyre, J; Nerrienet, E; Rey, E; Sim, KL; Tréluyer, JM; Urien, S1
Biwolé-Sida, M; Bork, K; Coudray, M; Cournil, A; Delaporte, E; Essomba, CN; Kouanfack, C; Laurent, C; Tonfack, CA1
Delaporte, E; Diouf, A; Etard, JF; Girard, PM; Landman, R; Laurent, C; Molinari, N; Ndoye, I; Ngom Guèye, NF; Sow, PS; Tchatchueng Mbougua, JB1
Bitarakwate, E; Byamugisha, J; Fowler, MG; Galla, M; Kayma, S; Kekitiinwa, A; Maganda, A; Matovu, J; Mubiru, M; Mudiope, P; Musoke, P; Namukwaya, Z; Salmond, W1
de Vincenzi, I1
Basu, S; Das, BK; Kumar, A1
Alvarez, A; Azcoaga-Lorenzo, A; del Amo, J; Ferreyra, C; Palma, PP; Velilla, E1
Baumann, J; Delviks-Frankenberry, KA; Lengruber, RB; Nikolenko, GN; Pathak, VK; Santos, AF; Soares, MA1
Albert, J; de Rivera, IL; Karlsson, AC; Largaespada, N; Murillo, W; Naver, L; Parham, L1
Fowler, MG; Hoover, DR; Kumwenda, J; Kumwenda, NI; Li, Q; Mipando, L; Mofenson, LM; Nkanaunena, K; Taha, TE; Taylor, A; Thigpen, MC1
Eshleman, SH; Fogel, J; Fowler, MG; Hoover, DR; Kumwenda, N; Mofenson, LM; Sun, J; Taha, TE; Taylor, AW1
Blevins, M; Burlison, JR; Ciampa, PJ; Moon, TD; Rothman, RL; Sidat, M; Vermund, SH1
Chu, J; Ciaranello, AL; Dabis, F; Engelsmann, B; Freedberg, KA; Keatinge, J; Maruva, M; Mugwagwa, R; Mushavi, A; Perez, F; Walensky, RP1
Arendt, V; Gras, A; Henry, AP; Karasi, JC; Karasi-Omes, C; Sauvageot, N; Schmit, JC; Schneider, S; Seguin-Devaux, C; Ternes, AM1
Dia, AT; Diallo, PD; Gaye, AM; Sow, PG1
Brocklehurst, P; Siegfried, N; Sint, TT; van der Merwe, L1
Atun, R; Ben-Smith, A; Chimbwandira, F; Chirwa, Z; Gilks, CF; Harries, AD; Jahn, A; Lynen, L; Makombe, SD; Meguid, T; Midiani, D; Mnthambala, A; Schouten, EJ; Shawa, M; Van Damme, W; van Oosterhout, JJ; Zachariah, R; Zolfo, M1
Bacheler, L; Dunn, DT; Gilks, C; Goodall, RL; Kaleebu, P; Kityo, C; Munderi, P; Pillay, D; Ranopa, M; Van Houtte, M1
Chen, S; Fowler, MG; Hoover, DR; Kumwenda, NI; Mipando, L; Mofenson, LM; Nkanaunena, K; Taha, TE; Taylor, A; Thigpen, MC1
Claassen, M; Preiser, W; van der Merwe, L; van Zyl, GU; Zeier, M1
Calis, JC; de Wit, TF; Geelen, SP; Sigaloff, KC; van Vugt, M1
Davis, CA; Hughes, SH; Parniak, MA1
Dawson, L; Dixon, DO; Lie, RK; Shah, SK1
Gibb, DM; Gilks, CF; Grosskurth, H; Hakim, J; Kityo, C; Mambule, I; Munderi, P; Reid, A; Ssali, F; Stöhr, W; Walker, AS1
Beck-Engeser, GB; Eilat, D; Wabl, M1
Achalapong, J; Beck, IA; Britto, P; Chotivanich, N; Cressey, TR; Frenkel, L; Jourdain, G; Maupin, R; Mirochnick, M; Ngo-Giang-Huong, N; Prommas, S; Puthanakit, T; Rasri, W; Roongpisuthipong, A; Shapiro, DE; Van Dyke, RB; Yuthavisuthi, P1
Drake, AL; Emery, S; Farquhar, C; Hitti, J; John-Stewart, G; Kiarie, J; Ongecha-Owuor, F; Overbaugh, J; Richardson, BA; Roxby, AC; Wald, A1
Back, DJ; Else, LJ; Khoo, SH; Taylor, S1
Aurpibul, L; Capparelli, E; Chokephaibulkit, K; Cressey, TR; Eksaengsri, A; Hongsiriwon, S; Kabat, B; Limwongse, C; McIntosh, K; Muresan, P; Ngampiyaskul, C; Sirisanthana, V; Smith, ME; Toye, M; Wittawatmongkol, O; Yogev, R1
Beck-Sagué, CM; Fernandez, AD; Leonardo-Guerrero, J; Nicholas, SW; Roman-Pouriet, J; Schmidt, NC1
Boltz, VF; Chow, JY; Coffin, JM; Gray, GE; Hall, DB; Hopley, MJ; Maldarelli, F; Martinson, NA; Mayers, D; McIntyre, JA; Mellors, JW; Palmer, S; Robinson, P1
Balzarini, J; Derudas, M; Grivel, JC; Introini, A; Lisco, A; Margolis, L; McGuigan, C; Merbah, M; Munawwar, A; Schinazi, RF; Vanpouille, C1
Anastos, K; Burger, H; Foley, B; Hamy, F; Kemal, KS; Klimkait, T; Mayers, D; Minin, VN; Petrovic, K; Ramirez, CM; Suchard, MA; Weiser, B1
Agu, KA; Akpoigbe, KJ; Badru, T; Chabikuli, O; Eluwa, GI; Hamelmann, C1
Choudhury, H; Das, A; Gorain, B; Nandi, U; Pal, TK; Roy, B1
Dugange, F; Harms, G; Hauser, A; Kuecherer, C; Kunz, A; Lau, I; Mbezi, P; Sewangi, J; Theuring, S; Ziske, J1
Beck, IA; Blanco, AJ; Carlsson, J; Dross, S; Frenkel, LM; Gantt, S; Gloyd, S; Jamisse, L; Matediana, E; Matunha, L; Micek, MA; Montoya, P; Seidel, K1
Adair, LS; Chasela, CS; Ellington, SR; Fiscus, SA; Hoffman, I; Hosseinipour, MC; Hudgens, MG; Jamieson, DJ; Kacheche, Z; Kamwendo, DD; Kayira, D; King, CC; Knight, RJ; Kourtis, AP; Martinson, F; Mofolo, IA; Sichali, DS; Soko, A; Tegha, G; van der Horst, C; Wiener, JB1
Chen, Z; Chu, Y; Qiu, M; Song, H; Wang, Q; Wu, Z; Yuan, Z1
Drake, AL; Emery, S; Farquhar, C; John-Stewart, GC; Kiarie, JN; Matemo, DN; Ongecha-Owuor, F; Overbaugh, J; Richardson, B; Roxby, AC; Wald, A1
Bastos, FI; Bethel, J; Bryson, YJ; Camarca, M; Ceriotto, M; Dickover, R; Fonseca, R; Gray, G; Grinsztejn, B; Joao, EC; Kreitchmann, R; Machado, D; Mirochnick, M; Mofenson, LM; Moreira, RI; Morgado, MG; Moye, J; Mussi-Pinhata, MM; Nielsen-Saines, K; Pilotto, JH; Pinto, J; Santos, B; Siberry, G; Theron, G; Veloso, VG; Watts, DH; Xu, J1
Abrams, EJ; Barlow-Mosha, L; Bobat, R; Chi, BH; Cotton, MF; Eshleman, SH; Hughes, MD; Jean-Philippe, P; Kamthunzi, P; Khadse, S; Lindsey, JC; Millar, L; Mofenson, LM; Moultrie, H; Mujuru, HA; Palumbo, P; Petzold, E; Purdue, L; Schimana, W; Violari, A1
Herman, BD; Radzio, J; Sluis-Cremer, N; Tachedjian, G; Yap, SH1
Jaye, A; Oko, F; Okomo, U; Peterson, I; Peterson, K; Togun, T; Townend, J1
Capeau, J; Danner, SA; Domingo, P; Feeney, ER; Mallon, PW; Reiss, P; van Agtmael, MA; van Vonderen, MG; Villarroya, F; Wit, F1
Bajunirwe, F; Kiwanuka, J; Nyesigire Ruhinda, E1
Côté, HC; Hukezalie, KR; Thumati, NR; Wong, JM1
Capparelli, E; Essex, M; Leidner, J; Lockman, S; Makhema, J; Moffat, C; Moss, M; Moyo, S; Ogwu, A; Rossi, S; Shapiro, RL1
Agbaji, O; Ekong, E; Graham, C; Hawkins, C; Idoko, J; Kanki, P; Meloni, S; Muazu, M; Murphy, R; Nimzing, L; Sankalé, JL; Thio, CL1
Ananworanich, J; Chomchey, N; Gerschenson, M; Hongchookiat, P; Jadwattanakul, T; Kerr, SJ; Kim, JH; Mathajittiphun, P; Phanuphak, N; Phanuphak, P; Pinyakorn, S; Praihirunyakit, P; Rungrojrat, P; Shikuma, C; Teeratakulpisarn, N; Valcour, V1
Adams, O; Bolten, M; Borkhardt, A; Laws, HJ; Neubert, J; Niehues, T; Pfeffer, M; Reuter, S; Stannigel, H1
Aweeka, FT; Huang, L; Levy, JA; Liu, L; Siu, V; Teque, F; Wang, L1
Babu, KN; Kumar, BR; Kumar, VR; Reddy, BP; Sreekanth, K1
Frenkel, L; Ton, Q1
Darak, S; Darak, T; Hutter, I; Janssen, F; Kulkarni, S; Kulkarni, V; Parchure, R1
Barr, CD; Essex, M; Makhema, J; Maruapula, D; Mongwato, D; Moyo, S; Novitsky, V; Pain, D; Wang, R; Weng, J1
Arnett, DK; Bagchi, S; Chi, BH; Heimburger, DC; Kabagambe, EK; Kiage, JN; Koethe, JR; Nyirenda, CK; Wellons, MF1
Adeyeye, M; Edowhorhu, G; Esseku, F; Gbadero, D; Joshi, A; Oyegbile, Y1
Holmes, D1
Aguilar, A; De La Torre, J; Del Arco, A; García-Alegría, J; Olalla, J; Pombo, M; Prada, JL; Ruiz-Mateas, F; Urdiales, D1
Delaporte, E; Desclaux, A; Koita Fall, MB; Ndoye, I; Taverne, B1
Ao, Z; Chen, L; Jayappa, KD; Kobinger, G; Liu, S; Wainberg, MA; Wu, G; Yao, X1
Aghokeng, A; Belec, L; Bertagnolio, S; Bunupuradah, T; Burda, S; Cane, P; Cappelli, G; Charpentier, C; Dagnra, AY; de Wit, TF; Deshpande, AK; El-Katib, Z; Eshleman, SH; Fleury, HJ; Fokam, J; Ford, N; Gody, JC; Hamers, RL; Hawkins, CA; Holmes, S; Hosseinipour, MC; Jordan, MR; Kanki, PJ; Katzenstein, D; Koyalta, DD; Kumwenda, JJ; Lallemant, M; Lynen, L; Manosuthi, W; Marconi, VC; Margot, NA; Moussa, S; Ndung'u, T; Ngo-Giang-Huong, N; Nyambi, PN; Orrell, C; Peeters, M; Rhee, SY; Ruxrungtham, K; Schapiro, JM; Schuurman, R; Shafer, RW; Sigaloff, KC; Sirivichayakul, S; Smith, D; Stevens, W; Tang, MW; van Zyl, GU; Wallis, CL; Zolfo, M1
Chamnanchanunt, S; Chierakul, W; Desakorn, V; Kiertiburanakul, S; Kyaw, NL; Manosuthi, W; Pitisuttithum, P; Sungkanuparph, S; Thanachartwet, V1
Chasela, C; Ellington, SR; Hosseinipour, M; Hyde, L; Jamieson, DJ; Kayira, D; Kourtis, AP; van der Horst, C; Wiener, J1
Boonsuk, S; Butchon, R; Chokephaibulkit, K; Kullert, N; Kulpeng, W; Phanuphak, N; Pilasant, S; Tantivess, S; Teerawattananon, Y; Tosanguan, K; Voramongkol, N; Werayingyong, P1
Bosco, O; Cruciani, M; Malena, M; Mengoli, C; Parisi, SG; Serpelloni, G1
Amie, SM; Bambara, RA; Daly, MB; Kim, B; Noble, E; Schinazi, RF1
Massawe, A; Mghamba, FW; Minzi, OM; Sasi, P1
Ampofo, WK; Barnor, JS; Brandful, JA; Ibe, S; Ishikawa, K; Nii-Trebi, NI; Ofori, SB; Sugiura, W; Yamaoka, S1
Gedefaw, L; Sahlemariam, Z; Yemane, T; Yilma, D1
de Oliveira, T; Lessells, RJ; Manasa, J; McGrath, N; Naidu, KK; Newell, ML; Skingsley, A1
Blanco, J1
Allen, M; Donnell, D; Fowler, MG; Guay, LA; Jackson, JB; Mmiro, F; Musoke, P; Mwatha, A; Owor, M1
Bentaleb, H; Cisse, VM; Dia Badiane, NM; Dieng, AB; Diop, BM; Diop, SA; Diouf, A; Fortes Déguénonvo, L; Ka, D; Lakhe, NA; Leye, MM; Manga, MN; Ndour, CT; Seydi, M; Soumaré, M; Sow, PS1
Chersich, MF; Farley, TM; Luchters, S; Meda, N; Mwaura, M; Newell, ML; Sartorius, BK; Temmerman, M1
Lu, H; Qi, T; Shen, Y; Wang, J; Wang, Z1
Gilks, CF; Goodall, RL; Gupta, RK; Kaleebu, P; Kityo, C; Lyagoba, F; Mugarura, L; Munderi, P; Pillay, D; Ranopa, M1
Doumbo, OK; Guirou, EA; Hendrix, CW; Kayentao, K; Nyunt, MM; Parsons, TL; Plowe, CV; Venkatesan, M1
Adedeji, WA; Adewole, IF; Akinola, IT; Akinyinka, OO; Aweeka, FT; Darin, KM; Fehintola, FA; Lindegardh, N; Ma, Q; Morse, GD; Murphy, RL; Ojengbede, O; Parikh, S; Scarsi, KK; Taiwo, B; Tarning, J1
Anino, E; Choge, JK; Khayeka-Wandabwa, C; Kweka, EJ; Ngemu, EK; Oyoo-Okoth, E1
Bharti, A; Chakravarty, J; Goel, R; Meena, LP; Rai, M; Sundar, S; Tiwary, NK1
Choun, K; De Weggheleire, A; Lynen, L; Phirum, L; Thai, S; van Griensven, J1
Boppana, SB; Chowdhury, N; Hsiao, NY; Hutto, C; Kroon, SM; Manicklal, S; Novak, Z; Pati, SK; van Niekerk, AM1
Audu, RA; Ekama, SO; Ezechi, OC; Odeigah, PG; Onwuamah, CK; Poirier, MC1
Dunn, DT; Gibb, DM; Gilks, CF; Goodall, RL; Kaleebu, P; Kasirye, R; Kityo, C; Mambule, I; Mugyenyi, P; Pillay, D; Walker, AS1
Aghokeng, AF; Chia, JE; Delaporte, E; Einterz, E; Eymard-Duvernay, S; Molina, JM; Mpoudi-Ngole, E; Peeters, M; Taieb, F1
Abongomera, G; Arach, B; Asiimwe, AR; Cook, A; Gibb, DM; Kabamba, D; Kayiwa, J; Kekitiinwa, A; Kenny, J; Kityo, C; Klein, N; Komunyena, J; Mirembe, G; Mulenga, V; Musiime, V; Nansubuga, C; Walker, SA; Wavamunno, P; Zangata, D1
Crowe, SM; David, M; Gare, J; Hearps, AC; Imara, U; Kaima, P; Kelly-Hanku, A; Kombati, Z; Ryan, CE; Siba, PM; Timbi, D1
Abbas, SQ; Abro, AG; Baig-Ansari, N; Kazi, MA; Mir, F; Qamar, FN; Rizvi, A; Zaidi, AK1
Holla, P; Jameel, S; Munshi, SU; Panda, H; Rewari, BB1
Gui, T; Guo, W; Jia, L; Jiao, L; Li, H; Li, J; Li, L; Liu, S; Liu, Y; Zhuang, D1
Clumeck, N; Delforge, M; Ilunga, J; Kabeya, K; Kadiebwe, D; Kapend, L; Kasamba, E; Matanda, S; Milolo, C; Mwamba, C; Necsoi, C; Vaira, D1
Audu, RA; Ezechi, OC; Herbertson, EC; Odeigah, PG; Onwuamah, CK; Ujah, IA1
Aoko, A; Bii, M; Close, N; Khamadi, S; Kiptoo, I; Langat, RC; Langat, RK; Maswai, J; Obiero, E; Sawe, FK; Shaffer, DN; Shikuku, KP; Sinei, S; Tarus, J; Yegon, P1
Fan, P; Li, J; Li, N; Liang, Y; Ma, Y; Sun, D; Wang, Z; Yang, W; Zhu, Q1
Aris, E; Baernighausen, T; Chalamilla, G; Fawzi, W; Hertzmark, E; Jackson, E; Machumi, L; Muya, A; Mwanyika-Sando, M; Sando, D; Spiegelman, D1
Gordon, M; Moodley, P; Naidoo, A; Parboosing, R; Paredes, R; Samuel, R; Singh, L1
Barlow-Mosha, L; Cotton, M; Dominguez, K; Ford, N; Penazzato, M1
Barr, E; Davies, J; Forster, JE; Kinzie, K; Levin, MJ; McFarland, EJ; Pappas, J; Paul, S; Smith, C; Weinberg, A1
Abrams, EJ; Epie, F; Geffner, ME; Jao, J; Kirmse, B; Kurland, IJ; LeRoith, D; Nshom, E; Powis, K; Qiu, Y; Sperling, RS; Tih, PM; Yu, C1
Bhardwaj, S; Chopra, M; Dinh, TH; Doherty, T; Goga, A; Jackson, D; Lombard, C; Mogashoa, M; Pillay, Y; Puren, A; Ramokolo, V; Shaffer, N; Sherman, G; Woldesenbet, S1
Antony, J; Arumugam, K; D'Souza, G; De Costa, A; Kumar, DS; Kumarasamy, N; Poongulali, S; Rewari, BB; Shastri, S; Shet, A1
Bonnet, F; Calmy, A; Ciaffi, L; Delhumeau, C; Fampou, JC; Hill, A; Menga, G; Nchotu Ngang, P; Rougemont, M; Stoll, B1
Cressey, TR; Jourdain, G; Kanjanavikai, P; Klinbuayaem, V; Koetsawang, S; Lallemant, M; Le Coeur, S; Mcintosh, K; Ngo-Giang-Huong, N; Sabsanong, P; Sirirungsi, W; Traisathit, P1
Chirwa, M; Ishikawa, N; Jimba, M; Kapyata, H; Komada, K; Miyano, S; Msiska, CY; Okawa, S; Syakantu, G; Yasuoka, J1
Abongomera, G; Asiimwe, A; Burger, D; Chabala, C; Chintu, C; Cook, AD; Gibb, DM; Kekitiinwa, A; Kenny, J; Kityo, C; Klein, N; McIlleron, H; Mirembe, G; Mulenga, V; Musiime, V; Owen-Powell, E; Thomason, MJ; Walker, AS1
Catalan, IC; de Rozieres, CM; Dowling, CC; Hoefer, MM; Kaul, M; Maung, R; Sanchez, AB; Sejbuk, NE; Varano, GP1
Federico, M; Frezza, C; Grelli, S; Macchi, B; Marino-Merlo, F; Mastino, A1
Agbaji, OO; Darin, KM; Eisen, G; Gashau, W; Kanki, PJ; Meloni, ST; Murphy, RL; Nkado, R; Okonkwo, P; Onwujekwe, DI; Rawizza, HE; Scarsi, KK; Tchetgen Tchetgen, EJ1
Cotton, MF; Holgate, S; Mirochnick, M; Nelson, A; Rabie, H; Wedderburn, C1
Godet, J; Mély, Y; Przybilla, F; Restle, T; Sharma, KK1
Maharaj, N; Moodley, D; Moodley, T; Sartorius, B; Sebitloane, M1
Fan, P; Li, N; Liang, Y; Nie, Y; Sun, D; Wang, Z; Yang, W; Zhu, Q1
Birnbaum, JM; Cha, A; Elsamadisi, P; Phipps, E; Su, CP1
Dogra, S; Gupta, A; Kumar, A; Suri, D1
Gordon, M; Julian, MN; Moodley, P; Naidoo, A; Parboosing, R; Paredes, R; Samuel, R; Singh, L1
Bacha, T; Olana, T; Tadesse, BT; Worku, W1
Birbal, S; Dheda, M; Ojewole, E; Oosthuizen, F1
Abach, J; Abongomera, G; Chabala, C; Colebunders, R; Cook, A; Gibb, DM; Kekitiinwa, A; Kityo, C; Lamorde, M; Mulenga, V; Musiime, V; Thomason, M; Walker, AS1
Basar, M; Bhosale, R; Bobat, R; Browning, R; Chi, BH; Chipato, T; Coletti, AS; Currier, JS; Fenton, T; Fiscus, SA; Flynn, PM; Fowler, MG; Gnanashanmugam, D; Klingman, KL; Loftis, AJ; Martinson, FE; McIntyre, J; Mlay, P; Mofenson, LM; Moodley, D; Owor, M; Purdue, L; Qin, M; Shapiro, DE; Siberry, GK; Strehlau, R; Taha, TE; Theron, GB; Violari, A1
Adesanya, OJ; Adeyeye, MC; Esseku, F; Gbadero, D; Joshi, A1
Barlow-Mosha, L; Borkowsky, W; Chen, J; Chi, BH; Deygoo, N; Duffy, PE; Gabriel, EE; Hobbs, CV; Ilmet, T; Jean Philippe, P; Kamthunzi, P; Kirmse, B; Li, Y; Mofenson, L; Musoke, P; Neal, J; Palumbo, P; Parikh, S; Petzold, E; Prescott, W; Tauzie, J; Tegha, G1
Alteri, C; Bernardi, S; Bertoli, A; Liuzzi, G; Manno, EC; Palma, P; Perno, CF; Rossi, P; Tchidjou, HK; Zangari, P1
Harrison, M; Matjila, M; Riemer, L; Tooke, L1
Dunn, DT; Gilks, C; Goodall, RL; Gupta, RK; Kaleebu, P; Kityo, C; Mugarura, L; Munderi, P; Nkurunziza, P; Pattery, T; Pillay, D1
Aarons, L; Borkird, T; Capparelli, EV; Cressey, TR; Jittayanun, K; Jourdain, G; Lallemant, M; Le Coeur, S; Luvira, A; Phanomcheong, S; Puangsombat, A; Punyawudho, B; Saenjum, C; Sukrakanchana, PO; Urien, S1
Awoke, T; Birlie, B; Braekers, R; Kasim, A; Shkedy, Z1
Canals, F; Gutiérrez, F; Masiá, M1
Brambilla, D; Ceffa, S; De Luca, A; Liotta, G; Luhanga, R; Magid, NA; Mancinelli, S; Marazzi, MC; Palombi, L; Sidumo, ZJ; Zanelli, G1
Emanuel, K; Fox, HS; Lamberty, BG; Morsey, B; Stauch, KL1
Abrams, EJ; Côté, HCF; Epie, F; Geffner, ME; Jao, J; Kirmse, B; Kurland, IJ; Leroith, D; Nshom, E; Powis, KM; Sperling, RS; Yu, C1
Chen, X; Fairley, CK; He, J; Jing, J; Mao, L; Sasadeusz, J; Su, S; Wei, X; Zeng, H; Zhang, L1
Aroke, D; Bechem, NN; Dimala, CA; Kadia, BM1
Cuong, DD; Dung, NT; Dung, NTH; Haneuse, S; Kinh, NV; Matsumoto, S; Oka, S; Tanuma, J; Thuy, PTT; Trung, NV; Vu, TV1
Awodele, O; Oshikoya, KA; Popoola, TD1
Castelnuovo, B; Gonza, P; Kambugu, A; Kiragga, AN; Mbabazi, O; Mubiru, F; Musomba, R; Ratanshi, RP1
Antony, J; Ashoor, HM; Blondal, E; Finkelstein, Y; Ghassemi, M; Gough, K; Hemmelgarn, BR; Hutton, B; Ivory, JD; Khan, PA; Lillie, E; Straus, SE; Tricco, AC; Vafaei, A; Veroniki, AA1
Desai, M; Dinh, C; Gonzalez, R; Haaland, RE; Heneine, W; Katana, A; Martin, A; Menendez, C; Otieno, K; Slutsker, L; Williamson, J1
Adeyeye, CM; Ali, I; Aliu, R; Awodele, O; Oni, Y1
Agyingi, K; Domkam, I; Joyce, AN; Keou, CK; Mbu, RE; Moudourou, S; Nanfack, A; Njefi, K; Sosso, S; Takang, W; Takou, D; Torimiro, JN1
Chendi, BH; Eyoh, A; Ikomey, GM; Jacobs, GB; Lyonga, E; Mesembe, M; Okomo Assoumou, MC; Yekwa, EL1
Huang, JP; Huang, WH; Luo, SD; Luo, XL; Mo, LD; Ni, ZY; Su, GS; Su, HZ; Wu, JY1
Aling, E; Bbosa, N; Kaleebu, P; Kapaata, A; Kateete, DP; Lunkuse, S; Nabirye, SE; Nannyonjo, M; Nassolo, F; Nsubuga, RN; Omooja, J; Sanyu, G; Segujja, F; Ssebaggala, E; Ssemwanga, D1
Anugulruengkitt, S; Chokephaibulkit, K; Cressey, TR; Jantarabenjakul, W; Ounchanum, P; Pancharoen, C; Punnahitanon, S; Puthanakit, T; Sophonphan, J; Srirompotong, U; Suntarattiwong, P1
Chen, IT; Chen, JK; Chen, YS; Lee, SS; Sy, CL; Tsai, HC; Tseng, YT; Weng, YW; Wu, KS1
Barros Silva, LCPB; da Silva, RMF; de Lima, LG; de Medeiros, FPM; de Sousa, ALMD; Lavra, ZMM; Neto, PJR; Rolim, LA; Rosa, TA; Wanderley Sales, VA1
Chi, BH; Fairlie, L; Farhad, M; Fenton, T; Fowler, MG; Moodley, D; Naik, S; Nakabiito, C; Stringer, JSA; Venkatesh, KK1
Ajibola, G; Batlang, O; Bennett, K; Capparelli, EV; Hughes, MD; Jean-Philippe, P; Kuritzkes, DR; Lichterfeld, M; Lockman, S; Makhema, J; Maswabi, K; Mohammed, T; Moyo, S; Sakoi, M; Shapiro, RL1
Teshale, AB; Tsegaye, AT; Wolde, HF1
Amzal, B; Cressey, TR; Jarupanich, T; Jourdain, G; Kanjanavikai, P; Klinbuayaem, V; Koetsawang, S; Lallemant, M; Le Coeur, S; Ngo-Giang-Huong, N; Rawangban, B; Sabsanong, P; Siriwachirachai, T; Sripan, P; Urien, S; Wanasiri, P1
Bae, J; Cook, RL; Delcher, C; Francois, K; Joseph, N; Pessoa-Brandão, L; Puttkammer, N; Rich, SN; Robin, E; Yaghjyan, L1
da Silva, CH; da Silva, CLO; Friedrich, L; Magdaleno, AM; Menegotto, M1
Morales-Pérez, M1
Blanche, S; Brossard, M; Dollfus, C; Faye, A; Frange, P; Le Chenadec, J; Mandelbrot, L; Tubiana, R; Warszawski, J1
Bhatt, N; Couto, A; Cuco, RM; Degomme, O; Juga, A; Loquiha, O; Meggi, B; Osman, N; Sevene, E; Sidat, M; Temermam, M; Vubil, A1
Ahmed, FO; Aning, BD; Ansah, RO; Ayisi-Boateng, NK; Enimil, AK; Ojuang, DA; Okeke, CB; Opoku, S; Sakyi, SA; Sarfo, AD; Senu, E; Wekesa, DN1
Adebisi, SA; Adedeji, NO; Adedeji, TA; Ajeigbe, AK; Ajose, AO; Akande, AA; Fawale, MB; Jeje, OA; Okesina, BA; Smith, OS1
Ali, S; Bayserkin, B; Dzissyuk, N; Issanov, A; Mukhatayev, Z; Mukhatayeva, A; Mustafa, A; Vermund, SH1
Abrams, EJ; Bonner, LB; Geffner, ME; Gerschenson, M; Jao, J; Kgole, S; Kurland, IJ; Legbedze, J; Makhema, J; Masasa, G; Mmalane, M; Mmasa, KN; Mohammed, T; Moyo, S; Powis, KM; Sun, S1
Aghokeng, A; Ateba Ndongo, F; Bilong, S; Djeuda, ABD; Eboumbou Moukoko, CE; Eyoum Bille, B; Fokam, J; Grace, N; Koki Ndombo, P; Moukoko Mbonjo, M; Ndjolo, A; Penda, CI1

Reviews

38 review(s) available for nevirapine and zidovudine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Resistance, drug failure, and disease progression.
    AIDS research and human retroviruses, 1994, Volume: 10, Issue:8

    Topics: Antiviral Agents; Disease Progression; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Humans; Nevirapine; Pyridines; Randomized Controlled Trials as Topic; Zalcitabine; Zidovudine

1994
Antiretroviral therapy: a guide to the most important trials.
    Schweizerische medizinische Wochenschrift, 1997, Mar-15, Volume: 127, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Indinavir; Lamivudine; Nevirapine; Pyridines; Ritonavir; Saquinavir; Stavudine; Viral Load; Zalcitabine; Zidovudine

1997
[Resistance to antiretroviral drugs].
    Medicina clinica, 1997, Oct-25, Volume: 109, Issue:14

    Topics: Antiviral Agents; Drug Resistance; Drug Resistance, Multiple; HIV Seropositivity; HIV-1; Humans; Lamivudine; Nevirapine; Point Mutation; Retroviridae; Retroviridae Infections; Zidovudine

1997
Antiretroviral chemotherapy.
    Current clinical topics in infectious diseases, 1998, Volume: 18

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Delavirdine; Didanosine; Dideoxynucleosides; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Nelfinavir; Nevirapine; Oxazines; Ritonavir; Saquinavir; Stavudine; Zalcitabine; Zidovudine

1998
Antiretrovirals.
    Mayo Clinic proceedings, 1999, Volume: 74, Issue:12

    Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Carbamates; Cyclopropanes; Delavirdine; Didanosine; Dideoxynucleosides; Female; Furans; HIV Infections; Humans; Indinavir; Lamivudine; Nelfinavir; Nevirapine; Oxazines; Pregnancy; Pregnancy Complications, Infectious; Protease Inhibitors; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Stavudine; Sulfonamides; Zalcitabine; Zidovudine

1999
Meta-analysis of two randomized controlled trials comparing combined zidovudine and didanosine therapy with combined zidovudine, didanosine, and nevirapine therapy in patients with HIV. INCAS study team.
    Journal of acquired immune deficiency syndromes (1999), 1999, Nov-01, Volume: 22, Issue:3

    Topics: Adult; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Middle Aged; Multivariate Analysis; Nevirapine; Proportional Hazards Models; Viral Load; Zidovudine

1999
[New therapy reduces AIDS passed to fetuses and costs less].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2000, Volume: 120, Issue:8

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Developing Countries; Female; Health Care Costs; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Premedication; Reverse Transcriptase Inhibitors; Zidovudine

2000
Update on preventing vertical transmission of HIV type 1.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2000, Sep-01, Volume: 57, Issue:17

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Prenatal Care; Zidovudine

2000
Management of the infant born to a mother infected with human immunodeficiency virus type 1 (HIV-1): current concepts.
    American journal of perinatology, 2000, Volume: 17, Issue:8

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Administration Schedule; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Zidovudine

2000
Prevention of mother-to-child transmission of HIV: challenges for the current decade.
    Bulletin of the World Health Organization, 2001, Volume: 79, Issue:12

    Topics: Anti-HIV Agents; Breast Feeding; Cesarean Section; Drug Resistance, Microbial; Female; Health Resources; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Premedication; Reverse Transcriptase Inhibitors; Risk Factors; United Nations; Zidovudine

2001
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    The Cochrane database of systematic reviews, 2002, Issue:1

    Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Zidovudine

2002
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    The Cochrane database of systematic reviews, 2002, Issue:2

    Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Zidovudine

2002
Mother to child transmission of HIV.
    Clinical evidence, 2002, Issue:7

    Topics: Anti-HIV Agents; Breast Feeding; Cesarean Section; Combined Modality Therapy; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Risk; Treatment Outcome; Zidovudine

2002
Mother to child transmission of HIV.
    Clinical evidence, 2002, Issue:8

    Topics: Anti-HIV Agents; Breast Feeding; Cesarean Section; Combined Modality Therapy; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine

2002
Antiretroviral therapy-induced psychosis: case report and brief review of the literature.
    HIV medicine, 2003, Volume: 4, Issue:2

    Topics: Adult; Antipsychotic Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Combinations; Female; Hallucinations; HIV Seropositivity; Humans; Lamivudine; Nevirapine; Psychoses, Substance-Induced; Zidovudine

2003
[Antiretrovirals].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2

    Topics: Acidosis, Lactic; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Didanosine; Hemophilia A; Hemorrhage; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Indinavir; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine

2003
The continuing evolution of HIV therapy.
    The AIDS reader, 2003, Volume: 13, Issue:12

    Topics: Adenine; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Carbamates; CD4 Lymphocyte Count; Cyclopropanes; Delayed-Action Preparations; Deoxycytidine; Didanosine; Dideoxynucleosides; Drug Monitoring; Emtricitabine; Furans; HIV Infections; Humans; Lamivudine; Nevirapine; Oligopeptides; Organophosphates; Organophosphonates; Organophosphorus Compounds; Oxazines; Pyridines; Randomized Controlled Trials as Topic; Stavudine; Sulfonamides; Tenofovir; Treatment Outcome; Viral Load; Zidovudine

2003
Preventing neonatal HIV: a review.
    Current HIV research, 2003, Volume: 1, Issue:3

    Topics: Anti-HIV Agents; Breast Feeding; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine

2003
HIV: mother to child transmission.
    Clinical evidence, 2005, Issue:13

    Topics: Administration, Intravaginal; Anti-HIV Agents; Breast Feeding; Cesarean Section; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine

2005
Do non-nucleoside reverse transcriptase inhibitors contribute to lipodystrophy?
    Drug safety, 2005, Volume: 28, Issue:12

    Topics: Alkynes; Anti-Retroviral Agents; Benzoxazines; Cardiovascular Diseases; Cyclopropanes; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Metabolic Syndrome; Nevirapine; Oxazines; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine; Zidovudine

2005
[The treatment of HIV infection].
    Presse medicale (Paris, France : 1983), 2005, Nov-19, Volume: 34, Issue:20 Pt 2

    Topics: Adenine; Anti-Retroviral Agents; Carbamates; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Therapy, Combination; Furans; HIV Infections; Humans; Lamivudine; Nevirapine; Organophosphates; Organophosphonates; Risk Factors; Sulfonamides; Tenofovir; Zidovudine

2005
Evidence behind the WHO guidelines: hospital care for children: what antiretroviral agents and regimens are effective in the prevention of mother-to-child transmission of HIV?
    Journal of tropical pediatrics, 2006, Volume: 52, Issue:4

    Topics: Anti-HIV Agents; Breast Feeding; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; World Health Organization; Zidovudine

2006
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    The Cochrane database of systematic reviews, 2007, Jan-24, Issue:1

    Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Zidovudine

2007
Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.
    Journal of clinical pharmacy and therapeutics, 2007, Volume: 32, Issue:3

    Topics: Anti-HIV Agents; Antimetabolites; Antiretroviral Therapy, Highly Active; Child; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Risk Factors; Treatment Outcome; Zidovudine

2007
Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine?
    HIV medicine, 2009, Volume: 10, Issue:7

    Topics: Adenine; Adult; Africa South of the Sahara; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Diseases; Child; Child, Preschool; Congenital Abnormalities; Disease Models, Animal; Drug Resistance, Viral; Female; Health Services Accessibility; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Macaca; Mitochondria; Nevirapine; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Zidovudine

2009
Optimal versus suboptimal treatment for HIV-infected pregnant women and HIV-exposed infants in clinical research studies.
    Journal of acquired immune deficiency syndromes (1999), 2009, Aug-15, Volume: 51, Issue:5

    Topics: Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Drug Resistance, Viral; Female; HIV; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine

2009
Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals.
    The Cochrane database of systematic reviews, 2010, Oct-06, Issue:10

    Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Child; Cyclopropanes; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; HIV Infections; Humans; Lamivudine; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Zidovudine

2010
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    The Cochrane database of systematic reviews, 2011, Jul-06, Issue:7

    Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Zidovudine

2011
HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review.
    The Lancet. Infectious diseases, 2011, Volume: 11, Issue:10

    Topics: Adolescent; Africa; Alkynes; Anti-HIV Agents; Asia; Benzoxazines; Child; Child, Preschool; Cross-Sectional Studies; Cyclopropanes; Developing Countries; Drug Resistance, Viral; Female; Health Resources; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Latin America; Lopinavir; Male; Mutation; Nevirapine; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Treatment Failure; Viral Load; Zidovudine

2011
Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid).
    Antiviral therapy, 2011, Volume: 16, Issue:8

    Topics: Adenine; Adult; Amniotic Fluid; Anti-HIV Agents; Cyclohexanes; Enfuvirtide; Female; Fetal Blood; Fetus; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Maraviroc; Nevirapine; Organophosphonates; Peptide Fragments; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pyrrolidinones; Raltegravir Potassium; Reverse Transcriptase Inhibitors; Tenofovir; Triazoles; Viral Load; Zidovudine

2011
HIV drug resistance in mothers and infants following use of antiretrovirals to prevent mother-to-child transmission.
    Current HIV research, 2013, Volume: 11, Issue:2

    Topics: Alkynes; Anti-HIV Agents; Aptamers, Nucleotide; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Developing Countries; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Mothers; Nevirapine; Point Mutation; Pregnancy; Pregnancy Complications, Infectious; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Sentinel Surveillance; Sequence Analysis, DNA; Viral Load; Zidovudine

2013
A randomized pahse I bioequivalence clinincal trial of a paediatric fixed-dose combination antiretroviral reconstitutable suspension in healthy adult volunteers.
    Antiviral therapy, 2013, Volume: 18, Issue:2

    Topics: Adult; Anti-HIV Agents; Cross-Over Studies; Drug Combinations; Female; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Therapeutic Equivalency; Young Adult; Zidovudine

2013
Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.
    The Cochrane database of systematic reviews, 2013, Jun-05, Issue:6

    Topics: Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Dideoxynucleosides; Drug Substitution; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lipids; Maintenance Chemotherapy; Middle Aged; Nevirapine; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Treatment Failure; Viral Load; Young Adult; Zidovudine

2013
Choice of antiretroviral drugs for postexposure prophylaxis for children: a systematic review.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Jun-01, Volume: 60 Suppl 3

    Topics: Anti-HIV Agents; Child; Child, Preschool; Cohort Studies; Dideoxynucleosides; Drug Combinations; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Nevirapine; Post-Exposure Prophylaxis; Pregnancy; Prospective Studies; Randomized Controlled Trials as Topic; Ritonavir; Zidovudine

2015
Developments in early diagnosis and therapy of HIV infection in newborns.
    Expert opinion on pharmacotherapy, 2018, Volume: 19, Issue:1

    Topics: Anti-HIV Agents; Early Diagnosis; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Ritonavir; Zidovudine

2018
Comparative safety and effectiveness of perinatal antiretroviral therapies for HIV-infected women and their children: Systematic review and network meta-analysis including different study designs.
    PloS one, 2018, Volume: 13, Issue:6

    Topics: Abnormalities, Drug-Induced; Alkynes; Anti-HIV Agents; Benzoxazines; Child; Congenital Abnormalities; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Network Meta-Analysis; Nevirapine; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Stavudine; Stillbirth; Zidovudine

2018
Factors associated with viral suppression and rebound among adult HIV patients on treatment: a retrospective study in Ghana.
    AIDS research and therapy, 2022, 05-25, Volume: 19, Issue:1

    Topics: Adult; Anti-HIV Agents; Ghana; HIV Infections; Humans; Lamivudine; Nevirapine; Retrospective Studies; Viral Load; Zidovudine

2022

Trials

125 trial(s) available for nevirapine and zidovudine

ArticleYear
Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1995, Feb-01, Volume: 8, Issue:2

    Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Male; Middle Aged; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; United States; Zidovudine

1995
Resistance, drug failure, and disease progression.
    AIDS research and human retroviruses, 1994, Volume: 10, Issue:8

    Topics: Antiviral Agents; Disease Progression; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Humans; Nevirapine; Pyridines; Randomized Controlled Trials as Topic; Zalcitabine; Zidovudine

1994
Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protoco
    Annals of internal medicine, 1996, Jun-15, Volume: 124, Issue:12

    Topics: Adult; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Erythema; Female; HIV Infections; HIV-1; Humans; Male; Nevirapine; Prospective Studies; Pyridines; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine

1996
A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patients. The Dutch-Italian-Australian Nevirapine Study Group.
    AIDS (London, England), 1996, Volume: 10, Issue:6

    Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Male; Nevirapine; Pyridines; Zidovudine

1996
Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection.
    The New England journal of medicine, 1997, May-08, Volume: 336, Issue:19

    Topics: Administration, Oral; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Nevirapine; Pyridines; RNA, Viral; Viral Load; Zidovudine

1997
Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team.
    Annals of internal medicine, 1997, Jun-15, Volume: 126, Issue:12

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Drug Therapy, Combination; HIV-1; Humans; Monitoring, Physiologic; Nevirapine; Phenotype; Prospective Studies; Pyridines; RNA, Viral; Viral Load; Zidovudine

1997
A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.
    JAMA, 1998, Mar-25, Volume: 279, Issue:12

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Nevirapine; RNA, Viral; Viral Load; Zidovudine

1998
Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy.
    AIDS (London, England), 1998, Sep-10, Volume: 12, Issue:13

    Topics: Anti-HIV Agents; Australia; Canada; CD4 Lymphocyte Count; Didanosine; Double-Blind Method; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Italy; Netherlands; Nevirapine; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine

1998
A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study T
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1998, Dec-01, Volume: 19, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV; Humans; Male; Nevirapine; Placebos; Reverse Transcriptase Inhibitors; RNA, Viral; Survival Rate; Time Factors; Zalcitabine; Zidovudine

1998
Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-HIV Agents; Didanosine; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Middle Aged; Models, Biological; Nevirapine; Zidovudine

1999
A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1999, Jan-01, Volume: 20, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nevirapine; Zidovudine

1999
Sequence clusters in human immunodeficiency virus type 1 reverse transcriptase are associated with subsequent virological response to antiretroviral therapy.
    The Journal of infectious diseases, 1999, Volume: 180, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Amino Acid Sequence; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; Evolution, Molecular; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Nevirapine; Sequence Alignment; Time Factors; Viral Load; Zidovudine

1999
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.
    Lancet (London, England), 1999, Sep-04, Volume: 354, Issue:9181

    Topics: Adult; Anti-HIV Agents; Double-Blind Method; Drug Administration Schedule; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Uganda; Zidovudine

1999
Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapy.
    AIDS (London, England), 2000, Jan-07, Volume: 14, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; DNA Mutational Analysis; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Reverse Transcriptase; HIV-1; Humans; Nevirapine; Placebos; Point Mutation; Regression Analysis; Reverse Transcriptase Inhibitors; Sequence Analysis, Protein; Viral Load; Zidovudine

2000
Patterns of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapine.
    The Journal of infectious diseases, 2000, Volume: 181, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Codon; Didanosine; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Nevirapine; Polymerase Chain Reaction; Zidovudine

2000
Meta-analysis of two randomized controlled trials comparing combined zidovudine and didanosine therapy with combined zidovudine, didanosine, and nevirapine therapy in patients with HIV. INCAS study team.
    Journal of acquired immune deficiency syndromes (1999), 1999, Nov-01, Volume: 22, Issue:3

    Topics: Adult; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Middle Aged; Multivariate Analysis; Nevirapine; Proportional Hazards Models; Viral Load; Zidovudine

1999
Nevirapine and perinatal transmission.
    AIDS patient care and STDs, 2000, Volume: 14, Issue:4

    Topics: Anti-HIV Agents; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; South Africa; Treatment Outcome; Zidovudine

2000
A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell counts >/=350/mm3.
    The Journal of infectious diseases, 2000, Volume: 181, Issue:5

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Didanosine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Indinavir; Injections, Subcutaneous; Interleukin-2; Lamivudine; Lymphocyte Count; Male; Nelfinavir; Nevirapine; Ritonavir; RNA, Viral; Saquinavir; Stavudine; Zalcitabine; Zidovudine

2000
Plasma HIV-1 copy number and in vitro infectivity of plasma prior to and during combination antiretroviral treatment.
    Antiviral research, 2000, Volume: 47, Issue:3

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Double-Blind Method; Drug Therapy, Combination; Giant Cells; HIV Infections; HIV-1; Humans; Nevirapine; RNA, Viral; Viral Load; Zidovudine

2000
Quality of life outcomes of combination zidovudine- didanosine-nevirapine and zidovudine-didanosine for antiretroviral-naive advanced HIV-infected patients.
    AIDS (London, England), 2000, Nov-10, Volume: 14, Issue:16

    Topics: Adult; Anti-HIV Agents; Didanosine; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Nevirapine; Quality of Life; Reverse Transcriptase Inhibitors; Treatment Outcome; Zidovudine

2000
Research study of combination AIDS therapies underway.
    AIDS patient care and STDs, 1996, Volume: 10, Issue:1

    Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; Humans; Lamivudine; Nevirapine; Pyridines; Zidovudine

1996
Viramune triple combo reduces viral load below limit of detection.
    AIDS patient care and STDs, 1997, Volume: 11, Issue:6

    Topics: Adult; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Male; Nevirapine; Randomized Controlled Trials as Topic; Viral Load; Zidovudine

1997
New double vs. triple antiviral combination study, CD4 200-500, no prior treatment.
    AIDS treatment news, 1995, Dec-01, Issue:no 236

    Topics: Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine

1995
Maintaining a low viral load with Nevirapine?
    TreatmentUpdate, 1998, Volume: 10, Issue:10

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine

1998
Virus sidesteps convergent therapy.
    GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:1

    Topics: Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Pyridines; Zidovudine

1995
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals.
    AIDS (London, England), 2001, Jun-15, Volume: 15, Issue:9

    Topics: Anti-HIV Agents; Didanosine; Double-Blind Method; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Nevirapine; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Treatment Outcome; Zidovudine

2001
Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine.
    AIDS (London, England), 2001, Jul-06, Volume: 15, Issue:10

    Topics: Anti-HIV Agents; Didanosine; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV Infections; HIV-1; Humans; Mutation; Nevirapine; Phenotype; Reverse Transcriptase Inhibitors; Zidovudine

2001
Effect of HIV-1 antiretroviral prophylaxis on hepatic and hematological parameters of African infants.
    AIDS (London, England), 2002, Apr-12, Volume: 16, Issue:6

    Topics: Alanine Transaminase; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Liver Function Tests; Malawi; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine

2002
A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study).
    Antiviral therapy, 2002, Volume: 7, Issue:2

    Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Argentina; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nelfinavir; Nevirapine; Reverse Transcriptase Inhibitors; RNA, Viral; Spain; Treatment Outcome; Zidovudine

2002
Time-dependent changes in HIV nucleoside analogue phosphorylation and the effect of hydroxyurea.
    AIDS (London, England), 2002, Dec-06, Volume: 16, Issue:18

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Interactions; Drug Resistance, Viral; Female; HIV Infections; Humans; Hydroxyurea; Lamivudine; Leukocytes, Mononuclear; Male; Middle Aged; Nevirapine; Nucleosides; Phosphorylation; Reverse Transcriptase Inhibitors; Zidovudine

2002
Compliance with antiretroviral regimens to prevent perinatal HIV-1 transmission in Kenya.
    AIDS (London, England), 2003, Jan-03, Volume: 17, Issue:1

    Topics: Adult; Anti-HIV Agents; Female; Focus Groups; Follow-Up Studies; Health Knowledge, Attitudes, Practice; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Nevirapine; Patient Compliance; Patient Selection; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Zidovudine

2003
A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
    The Journal of infectious diseases, 2003, Mar-01, Volume: 187, Issue:5

    Topics: Adult; Anti-HIV Agents; Delivery, Obstetric; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Treatment Outcome; Zidovudine

2003
Genotype and phenotype at baseline and at failure in human immunodeficiency virus-infected antiretroviral-naive patients in a randomized trial comparing zidovudine and lamivudine plus nelfinavir or nevirapine.
    The Journal of infectious diseases, 2003, Feb-15, Volume: 187, Issue:4

    Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Argentina; Cohort Studies; Drug Therapy, Combination; Genotype; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Middle Aged; Mutation; Nelfinavir; Nevirapine; Phenotype; Reverse Transcriptase Inhibitors; Spain; Treatment Failure; Zidovudine

2003
Feeding risk cut for HIV-infected women.
    Lancet (London, England), 2003, Jul-26, Volume: 362, Issue:9380

    Topics: Anti-HIV Agents; Breast Feeding; Didanosine; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Rwanda; Uganda; Zidovudine

2003
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.
    Lancet (London, England), 2003, Sep-13, Volume: 362, Issue:9387

    Topics: Adult; Anti-HIV Agents; Disease Transmission, Infectious; Drug Administration Schedule; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor Onset; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Uganda; Zidovudine

2003
Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial.
    Lancet (London, England), 2003, Oct-11, Volume: 362, Issue:9391

    Topics: Anti-HIV Agents; Female; Follow-Up Studies; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine

2003
Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for early diagnosis of perinatal HIV-1 infection.
    Journal of acquired immune deficiency syndromes (1999), 2003, Dec-15, Volume: 34, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; DNA, Viral; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Lymphocytes; Nevirapine; Nucleic Acid Amplification Techniques; Predictive Value of Tests; RNA, Viral; Sensitivity and Specificity; Zidovudine

2003
TMC125 exerts similar initial antiviral potency as a five-drug, triple class antiretroviral regimen.
    AIDS (London, England), 2003, Dec-05, Volume: 17, Issue:18

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dideoxynucleosides; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Nevirapine; Nitriles; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Zidovudine

2003
Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.
    Antiviral therapy, 2004, Volume: 9, Issue:2

    Topics: Adult; Aged; Anti-HIV Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Seropositivity; Humans; Lamivudine; Lymphocyte Activation; Male; Middle Aged; Nelfinavir; Nevirapine; Reverse Transcriptase Inhibitors; T-Lymphocyte Subsets; Zidovudine

2004
Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.
    The New England journal of medicine, 2004, Jul-15, Volume: 351, Issue:3

    Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gestational Age; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Male; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimester, Third; Risk Factors; RNA, Viral; Thailand; Viral Load; Zidovudine

2004
Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.
    The New England journal of medicine, 2004, Jul-15, Volume: 351, Issue:3

    Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Double-Blind Method; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; HIV Infections; HIV-1; Humans; Labor, Obstetric; Logistic Models; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Risk Factors; RNA, Viral; Treatment Failure; Viral Load; Zidovudine

2004
Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
    JAMA, 2004, Jul-14, Volume: 292, Issue:2

    Topics: Adult; AIDS Serodiagnosis; Anti-HIV Agents; Delivery, Obstetric; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Malawi; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Survival Analysis; Viral Load; Zidovudine

2004
Haematological changes in African children who received short-term prophylaxis with nevirapine and zidovudine at birth.
    Annals of tropical paediatrics, 2004, Volume: 24, Issue:4

    Topics: Agranulocytosis; Anemia; Anti-HIV Agents; Blood Cell Count; Drug Therapy, Combination; Female; Hematocrit; Hemoglobins; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Longitudinal Studies; Nevirapine; Risk Factors; RNA, Viral; Zidovudine

2004
Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1.
    Journal of acquired immune deficiency syndromes (1999), 2005, Mar-01, Volume: 38, Issue:3

    Topics: Adolescent; Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Thailand; Zidovudine

2005
Field assessment of generic antiretroviral drugs: a prospective cohort study in Cameroon.
    Antiviral therapy, 2005, Volume: 10, Issue:2

    Topics: Adult; Anti-HIV Agents; Cameroon; CD4 Lymphocyte Count; Cohort Studies; Drug Resistance, Viral; Drug Therapy, Combination; Drugs, Generic; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Nevirapine; Prospective Studies; Stavudine; Treatment Outcome; Viral Load; Zidovudine

2005
Antiretroviral treatment simplification with 3 NRTIs or 2 NRTIs plus nevirapine in HIV-1-infected patients treated with successful first-line HAART.
    Journal of acquired immune deficiency syndromes (1999), 2005, Jul-01, Volume: 39, Issue:3

    Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Male; Mutation; Nevirapine; Patient Compliance; Patient Satisfaction; Prospective Studies; Quality of Life; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine

2005
A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers.
    AIDS (London, England), 2005, Aug-12, Volume: 19, Issue:12

    Topics: Anti-HIV Agents; Bottle Feeding; Breast Feeding; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Survival Analysis; Treatment Outcome; Zidovudine

2005
Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment.
    The Journal of infectious diseases, 2005, Sep-01, Volume: 192, Issue:5

    Topics: Adult; Anti-HIV Agents; Botswana; Breast Feeding; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Lactation; Lamivudine; Milk, Human; Nevirapine; Reverse Transcriptase Inhibitors; Statistics, Nonparametric; Zidovudine

2005
Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine.
    AIDS (London, England), 2005, Sep-02, Volume: 19, Issue:13

    Topics: Adult; Anti-HIV Agents; DNA, Viral; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Milk, Human; Nevirapine; Postnatal Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; RNA, Viral; Zidovudine

2005
A randomized crossover study to determine bioequivalence of generic and brand name nevirapine, zidovudine, and lamivudine in HIV-negative women in India.
    Journal of acquired immune deficiency syndromes (1999), 2006, Feb-01, Volume: 41, Issue:2

    Topics: Administration, Oral; Adult; Anti-HIV Agents; Cohort Studies; Confidence Intervals; Cross-Over Studies; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Drugs, Generic; Female; HIV Infections; HIV Seronegativity; Humans; India; Lamivudine; Nevirapine; Tablets; Therapeutic Equivalency; Zidovudine

2006
A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity.
    HIV medicine, 2006, Volume: 7, Issue:2

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Black or African American; CD4 Lymphocyte Count; Cholesterol; Dideoxynucleosides; Drug Combinations; Female; Hispanic or Latino; HIV Infections; HIV-1; Humans; Hyperlipidemias; Lactic Acid; Lamivudine; Male; Nelfinavir; Nevirapine; Prospective Studies; Sex Factors; Stavudine; Treatment Outcome; Triglycerides; Zidovudine

2006
Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana.
    AIDS (London, England), 2006, Jun-12, Volume: 20, Issue:9

    Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Botswana; Drug Administration Schedule; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Logistic Models; Nevirapine; Postpartum Period; Treatment Outcome; Zidovudine

2006
Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
    JAMA, 2006, Aug-16, Volume: 296, Issue:7

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Botswana; Breast Feeding; Disease-Free Survival; Female; HIV Infections; HIV-1; Humans; Infant; Infant Formula; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine

2006
A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Jan-01, Volume: 44, Issue:1

    Topics: Adult; Anti-HIV Agents; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Reverse Transcriptase Inhibitors; Zidovudine; Zimbabwe

2007
Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: a study within the Drug Resource Enhancement Against AIDS and Malnutrition Program.
    Journal of acquired immune deficiency syndromes (1999), 2007, Mar-01, Volume: 44, Issue:3

    Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV; HIV Infections; Humans; Lamivudine; Milk, Human; Nevirapine; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; RNA, Viral; Stavudine; Zidovudine

2007
Response to antiretroviral therapy after a single, peripartum dose of nevirapine.
    The New England journal of medicine, 2007, Jan-11, Volume: 356, Issue:2

    Topics: Adult; Anti-Retroviral Agents; Double-Blind Method; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Labor, Obstetric; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Proportional Hazards Models; Prospective Studies; Risk Factors; RNA, Viral; Treatment Failure; Viral Load; Zidovudine

2007
Two-year morbidity-mortality and alternatives to prolonged breast-feeding among children born to HIV-infected mothers in Côte d'Ivoire.
    PLoS medicine, 2007, Volume: 4, Issue:1

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; Cohort Studies; Cote d'Ivoire; Female; HIV Infections; Humans; Infant; Infant Formula; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Milk, Human; Morbidity; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Time Factors; Treatment Outcome; Zidovudine

2007
Late postnatal transmission of HIV-1 and associated factors.
    The Journal of infectious diseases, 2007, Jul-01, Volume: 196, Issue:1

    Topics: Breast Feeding; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Incidence; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Malawi; Milk, Human; Nevirapine; Risk Factors; RNA, Viral; Time Factors; Zidovudine

2007
Pathology of placenta in HIV infection.
    Indian journal of pathology & microbiology, 2007, Volume: 50, Issue:3

    Topics: Anti-HIV Agents; Chorioamnionitis; Female; Fetal Death; HIV Infections; Humans; Hyperplasia; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Reverse Transcriptase Inhibitors; Treatment Outcome; Trophoblasts; Zidovudine

2007
Mother-to-child transmission of HIV among women who chose not to exclusively breastfeed their infants in Pune, India.
    The Indian journal of medical research, 2007, Volume: 126, Issue:2

    Topics: Adult; Anti-HIV Agents; Bottle Feeding; Breast Feeding; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; India; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine

2007
Pharmacokinetics of lamivudine, zidovudine, and nevirapine administered as a fixed-dose combination formulation versus coadministration of the individual products.
    Journal of clinical pharmacology, 2007, Volume: 47, Issue:11

    Topics: Adolescent; Adult; Cross-Sectional Studies; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Zidovudine

2007
Twenty-four-week safety and tolerability of nevirapine vs. abacavir in combination with zidovudine/lamivudine as first-line antiretroviral therapy: a randomized double-blind trial (NORA).
    Tropical medicine & international health : TM & IH, 2008, Volume: 13, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Dideoxynucleosides; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Treatment Outcome; Uganda; Zidovudine

2008
Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.
    AIDS research and human retroviruses, 2008, Volume: 24, Issue:3

    Topics: Adult; Anemia; Anti-HIV Agents; Cameroon; CD4 Lymphocyte Count; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Multivariate Analysis; Nevirapine; Patient Compliance; Peripheral Nervous System Diseases; Prospective Studies; Stavudine; Treatment Outcome; Viral Load; Zidovudine

2008
Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
    The New England journal of medicine, 2008, 07-10, Volume: 359, Issue:2

    Topics: Anti-HIV Agents; Breast Feeding; Developing Countries; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Malawi; Male; Milk, Human; Neutropenia; Nevirapine; Proportional Hazards Models; Risk Factors; Zidovudine

2008
HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission.
    AIDS (London, England), 2008, Jul-31, Volume: 22, Issue:12

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cell-Free System; DNA, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Milk, Human; Nevirapine; Postpartum Period; RNA, Viral; Time Factors; Treatment Outcome; Viral Load; Zidovudine

2008
Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants.
    AIDS (London, England), 2008, Aug-20, Volume: 22, Issue:13

    Topics: Alanine Transaminase; Anti-HIV Agents; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Aspartate Aminotransferases; Biomarkers; Botswana; Breast Feeding; Cohort Studies; Female; Follow-Up Studies; Hemoglobins; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Neutropenia; Nevirapine; Platelet Count; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Zidovudine

2008
Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.
    Antiviral therapy, 2008, Volume: 13, Issue:6

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Milk, Human; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; Treatment Outcome; Zidovudine

2008
Risk factors for early and late transmission of HIV via breast-feeding among infants born to HIV-infected women in a randomized clinical trial in Botswana.
    The Journal of infectious diseases, 2009, Feb-01, Volume: 199, Issue:3

    Topics: Adult; Anti-HIV Agents; Botswana; Breast Feeding; Female; HIV Infections; HIV-1; Humans; Infant; Infant Formula; Infant, Newborn; Infectious Disease Transmission, Vertical; Milk, Human; Nevirapine; Risk Factors; RNA, Viral; Zidovudine

2009
A randomized, open-label study of a nucleoside analogue reverse transcriptase inhibitor-sparing regimen in antiretroviral-naive HIV-infected patients.
    Journal of acquired immune deficiency syndromes (1999), 2009, Mar-01, Volume: 50, Issue:3

    Topics: Adult; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Lopinavir; Male; Nevirapine; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Viral Load; Zidovudine

2009
Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:5

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Intra-Abdominal Fat; Lopinavir; Male; Middle Aged; Nevirapine; Pyrimidinones; Radiography, Abdominal; Stavudine; Thigh; Viral Load; Zidovudine

2009
Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China.
    International journal of STD & AIDS, 2009, Volume: 20, Issue:4

    Topics: Adult; CD4 Lymphocyte Count; China; Cohort Studies; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine

2009
First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir.
    AIDS (London, England), 2009, Jul-17, Volume: 23, Issue:11

    Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Density; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Osteoporosis; Pyrimidinones; Ritonavir; Young Adult; Zidovudine

2009
Lower risk of resistance after short-course HAART compared with zidovudine/single-dose nevirapine used for prevention of HIV-1 mother-to-child transmission.
    Journal of acquired immune deficiency syndromes (1999), 2009, Aug-15, Volume: 51, Issue:5

    Topics: Amino Acid Substitution; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Base Sequence; DNA Primers; DNA, Viral; Drug Resistance, Viral; Female; Genes, pol; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Kenya; Mutation, Missense; Nevirapine; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Time Factors; Zidovudine

2009
Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda.
    Journal of acquired immune deficiency syndromes (1999), 2009, Sep-01, Volume: 52, Issue:1

    Topics: Anti-HIV Agents; Breast Feeding; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Multivariate Analysis; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Proportional Hazards Models; Uganda; Viral Load; Zidovudine

2009
Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    The Journal of infectious diseases, 2009, Nov-15, Volume: 200, Issue:10

    Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; CD4 Lymphocyte Count; Chemoprevention; Drug Administration Schedule; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Malawi; Male; Nevirapine; Pregnancy; Young Adult; Zidovudine

2009
Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial.
    PLoS medicine, 2009, Volume: 6, Issue:10

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Viral Load; Zidovudine

2009
Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir.
    The Journal of infectious diseases, 2010, Jan-01, Volume: 201, Issue:1

    Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Mutation; Nevirapine; RNA, Viral; Uganda; Viral Load; Zidovudine

2010
Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial.
    Lancet (London, England), 2009, Dec-19, Volume: 374, Issue:9707

    Topics: Adenine; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Community Health Services; Female; HIV; HIV Infections; Home Care Services; Humans; Lamivudine; Male; Nevirapine; Organophosphonates; Stavudine; Tenofovir; Uganda; Zidovudine

2009
Temporal reduction of HIV type 1 viral load in breast milk by single-dose nevirapine during prevention of MTCT.
    AIDS research and human retroviruses, 2009, Volume: 25, Issue:12

    Topics: Anti-HIV Agents; Breast Feeding; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Milk, Human; Nevirapine; Postpartum Period; Viral Load; Zidovudine

2009
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.
    Lancet (London, England), 2010, Jan-09, Volume: 375, Issue:9709

    Topics: Adenine; Adolescent; Adult; Africa; Aged; Anemia; Anti-Retroviral Agents; CD4 Lymphocyte Count; Creatinine; Dideoxynucleosides; Disease Progression; Drug Monitoring; Female; Glomerular Filtration Rate; Hemoglobins; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Male; Middle Aged; Neutropenia; Neutrophils; Nevirapine; Organophosphonates; RNA, Viral; Tenofovir; Urea; Viral Load; Zidovudine

2010
Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
    HIV medicine, 2010, Volume: 11, Issue:5

    Topics: Adult; Body Weight; CD4 Lymphocyte Count; Dideoxynucleosides; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Medication Adherence; Middle Aged; Nevirapine; Recurrence; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Uganda; Viral Load; Zidovudine

2010
Eighteen-month follow-up of HIV-1-infected mothers and their children enrolled in the Kesho Bora study observational cohorts.
    Journal of acquired immune deficiency syndromes (1999), 2010, Volume: 54, Issue:5

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; Burkina Faso; CD4 Lymphocyte Count; Chemoprevention; Cohort Studies; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Kenya; Male; Mothers; Nevirapine; Prospective Studies; South Africa; Viral Load; Zidovudine

2010
Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.
    The New England journal of medicine, 2010, Jun-17, Volume: 362, Issue:24

    Topics: Adult; Anti-Retroviral Agents; Breast Feeding; CD4 Lymphocyte Count; Drug Hypersensitivity; Drug Therapy, Combination; Female; HIV Infections; HIV Seronegativity; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Lamivudine; Male; Neutropenia; Nevirapine; Pregnancy; Risk Factors; Stevens-Johnson Syndrome; Young Adult; Zidovudine

2010
Antiretroviral regimens in pregnancy and breast-feeding in Botswana.
    The New England journal of medicine, 2010, Jun-17, Volume: 362, Issue:24

    Topics: Adult; Antiretroviral Therapy, Highly Active; Breast Feeding; CD4 Lymphocyte Count; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Neutropenia; Nevirapine; Patient Compliance; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; RNA, Viral; Viral Load; Young Adult; Zidovudine

2010
Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: the Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges.
    Contemporary clinical trials, 2011, Volume: 32, Issue:1

    Topics: Africa, Eastern; Africa, Southern; Africa, Western; Anti-Retroviral Agents; Breast Feeding; Child, Preschool; Clinical Protocols; Cohort Studies; Delivery, Obstetric; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Mothers; Nevirapine; Pregnancy; Pyrimidinones; Research Design; Ritonavir; Zidovudine

2011
Growth of infants born to HIV-infected women in South Africa according to maternal and infant characteristics.
    Tropical medicine & international health : TM & IH, 2010, Volume: 15, Issue:11

    Topics: Adult; Anti-HIV Agents; Body Height; Body Weight; CD4 Lymphocyte Count; Epidemiologic Methods; Female; Growth Disorders; HIV Infections; Humans; Infant Formula; Infant Nutritional Physiological Phenomena; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Maternal Age; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Young Adult; Zidovudine

2010
Population pharmacokinetics of nevirapine in HIV-1-infected pregnant women and their neonates.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:1

    Topics: Adenine; Adult; Anti-HIV Agents; Deoxycytidine; Emtricitabine; Female; HIV Infections; Humans; Infant, Newborn; Nevirapine; Organophosphonates; Pregnancy; Tenofovir; Treatment Outcome; Young Adult; Zidovudine

2011
Long-term effectiveness and safety of didanosine combined with lamivudine and efavirenz or nevirapine in antiretroviral-naive patients: a 9-year cohort study in Senegal.
    Tropical medicine & international health : TM & IH, 2011, Volume: 16, Issue:2

    Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Treatment Outcome; Viral Load; Zidovudine

2011
Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    The Lancet. Infectious diseases, 2011, Volume: 11, Issue:3

    Topics: Adult; Africa South of the Sahara; Anti-HIV Agents; Breast Feeding; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Young Adult; Zidovudine

2011
Postexposure prophylaxis of breastfeeding HIV-exposed infants with antiretroviral drugs to age 14 weeks: updated efficacy results of the PEPI-Malawi trial.
    Journal of acquired immune deficiency syndromes (1999), 2011, Aug-01, Volume: 57, Issue:4

    Topics: Anti-HIV Agents; Breast Feeding; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Malawi; Male; Nevirapine; Post-Exposure Prophylaxis; Zidovudine

2011
Residual activity of two HIV antiretroviral regimens prescribed without virological monitoring.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dideoxynucleosides; HIV Infections; HIV-1; Humans; Lamivudine; Nevirapine; RNA, Viral; Viral Load; Zidovudine

2011
Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in Africa.
    Antiviral therapy, 2011, Volume: 16, Issue:7

    Topics: Adenine; Adult; Africa; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Creatinine; Dideoxynucleosides; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Kidney Glomerulus; Lamivudine; Male; Nevirapine; Organophosphonates; Risk Factors; Tenofovir; Time Factors; Zidovudine

2011
A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Jan-15, Volume: 54, Issue:2

    Topics: Adolescent; Adult; Anti-HIV Agents; Drug Administration Schedule; Drug Resistance, Viral; Female; HIV; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Middle Aged; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Viral Load; Zidovudine

2012
Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial.
    The Journal of infectious diseases, 2012, Feb-01, Volume: 205, Issue:3

    Topics: Acyclovir; Adolescent; Adult; Anti-HIV Agents; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Kenya; Milk, Human; Nevirapine; Placebos; Plasma; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; Treatment Outcome; Valacyclovir; Valine; Viral Load; Young Adult; Zidovudine

2012
Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children.
    Antiviral therapy, 2011, Volume: 16, Issue:8

    Topics: Anti-HIV Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Biological Availability; Body Weight; Child; Child, Preschool; Cytochrome P-450 CYP2B6; Drug Administration Schedule; Drug Combinations; Drug Dosage Calculations; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; HIV; HIV Infections; Humans; Infant; Lamivudine; Male; Nevirapine; Oxidoreductases, N-Demethylating; Reverse Transcriptase Inhibitors; Tablets; Zidovudine

2011
Short-course Combivir after single-dose nevirapine reduces but does not eliminate the emergence of nevirapine resistance in women.
    Antiviral therapy, 2012, Volume: 17, Issue:2

    Topics: Anti-HIV Agents; Drug Combinations; Drug Resistance, Viral; Female; Genotype; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; Viral Load; Zidovudine

2012
Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial.
    Lancet (London, England), 2012, Jun-30, Volume: 379, Issue:9835

    Topics: Adult; Anti-Retroviral Agents; Breast Feeding; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Young Adult; Zidovudine

2012
Effects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2.
    PloS one, 2012, Volume: 7, Issue:6

    Topics: Acyclovir; Antiviral Agents; Biomarkers; CD4 Antigens; Disease Progression; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Kenya; Linear Models; Nevirapine; Postpartum Period; Pregnancy; RNA, Viral; Valacyclovir; Valine; Zidovudine

2012
Three postpartum antiretroviral regimens to prevent intrapartum HIV infection.
    The New England journal of medicine, 2012, Jun-21, Volume: 366, Issue:25

    Topics: Anti-Retroviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant Formula; Infant, Newborn; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Lamivudine; Male; Nelfinavir; Nevirapine; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Zidovudine

2012
Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children.
    The New England journal of medicine, 2012, Jun-21, Volume: 366, Issue:25

    Topics: Anti-Retroviral Agents; CD4 Lymphocyte Count; Child, Preschool; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Kaplan-Meier Estimate; Lamivudine; Lopinavir; Male; Nevirapine; Ritonavir; RNA, Viral; Zidovudine

2012
Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.
    BMC pediatrics, 2012, Jul-08, Volume: 12

    Topics: Adolescent; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Child; Child, Preschool; Cohort Studies; Cyclopropanes; Drug Combinations; Female; Follow-Up Studies; Gambia; HIV Infections; HIV-1; HIV-2; Humans; Infant; Kaplan-Meier Estimate; Lamivudine; Lopinavir; Male; Nevirapine; Reverse Transcriptase Inhibitors; Ritonavir; Treatment Outcome; Viral Load; Zidovudine

2012
Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA.
    AIDS (London, England), 2012, Nov-13, Volume: 26, Issue:17

    Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anti-HIV Agents; Atrophy; CD4 Lymphocyte Count; DNA, Mitochondrial; Drug Combinations; Drug Therapy, Combination; HIV Seropositivity; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Prospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Subcutaneous Fat; Treatment Outcome; Young Adult; Zidovudine

2012
Anaemia in HIV-infected children: severity, types and effect on response to HAART.
    BMC pediatrics, 2012, Oct-31, Volume: 12

    Topics: Adolescent; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Cross-Sectional Studies; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Lamivudine; Logistic Models; Male; Nevirapine; Prevalence; Prospective Studies; Severity of Illness Index; Treatment Outcome; Uganda; Zidovudine

2012
Therapeutic levels of lopinavir in late pregnancy and abacavir passage into breast milk in the Mma Bana Study, Botswana.
    Antiviral therapy, 2013, Volume: 18, Issue:4

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Botswana; Breast Feeding; Dideoxynucleosides; Female; HIV Infections; HIV-1; Humans; Infant; Lactation; Lamivudine; Lopinavir; Middle Aged; Milk, Human; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Zidovudine

2013
A 72-week randomized study of the safety and efficacy of a stavudine to zidovudine switch at 24 weeks compared to zidovudine or tenofovir disoproxil fumarate when given with lamivudine and nevirapine.
    Antiviral therapy, 2012, Volume: 17, Issue:8

    Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Diet; Drug Administration Schedule; Drug Substitution; Female; Glomerular Filtration Rate; Hemoglobins; HIV Infections; Humans; Lamivudine; Male; Nevirapine; Organophosphonates; Peripheral Nervous System Diseases; Stavudine; Tenofovir; Treatment Outcome; Viral Load; Zidovudine

2012
Short communication: effect of short-course antenatal zidovudine and single-dose nevirapine on the BED capture enzyme immunoassay levels in HIV type 1 subtype C infection.
    AIDS research and human retroviruses, 2013, Volume: 29, Issue:6

    Topics: Adult; Anti-HIV Agents; Drug Administration Schedule; Female; HIV Antibodies; HIV Infections; HIV-1; Humans; Immunoenzyme Techniques; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Young Adult; Zidovudine

2013
A randomized pahse I bioequivalence clinincal trial of a paediatric fixed-dose combination antiretroviral reconstitutable suspension in healthy adult volunteers.
    Antiviral therapy, 2013, Volume: 18, Issue:2

    Topics: Adult; Anti-HIV Agents; Cross-Over Studies; Drug Combinations; Female; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Therapeutic Equivalency; Young Adult; Zidovudine

2013
Health outcomes of HIV-exposed uninfected African infants.
    AIDS (London, England), 2013, Mar-13, Volume: 27, Issue:5

    Topics: Anti-Retroviral Agents; Antiviral Agents; Breast Feeding; Cause of Death; Drug Therapy, Combination; Female; HIV Seropositivity; HIV-1; Humans; Infant; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Malawi; Morbidity; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Proportional Hazards Models; Zidovudine

2013
Long-term follow-up of children in the HIVNET 012 perinatal HIV prevention trial: five-year growth and survival.
    Journal of acquired immune deficiency syndromes (1999), 2013, Dec-15, Volume: 64, Issue:5

    Topics: Anthropometry; Anti-HIV Agents; Body Height; Body Weight; Chemoprevention; Child, Preschool; Female; Follow-Up Studies; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Nevirapine; Pregnancy; Survival Analysis; Zidovudine

2013
Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial in three African countries.
    BMC infectious diseases, 2013, Nov-06, Volume: 13

    Topics: Adult; Africa South of the Sahara; Anemia; Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine

2013
High rate of HIV resuppression after viral failure on first-line antiretroviral therapy in the absence of switch to second-line therapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Volume: 58, Issue:7

    Topics: Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; Humans; Lamivudine; Nevirapine; Viral Load; Viremia; Zidovudine

2014
Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.
    BMC research notes, 2014, Jan-21, Volume: 7

    Topics: Administration, Oral; Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Counseling; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Infusions, Intravenous; Kenya; Lamivudine; Medication Adherence; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Socioeconomic Factors; Viral Load; Viremia; Young Adult; Zidovudine

2014
High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial.
    PloS one, 2014, Volume: 9, Issue:3

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cross-Sectional Studies; Dideoxynucleosides; Drug Combinations; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Probability; Retrospective Studies; RNA, Viral; Tenofovir; Uganda; Viral Load; Zidovudine

2014
Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial.
    Antiviral therapy, 2014, Volume: 19, Issue:3

    Topics: Anthropometry; Anti-HIV Agents; Child; Child, Preschool; Cross-Sectional Studies; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Lipid Metabolism; Lipodystrophy; Lipoproteins, HDL; Lipoproteins, LDL; Male; Nevirapine; Stavudine; Triglycerides; Viral Load; Zidovudine

2014
First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting.
    AIDS (London, England), 2014, May-15, Volume: 28, Issue:8

    Topics: Adenine; Adult; CD4 Lymphocyte Count; Deoxycytidine; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Tenofovir; Treatment Outcome; Viral Load; Zidovudine

2014
Kericho CLinic-based ART Diagnostic Evaluation (CLADE): design, accrual, and baseline characteristics of a randomized controlled trial conducted in predominately rural, district-level, HIV clinics of Kenya.
    PloS one, 2015, Volume: 10, Issue:2

    Topics: Adult; Anti-HIV Agents; Cost-Benefit Analysis; Female; HIV Infections; HIV-1; Humans; Kenya; Male; Middle Aged; Nevirapine; Prospective Studies; Research Design; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load; Zidovudine

2015
Safety of zidovudine dose reduction in treatment-naïve HIV infected patients. A randomized controlled study (MiniZID).
    HIV medicine, 2016, Volume: 17, Issue:3

    Topics: Adult; Anemia; Anti-HIV Agents; Cameroon; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Nevirapine; Prospective Studies; Treatment Outcome; Zidovudine

2016
Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand.
    AIDS (London, England), 2015, Nov-28, Volume: 29, Issue:18

    Topics: Adult; Anti-HIV Agents; Chemoprevention; DNA, Viral; Double-Blind Method; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Placebos; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Thailand; Treatment Outcome; Young Adult; Zidovudine

2015
Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial.
    The Lancet. Infectious diseases, 2016, Volume: 16, Issue:2

    Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Child; Child, Preschool; Cyclopropanes; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Lamivudine; Male; Nevirapine; Stavudine; Tablets; Uganda; Zambia; Zidovudine

2016
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.
    The New England journal of medicine, 2016, 11-03, Volume: 375, Issue:18

    Topics: Adult; Anti-Retroviral Agents; Black or African American; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; Gestational Age; HIV Infections; Humans; Infant; Infant Mortality; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Nevirapine; Perinatal Care; Pregnancy; Pregnancy Outcome; Tenofovir; Young Adult; Zidovudine

2016
A randomized two-way crossover bioequivalence study in healthy adult volunteers of paediatric zidovudine/lamivudine/nevirapine fast-disintegrating fixed-dose combination tablet.
    The Journal of pharmacy and pharmacology, 2017, Volume: 69, Issue:4

    Topics: Adult; Cross-Over Studies; Drug Combinations; Female; Healthy Volunteers; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Solubility; Tablets; Therapeutic Equivalency; Young Adult; Zidovudine

2017
Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor- Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy, IMPAACT P1068s, Substudy to P1060.
    PloS one, 2016, Volume: 11, Issue:12

    Topics: Antimalarials; CD4 Lymphocyte Count; Child; Child, Preschool; Coinfection; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant; Lamivudine; Lopinavir; Malaria, Falciparum; Malawi; Male; Nevirapine; Plasmodium falciparum; Reverse Transcriptase Inhibitors; Ritonavir; Viral Load; Zidovudine

2016
Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for Neonates.
    Journal of acquired immune deficiency syndromes (1999), 2017, 08-15, Volume: 75, Issue:5

    Topics: Anti-HIV Agents; Breast Feeding; Chemoprevention; Clinical Protocols; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Nevirapine; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Thailand; World Health Organization; Zidovudine

2017
Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis.
    AIDS (London, England), 2019, 12-01, Volume: 33, Issue:15

    Topics: Adult; Anti-HIV Agents; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Emtricitabine; Female; Gestational Age; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Logistic Models; Lopinavir; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Risk; Ritonavir; Tenofovir; Ultrasonography, Prenatal; Young Adult; Zidovudine

2019
Lower Insulin Sensitivity in Newborns With In Utero HIV and Antiretroviral Exposure Who Are Uninfected in Botswana.
    The Journal of infectious diseases, 2022, 11-28, Volume: 226, Issue:11

    Topics: Anti-HIV Agents; Anti-Retroviral Agents; Botswana; Female; HIV Infections; Humans; Infant; Infant, Newborn; Insulin Resistance; Nevirapine; Pregnancy; Zidovudine

2022

Other Studies

485 other study(ies) available for nevirapine and zidovudine

ArticleYear
Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 2. Analogues of 3-aminopyridin-2(1H)-one.
    Journal of medicinal chemistry, 1992, Oct-16, Volume: 35, Issue:21

    Topics: Aminopyridines; Antiviral Agents; Benzoxazoles; Cells, Cultured; HIV Reverse Transcriptase; HIV-1; Pyridones; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

1992
Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 1. Tricyclic pyridobenzo- and dipyridodiazepinones.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:7

    Topics: Antiviral Agents; Azepines; Benzodiazepinones; Chemical Phenomena; Chemistry; HIV-1; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

1991
Synthesis and anti-HIV-1 activity of a series of imidazo[1,5-b]pyridazines.
    Journal of medicinal chemistry, 1993, Nov-26, Volume: 36, Issue:24

    Topics: Antiviral Agents; Cell Division; Cell Line; Crystallization; HIV Reverse Transcriptase; HIV-1; Imidazoles; Molecular Structure; Pyridazines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Virus Replication; Zidovudine

1993
1,2,3-Triazole-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D- ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"-oxathiole 2",2"-dioxide) (TSAO) analogues: synthesis and anti-HIV-1 activity.
    Journal of medicinal chemistry, 1994, Nov-25, Volume: 37, Issue:24

    Topics: Antiviral Agents; Base Sequence; Cells, Cultured; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Reverse Transcriptase Inhibitors; Spiro Compounds; Structure-Activity Relationship; Thymidine; Triazoles; Uridine

1994
Thiadiazole derivatives: highly potent and specific HIV-1 reverse transcriptase inhibitors.
    Journal of medicinal chemistry, 1995, Jun-09, Volume: 38, Issue:12

    Topics: Antiviral Agents; Cell Line; HIV Reverse Transcriptase; HIV-1; Humans; Reverse Transcriptase Inhibitors; Thiadiazoles

1995
Synthesis and anti-HIV-1 activity of thio analogues of dihydroalkoxybenzyloxopyrimidines.
    Journal of medicinal chemistry, 1995, Aug-18, Volume: 38, Issue:17

    Topics: Antiviral Agents; Cell Line; Cytopathogenic Effect, Viral; HIV-1; Humans; Magnetic Resonance Spectroscopy; Pyrimidines; Structure-Activity Relationship

1995
5-chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase.
    Journal of medicinal chemistry, 1993, Apr-30, Volume: 36, Issue:9

    Topics: Animals; Antiviral Agents; Base Sequence; Biological Availability; HIV; HIV Reverse Transcriptase; HIV-1; Indoles; Macaca mulatta; Molecular Sequence Data; Molecular Structure; Reverse Transcriptase Inhibitors; Sulfoxides

1993
Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships of novel substituted indole analogues and the identification of 1-[(5-methanesulfonamido-1H-indol-2-yl)-carbonyl]-4-[3- [(1-methylethyl)amino]-pyridinyl]pi
    Journal of medicinal chemistry, 1993, May-14, Volume: 36, Issue:10

    Topics: Antiviral Agents; Delavirdine; Indoles; Piperazines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Virus Replication

1993
Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs.
    Journal of medicinal chemistry, 1995, Dec-08, Volume: 38, Issue:25

    Topics: Animals; Antiviral Agents; Cell Line; HIV-1; Humans; Isothiocyanates; Rats; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiazoles; Thiourea

1995
2-Sulfonyl-4-chloroanilino moiety: a potent pharmacophore for the anti-human immunodeficiency virus type 1 activity of pyrrolyl aryl sulfones.
    Journal of medicinal chemistry, 1996, Jan-19, Volume: 39, Issue:2

    Topics: Antiviral Agents; Cell Line; Cytopathogenic Effect, Viral; HIV-1; HIV-2; Magnetic Resonance Spectroscopy; Sulfinic Acids; Sulfones

1996
Pyrrolobenzothiazepinones and pyrrolobenzoxazepinones: novel and specific non-nucleoside HIV-1 reverse transcriptase inhibitors with antiviral activity.
    Journal of medicinal chemistry, 1996, Jul-05, Volume: 39, Issue:14

    Topics: Antiviral Agents; Cell Line; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Molecular Structure; Oxazepines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Structure-Activity Relationship; Thiazepines

1996
Dihydro(alkylthio)(naphthylmethyl)oxopyrimidines: novel non-nucleoside reverse transcriptase inhibitors of the S-DABO series.
    Journal of medicinal chemistry, 1997, May-09, Volume: 40, Issue:10

    Topics: Cell Line; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Magnetic Resonance Spectroscopy; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

1997
Novel 1,1,3-trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine derivatives as non-nucleoside reverse transcriptase inhibitors that inhibit human immunodeficiency virus type 1 replication.
    Journal of medicinal chemistry, 1998, Oct-08, Volume: 41, Issue:21

    Topics: Cell Line; HIV Reverse Transcriptase; HIV-1; Humans; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiadiazines; Virus Replication

1998
Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus.
    Bioorganic & medicinal chemistry letters, 1999, Jun-07, Volume: 9, Issue:11

    Topics: Anti-HIV Agents; Delavirdine; Drug Design; Humans; Inhibitory Concentration 50; Kinetics; Models, Molecular; Nevirapine; Pyridines; Thiourea

1999
N-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea and N'-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-chloropyridyl)]-thiourea as potent inhibitors of multidrug-resistant human immunodeficiency virus-1.
    Bioorganic & medicinal chemistry letters, 1999, Sep-20, Volume: 9, Issue:18

    Topics: Aminopyridines; Anti-HIV Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Reverse Transcriptase Inhibitors; Thiourea

1999
N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)] thiourea as a potent inhibitor of NNI-resistant and multidrug-resistant human immunodeficiency virus-1.
    Bioorganic & medicinal chemistry letters, 1999, Dec-20, Volume: 9, Issue:24

    Topics: Anti-HIV Agents; Cells, Cultured; HIV-1; Humans; Microbial Sensitivity Tests; Models, Molecular; Pyridines; Reverse Transcriptase Inhibitors; Thiourea; Virus Replication

1999
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Synthesis and antiviral activity of 4-benzyl pyridinone derivatives as potent and selective non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors.
    Journal of medicinal chemistry, 2000, Oct-19, Volume: 43, Issue:21

    Topics: Anti-HIV Agents; Cell Line; Cells, Cultured; Drug Resistance, Microbial; HIV-1; Humans; Pyridones; Recombinant Proteins; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Structure-Activity Relationship; Virion; Virus Replication

2000
Quinoxalinylethylpyridylthioureas (QXPTs) as potent non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors. Further SAR studies and identification of a novel orally bioavailable hydrazine-based antiviral agent.
    Journal of medicinal chemistry, 2001, Feb-01, Volume: 44, Issue:3

    Topics: Animals; Anti-HIV Agents; Biological Availability; Cell Line; Didanosine; Drug Synergism; HIV Reverse Transcriptase; HIV-1; Humans; Mice; Models, Molecular; Pyridines; Quinoxalines; Reverse Transcriptase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Thiourea; Zidovudine

2001
The biological effects of structural variation at the meta position of the aromatic rings and at the end of the alkenyl chain in the alkenyldiarylmethane series of non-nucleoside reverse transcriptase inhibitors.
    Journal of medicinal chemistry, 2001, Nov-22, Volume: 44, Issue:24

    Topics: Alkenes; Benzene Derivatives; Cell Line; Cytopathogenic Effect, Viral; Drug Resistance, Multiple; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Humans; In Vitro Techniques; Leukocytes, Mononuclear; Models, Molecular; Monocytes; Mutagenesis, Site-Directed; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Virus Replication

2001
Threshold interaction energy of NRTI's (2'-deoxy 3'-substituted nucleosidic analogs of reverse transcriptase inhibitors) to undergo competitive inhibition.
    Bioorganic & medicinal chemistry letters, 2004, May-17, Volume: 14, Issue:10

    Topics: Anti-HIV Agents; Binding, Competitive; Inhibitory Concentration 50; Models, Molecular; Nucleosides; Protein Binding; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thermodynamics

2004
Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.
    Journal of medicinal chemistry, 2005, Nov-17, Volume: 48, Issue:23

    Topics: Amino Acid Sequence; Animals; Anti-HIV Agents; Binding Sites; Cells, Cultured; Conserved Sequence; Drug Design; Drug Resistance, Viral; Drug Synergism; HIV Reverse Transcriptase; HIV-1; Humans; Macrophages; Mice; Models, Molecular; Mutation; Oxazepines; Pyrroles; Reverse Transcriptase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Virus Replication; Zidovudine

2005
Parallel solution-phase and microwave-assisted synthesis of new S-DABO derivatives endowed with subnanomolar anti-HIV-1 activity.
    Journal of medicinal chemistry, 2005, Dec-15, Volume: 48, Issue:25

    Topics: Anti-HIV Agents; Cell Line; Drug Resistance, Multiple, Viral; HIV Reverse Transcriptase; HIV-1; Humans; Microwaves; Models, Molecular; Mutation; Pyrimidines; Pyrimidinones; Reverse Transcriptase Inhibitors; Solutions; Structure-Activity Relationship

2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Synthesis and biological investigation of S-aryl-S-DABO derivatives as HIV-1 inhibitors.
    Bioorganic & medicinal chemistry letters, 2006, Jul-01, Volume: 16, Issue:13

    Topics: Anti-HIV Agents; Binding Sites; Cell Death; Cell Line; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Pyrimidines; Reverse Transcriptase Inhibitors; Stereoisomerism; Structure-Activity Relationship

2006
Selective inhibition of porcine endogenous retrovirus replication in human cells by acyclic nucleoside phosphonates.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Adenine; Amino Acid Sequence; Animals; Antiviral Agents; Catalysis; Cell Line; Dose-Response Relationship, Drug; Endogenous Retroviruses; HIV-1; Humans; Kidney; Molecular Sequence Data; Organophosphonates; Polymerase Chain Reaction; Protein Structure, Tertiary; Reverse Transcriptase Inhibitors; Stavudine; Swine; Swine, Miniature; Tenofovir; Virus Replication; Zidovudine

2007
Intracellular metabolism and persistence of the anti-human immunodeficiency virus activity of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine, a novel thymidine analog.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11

    Topics: Anti-HIV Agents; Cell Line; Dideoxynucleotides; Dose-Response Relationship, Drug; HeLa Cells; HIV; Humans; Phosphorylation; Reverse Transcriptase Inhibitors; Stavudine; Thymine Nucleotides; Virus Replication; Zidovudine

2007
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Synthesis and anti-HIV evaluation of novel 1,3-disubstituted thieno[3,2-c][1,2,6]thiadiazin-4(3H)-one 2,2-dioxides(TTDDs).
    Bioorganic & medicinal chemistry, 2008, Jan-01, Volume: 16, Issue:1

    Topics: Cell Line; Heterocyclic Oxides; HIV-1; Humans; Inhibitory Concentration 50; Molecular Structure; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiadiazines

2008
Dihydro-alkylthio-benzyl-oxopyrimidines as inhibitors of reverse transcriptase: synthesis and rationalization of the biological data on both wild-type enzyme and relevant clinical mutants.
    Journal of medicinal chemistry, 2007, Dec-27, Volume: 50, Issue:26

    Topics: Anti-HIV Agents; Cell Line; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Mutation; Pyrimidines; Quantitative Structure-Activity Relationship; Recombinant Proteins; Reverse Transcriptase Inhibitors; Sulfides

2007
Mutations in human immunodeficiency virus type 1 integrase confer resistance to the naphthyridine L-870,810 and cross-resistance to the clinical trial drug GS-9137.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6

    Topics: Cell Line; Drug Resistance, Viral; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Models, Molecular; Mutation; Naphthyridines; Quinolones; Virus Replication

2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Bioorganic & medicinal chemistry letters, 2008, Oct-15, Volume: 18, Issue:20

    Topics: Anti-HIV Agents; Biological Assay; Cell Line; Chemistry, Pharmaceutical; Drug Design; Drug Evaluation, Preclinical; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Chemical; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiadiazoles; Virus Replication

2008
Studies on anti-HIV quinolones: new insights on the C-6 position.
    Bioorganic & medicinal chemistry, 2009, Jan-15, Volume: 17, Issue:2

    Topics: Anti-HIV Agents; HIV; Humans; Quinolones; Structure-Activity Relationship; Transcription, Genetic; Virus Replication

2009
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Bioorganic & medicinal chemistry, 2009, Jan-15, Volume: 17, Issue:2

    Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship

2009
Specific targeting of highly conserved residues in the HIV-1 reverse transcriptase primer grip region. 2. Stereoselective interaction to overcome the effects of drug resistant mutations.
    Journal of medicinal chemistry, 2009, Feb-26, Volume: 52, Issue:4

    Topics: Anti-HIV Agents; Conserved Sequence; Drug Resistance; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Mutation; Reverse Transcriptase Inhibitors; Stereoisomerism; Structure-Activity Relationship

2009
Human immunodeficiency virus type 1 isolates with the reverse transcriptase (RT) mutation Q145M retain nucleoside and nonnucleoside RT inhibitor susceptibility.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Amino Acid Sequence; Anti-HIV Agents; Drug Resistance, Viral; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Nucleosides; Phenotype; Reverse Transcriptase Inhibitors

2009
Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Adult; Amniotic Fluid; Anti-HIV Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Fetal Blood; Genitalia, Female; HIV-1; Humans; Hydrocortisone; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral

2009
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Synthesis and anti-HIV activity evaluation of 2-(4-(naphthalen-2-yl)-1,2,3-thiadiazol-5-ylthio)-N-acetamides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:11

    Topics: Acetamides; Anti-HIV Agents; Cell Line; HIV Infections; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Models, Molecular; Protein Binding; Structure-Activity Relationship

2009
Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Bioorganic & medicinal chemistry, 2009, Aug-15, Volume: 17, Issue:16

    Topics: Acetanilides; Anti-HIV Agents; Binding Sites; Computer Simulation; HIV Reverse Transcriptase; Humans; Imidazoles; Structure-Activity Relationship

2009
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
    Bioorganic & medicinal chemistry, 2009, Oct-01, Volume: 17, Issue:19

    Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Biomimetic synthesis and anti-HIV activity of dimeric phloroglucinols.
    Bioorganic & medicinal chemistry, 2010, Mar-01, Volume: 18, Issue:5

    Topics: Anti-HIV Agents; Biomimetic Materials; Dimerization; HIV Infections; HIV Reverse Transcriptase; Humans; Phloroglucinol; Structure-Activity Relationship; Virus Replication

2010
Combinations of mutations in the connection domain of human immunodeficiency virus type 1 reverse transcriptase: assessing the impact on nucleoside and nonnucleoside reverse transcriptase inhibitor resistance.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Amino Acid Substitution; Anti-HIV Agents; Drug Resistance, Viral; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutagenesis, Site-Directed; Mutation; Nucleosides; Phenotype; pol Gene Products, Human Immunodeficiency Virus; Protein Structure, Tertiary; Reverse Transcriptase Inhibitors; Virus Replication

2010
"Viologen" dendrimers as antiviral agents: the effect of charge number and distance.
    Journal of medicinal chemistry, 2010, May-13, Volume: 53, Issue:9

    Topics: Anti-HIV Agents; Antiviral Agents; Cell Line; Dendrimers; HIV; Humans; Static Electricity; Structure-Activity Relationship; Viologens

2010
Diarylaniline derivatives as a distinct class of HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Journal of medicinal chemistry, 2010, Jul-08, Volume: 53, Issue:13

    Topics: Aniline Compounds; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Hydrogen Bonding; Magnetic Resonance Spectroscopy; Models, Molecular; Reverse Transcriptase Inhibitors; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship

2010
Anti-HIV and antiplasmodial activity of original flavonoid derivatives.
    Bioorganic & medicinal chemistry, 2010, Aug-15, Volume: 18, Issue:16

    Topics: Anti-HIV Agents; Antimalarials; Cell Line; Cell Survival; Flavonoids; HIV; HIV Infections; Humans; Malaria, Falciparum; Plasmodium falciparum

2010
Lersivirine, a nonnucleoside reverse transcriptase inhibitor with activity against drug-resistant human immunodeficiency virus type 1.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10

    Topics: Cell Line; Cell Line, Tumor; Crystallography, X-Ray; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Mutagenesis, Site-Directed; Nitriles; Pyrazoles; Reverse Transcriptase Inhibitors

2010
Identification and characterization of persistent intracellular human immunodeficiency virus type 1 integrase strand transfer inhibitor activity.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:1

    Topics: Adenine; Anti-HIV Agents; Cell Line; HeLa Cells; HIV-1; Humans; Integrase Inhibitors; Organophosphonates; Pyrrolidinones; Quinolones; Raltegravir Potassium; Tenofovir; Zidovudine

2011
Synthesis and biological evaluation of novel dihydro-aryl/alkylsulfanyl-cyclohexylmethyl-oxopyrimidines (S-DACOs) as high active anti-HIV agents.
    Bioorganic & medicinal chemistry letters, 2011, Jan-15, Volume: 21, Issue:2

    Topics: Anti-HIV Agents; Cell Line; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Nevirapine; Pyrimidines; Structure-Activity Relationship; Zidovudine

2011
Synthesis of 9-substituted derivatives of berberine as anti-HIV agents.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:4

    Topics: Anti-HIV Agents; Berberine; Biological Products; Cell Line; HIV Reverse Transcriptase; HIV-1; Humans

2011
Antiviral activity of seed extract from Citrus bergamia towards human retroviruses.
    Bioorganic & medicinal chemistry, 2011, Mar-15, Volume: 19, Issue:6

    Topics: Benzoxepins; Citrus; HIV Reverse Transcriptase; HIV-1; Humans; Limonins; Reverse Transcriptase Inhibitors; Seeds

2011
Asymmetric total synthesis of (+)- and (-)-clusianone and (+)- and (-)-clusianone methyl enol ether via ACC alkylation and evaluation of their anti-HIV activity.
    Bioorganic & medicinal chemistry letters, 2011, Apr-15, Volume: 21, Issue:8

    Topics: Alkylation; Anti-HIV Agents; Benzophenones; Benzoquinones; Bridged Bicyclo Compounds; Cell Line; Ethers; HIV; Humans; Stereoisomerism

2011
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Bioorganic & medicinal chemistry, 2011, Jul-15, Volume: 19, Issue:14

    Topics: Anti-HIV Agents; Cell Line, Tumor; Crystallography, X-Ray; Dose-Response Relationship, Drug; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Pyrimidinones; Reverse Transcriptase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Virus Replication

2011
Synthesis and structure-activity relationship of novel diarylpyrimidines with hydromethyl linker (CH(OH)-DAPYs) as HIV-1 NNRTIs.
    Bioorganic & medicinal chemistry, 2011, Sep-01, Volume: 19, Issue:17

    Topics: Aniline Compounds; Cell Line; Chlorine; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

2011
Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of novel 2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides as potent HIV-1 inhibitors.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:10

    Topics: Acetamides; Anti-HIV Agents; Cell Line; HIV Infections; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Triazoles; Virus Replication

2011
Design, synthesis and biological evaluation of cycloalkyl arylpyrimidines (CAPYs) as HIV-1 NNRTIs.
    Bioorganic & medicinal chemistry, 2011, Dec-01, Volume: 19, Issue:23

    Topics: Anti-HIV Agents; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

2011
Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors.
    European journal of medicinal chemistry, 2012, Volume: 51

    Topics: Anti-HIV Agents; Cell Line; Chemistry Techniques, Synthetic; HIV Reverse Transcriptase; HIV-1; Inhibitory Concentration 50; Piperidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Triazines

2012
Chiral resolution, absolute configuration assignment and biological activity of racemic diarylpyrimidine CH(OH)-DAPY as potent nonnucleoside HIV-1 reverse transcriptase inhibitors.
    European journal of medicinal chemistry, 2012, Volume: 53

    Topics: HIV Reverse Transcriptase; HIV-1; HIV-2; Models, Molecular; Protein Conformation; Pyrimidines; Reverse Transcriptase Inhibitors; Stereoisomerism

2012
Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors.
    Bioorganic & medicinal chemistry, 2012, Jun-15, Volume: 20, Issue:12

    Topics: Amines; Anti-HIV Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Design; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Piperidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Triazines

2012
Diverse combinatorial design, synthesis and in vitro evaluation of new HEPT analogues as potential non-nucleoside HIV-1 reverse transcription inhibitors.
    European journal of medicinal chemistry, 2012, Volume: 54

    Topics: Cell Line; Chemistry Techniques, Synthetic; Combinatorial Chemistry Techniques; Drug Design; HIV Reverse Transcriptase; HIV-1; Reverse Transcriptase Inhibitors; Thymine

2012
New nitrogen containing substituents at the indole-2-carboxamide yield high potent and broad spectrum indolylarylsulfone HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Journal of medicinal chemistry, 2012, Jul-26, Volume: 55, Issue:14

    Topics: Cell Line; HIV Reverse Transcriptase; HIV-1; Indoles; Mutation; Nitrogen; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Sulfones

2012
Arylazolyl(azinyl)thioacetanilides. Part 10: design, synthesis and biological evaluation of novel substituted imidazopyridinylthioacetanilides as potent HIV-1 inhibitors.
    Bioorganic & medicinal chemistry, 2012, Sep-15, Volume: 20, Issue:18

    Topics: Acetanilides; Anti-HIV Agents; Cell Line; Dose-Response Relationship, Drug; Drug Design; HIV-1; Humans; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Virus Replication

2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Structure-based bioisosterism design, synthesis and biological evaluation of novel 1,2,4-triazin-6-ylthioacetamides as potent HIV-1 NNRTIs.
    Bioorganic & medicinal chemistry letters, 2012, Dec-01, Volume: 22, Issue:23

    Topics: Binding Sites; Cell Line; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Docking Simulation; Protein Structure, Tertiary; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thioglycolates; Triazines

2012
Discovery of novel 2-(3-(2-chlorophenyl)pyrazin-2-ylthio)-N-arylacetamides as potent HIV-1 inhibitors using a structure-based bioisosterism approach.
    Bioorganic & medicinal chemistry, 2012, Dec-01, Volume: 20, Issue:23

    Topics: Anti-HIV Agents; Drug Design; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Structure-Activity Relationship; Thioacetamide

2012
Synthesis, biological evaluation and molecular modeling of 4,6-diarylpyrimidines and diarylbenzenes as novel non-nucleosides HIV-1 reverse transcriptase inhibitors.
    European journal of medicinal chemistry, 2012, Volume: 58

    Topics: Anti-HIV Agents; Antineoplastic Agents; Benzene Derivatives; Cell Survival; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Models, Molecular; Molecular Structure; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Tumor Cells, Cultured

2012
Cytotoxic, antitopoisomerase IIα, and anti-HIV-1 activities of triterpenoids isolated from leaves and twigs of Gardenia carinata.
    Journal of natural products, 2013, Apr-26, Volume: 76, Issue:4

    Topics: Anti-HIV Agents; Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Gardenia; HIV-1; Microbial Sensitivity Tests; Molecular Structure; Plant Leaves; Plant Stems; Thailand; Topoisomerase II Inhibitors; Triterpenes

2013
Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    European journal of medicinal chemistry, 2013, Volume: 65

    Topics: Anti-HIV Agents; Benzophenones; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Design; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

2013
Synthesis and evaluation of novel 3-(3,5-dimethylbenzyl)uracil analogs as potential anti-HIV-1 agents.
    Bioorganic & medicinal chemistry, 2013, Sep-15, Volume: 21, Issue:18

    Topics: Binding Sites; Cell Line; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Dynamics Simulation; Picolinic Acids; Protein Structure, Tertiary; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Uracil; Virus Replication

2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Towards new C6-rigid S-DABO HIV-1 reverse transcriptase inhibitors: synthesis, biological investigation and molecular modeling studies.
    Bioorganic & medicinal chemistry, 2013, Nov-01, Volume: 21, Issue:21

    Topics: Binding Sites; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Docking Simulation; Protein Binding; Protein Structure, Tertiary; Pyrimidines; Pyrimidinones; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

2013
Design, synthesis and preliminary SAR studies of novel N-arylmethyl substituted piperidine-linked aniline derivatives as potent HIV-1 NNRTIs.
    Bioorganic & medicinal chemistry, 2014, Jan-01, Volume: 22, Issue:1

    Topics: Aniline Compounds; Anti-HIV Agents; Drug Design; HIV-1; Humans; Models, Molecular; Piperidines; Structure-Activity Relationship

2014
Phenylspirodrimanes with anti-HIV activity from the sponge-derived fungus Stachybotrys chartarum MXH-X73.
    Journal of natural products, 2013, Dec-27, Volume: 76, Issue:12

    Topics: Animals; Anti-HIV Agents; HIV-1; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Polycyclic Sesquiterpenes; Porifera; Reverse Transcriptase Inhibitors; Sesquiterpenes; Spiro Compounds; Stachybotrys; Structure-Activity Relationship

2013
Discovery of nitropyridine derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors via a structure-based core refining approach.
    European journal of medicinal chemistry, 2014, Apr-09, Volume: 76

    Topics: Cell Line; Drug Discovery; HIV Reverse Transcriptase; HIV-1; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Pyridines; Reverse Transcriptase Inhibitors; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Virus Replication

2014
Structural modifications of CH(OH)-DAPYs as new HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Bioorganic & medicinal chemistry, 2014, Apr-15, Volume: 22, Issue:8

    Topics: Binding Sites; Cell Line; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Docking Simulation; Protein Structure, Tertiary; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

2014
New indolylarylsulfones as highly potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors.
    European journal of medicinal chemistry, 2014, Jun-10, Volume: 80

    Topics: Cell Line; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Indoles; Inhibitory Concentration 50; Models, Molecular; Protein Conformation; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Sulfones

2014
Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Bioorganic & medicinal chemistry, 2014, Jun-15, Volume: 22, Issue:12

    Topics: Anti-HIV Agents; Benzamides; Cell Survival; Cells, Cultured; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Tumor Cells, Cultured; Virus Replication

2014
Synthesis of novel fluoro analogues of MKC442 as microbicides.
    Journal of medicinal chemistry, 2014, Jun-26, Volume: 57, Issue:12

    Topics: Anti-HIV Agents; Cell Line; Drug Resistance, Viral; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Pyrimidinones; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Uracil

2014
Jatrophane diterpenes as inhibitors of chikungunya virus replication: structure-activity relationship and discovery of a potent lead.
    Journal of natural products, 2014, Jun-27, Volume: 77, Issue:6

    Topics: Alphavirus Infections; Antiviral Agents; Chikungunya Fever; Chikungunya virus; Diterpenes; Euphorbia; France; HIV-1; HIV-2; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Semliki forest virus; Sindbis Virus; Structure-Activity Relationship; Virus Replication

2014
Design and synthesis of a new series of modified CH-diarylpyrimidines as drug-resistant HIV non-nucleoside reverse transcriptase inhibitors.
    European journal of medicinal chemistry, 2014, Jul-23, Volume: 82

    Topics: Anti-HIV Agents; Dose-Response Relationship, Drug; Drug Design; HIV Reverse Transcriptase; HIV-1; HIV-2; Microbial Sensitivity Tests; Molecular Structure; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

2014
2,4,5-Trisubstituted thiazole derivatives: a novel and potent class of non-nucleoside inhibitors of wild type and mutant HIV-1 reverse transcriptase.
    European journal of medicinal chemistry, 2014, Oct-06, Volume: 85

    Topics: Drug Design; Drug Resistance, Viral; HEK293 Cells; HIV Reverse Transcriptase; HIV-1; Humans; Inhibitory Concentration 50; Models, Molecular; Mutation; Protein Conformation; Quantitative Structure-Activity Relationship; Reverse Transcriptase Inhibitors; Thiazoles

2014
Design, synthesis and anti-HIV evaluation of novel diarylnicotinamide derivatives (DANAs) targeting the entrance channel of the NNRTI binding pocket through structure-guided molecular hybridization.
    European journal of medicinal chemistry, 2014, Nov-24, Volume: 87

    Topics: Anti-HIV Agents; Catalytic Domain; Dose-Response Relationship, Drug; Drug Design; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Molecular Structure; Niacinamide; Protein Conformation; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Tumor Cells, Cultured

2014
Synthesis and biological evaluation of DAPY-DPEs hybrids as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Bioorganic & medicinal chemistry, 2015, Feb-01, Volume: 23, Issue:3

    Topics: Anti-HIV Agents; Binding Sites; Cell Line; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

2015
Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches.
    European journal of medicinal chemistry, 2015, Mar-06, Volume: 92

    Topics: Anti-HIV Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Heterocyclic Compounds; Heterocyclic Compounds, 2-Ring; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Nitrogen; Reverse Transcriptase Inhibitors; Solubility; Structure-Activity Relationship; Sulfones

2015
Design, synthesis of new β-carboline derivatives and their selective anti-HIV-2 activity.
    Bioorganic & medicinal chemistry letters, 2015, Mar-15, Volume: 25, Issue:6

    Topics: Carbolines; Drug Design; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Piperazines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

2015
Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 4: design, synthesis and biological evaluation of novel imidazo[1,2-a]pyrazines.
    European journal of medicinal chemistry, 2015, Mar-26, Volume: 93

    Topics: Anti-HIV Agents; Chemistry Techniques, Synthetic; Computational Biology; Drug Design; HIV Reverse Transcriptase; HIV-1; Imidazoles; Molecular Docking Simulation; Protein Conformation; Pyrazines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

2015
Anti-HIV diarylpyrimidine-quinolone hybrids and their mode of action.
    Bioorganic & medicinal chemistry, 2015, Jul-01, Volume: 23, Issue:13

    Topics: Anti-HIV Agents; Binding Sites; Cell Line; Drug Design; Granulocyte Precursor Cells; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Molecular Docking Simulation; Pyrimidines; Quinolones; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Tetradecanoylphorbol Acetate; Virus Latency

2015
Antiviral Activity of Flexibilane and Tigliane Diterpenoids from Stillingia lineata.
    Journal of natural products, 2015, May-22, Volume: 78, Issue:5

    Topics: Antiviral Agents; Chikungunya virus; Diterpenes; Euphorbiaceae; France; HCT116 Cells; HIV-1; HIV-2; Humans; Macrocyclic Compounds; MCF-7 Cells; Molecular Structure; Semliki forest virus; Sindbis Virus; Virus Replication

2015
Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV Activity.
    Journal of medicinal chemistry, 2015, Dec-24, Volume: 58, Issue:24

    Topics: Anti-HIV Agents; Benzamides; Cell Line, Tumor; Drug Resistance, Viral; gag Gene Products, Human Immunodeficiency Virus; Glutamic Acid; Glycine; HIV-1; Humans; Isoleucine; Molecular Docking Simulation; Molecular Dynamics Simulation; Organoselenium Compounds; Simian Immunodeficiency Virus; Structure-Activity Relationship

2015
Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives targeting the entrance channel of NNRTI binding pocket.
    European journal of medicinal chemistry, 2016, Feb-15, Volume: 109

    Topics: Anti-HIV Agents; Binding Sites; Drug Design; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Docking Simulation; Point Mutation; Pyridines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

2016
Design, synthesis and evaluation of novel HIV-1 NNRTIs with dual structural conformations targeting the entrance channel of the NNRTI binding pocket.
    European journal of medicinal chemistry, 2016, Jun-10, Volume: 115

    Topics: Anti-HIV Agents; Binding Sites; Dose-Response Relationship, Drug; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Structure; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Virus Replication

2016
Design, synthesis and anti-HIV activity of novel quinoxaline derivatives.
    European journal of medicinal chemistry, 2016, Jul-19, Volume: 117

    Topics: Animals; Anti-HIV Agents; Chlorocebus aethiops; Computer Simulation; Drug Design; HIV Integrase; Molecular Docking Simulation; Quantitative Structure-Activity Relationship; Quinoxalines; Vero Cells

2016
1,6-Bis[(benzyloxy)methyl]uracil derivatives-Novel antivirals with activity against HIV-1 and influenza H1N1 virus.
    Bioorganic & medicinal chemistry, 2016, 06-01, Volume: 24, Issue:11

    Topics: Animals; Antiviral Agents; Cells, Cultured; Dogs; Dose-Response Relationship, Drug; HIV-1; Influenza A Virus, H1N1 Subtype; Madin Darby Canine Kidney Cells; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Uracil

2016
Synthesis and antiproliferative evaluation of novel 2-(4H-1,2,4-triazole-3-ylthio)acetamide derivatives as inducers of apoptosis in cancer cells.
    European journal of medicinal chemistry, 2016, Oct-04, Volume: 121

    Topics: Acetamides; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Membrane Potential, Mitochondrial; Structure-Activity Relationship; Triazoles

2016
Systematic evaluation of methyl ester bioisosteres in the context of developing alkenyldiarylmethanes (ADAMs) as non-nucleoside reverse transcriptase inhibitors (NNRTIs) for anti-HIV-1 chemotherapy.
    Bioorganic & medicinal chemistry, 2016, 07-01, Volume: 24, Issue:13

    Topics: Anti-HIV Agents; Drug Stability; Esters; HIV-1; Humans; Inhibitory Concentration 50; Methane; Models, Molecular; Reverse Transcriptase Inhibitors

2016
Structural optimization of pyridine-type DAPY derivatives to exploit the tolerant regions of the NNRTI binding pocket.
    European journal of medicinal chemistry, 2016, Oct-04, Volume: 121

    Topics: Binding Sites; Dose-Response Relationship, Drug; Drug Design; HIV Reverse Transcriptase; Molecular Docking Simulation; Protein Conformation; Pyridines; Pyrimidines; Reverse Transcriptase Inhibitors; Solubility; Structure-Activity Relationship; Water

2016
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone

2016
Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles.
    Journal of medicinal chemistry, 2016, 09-08, Volume: 59, Issue:17

    Topics: Animals; Anti-HIV Agents; Cell Line, Tumor; Drug Resistance, Viral; Heterocyclic Compounds, 2-Ring; HIV Reverse Transcriptase; HIV-1; Humans; Male; Mice; Molecular Docking Simulation; Mutation; Pyrimidines; Rats, Sprague-Dawley; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Sulfonamides; Thiophenes

2016
Synthesis of arylated coumarins by Suzuki-Miyaura cross-coupling. Reactions and anti-HIV activity.
    Bioorganic & medicinal chemistry, 2016, 11-01, Volume: 24, Issue:21

    Topics: Anti-HIV Agents; Cell Line, Tumor; Coumarins; Crystallography, X-Ray; Dose-Response Relationship, Drug; HIV-1; HIV-2; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Structure-Activity Relationship

2016
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Discovery of uracil-bearing DAPYs derivatives as novel HIV-1 NNRTIs via crystallographic overlay-based molecular hybridization.
    European journal of medicinal chemistry, 2017, Apr-21, Volume: 130

    Topics: Animals; Anti-HIV Agents; Cell Line; Drug Discovery; HIV Reverse Transcriptase; HIV-1; Mice; Models, Molecular; Reverse Transcriptase Inhibitors; Solubility; Structure-Activity Relationship; Uracil

2017
Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120.
    Journal of medicinal chemistry, 2017, 04-13, Volume: 60, Issue:7

    Topics: Anti-HIV Agents; Biomimetic Materials; CD4 Antigens; Cell Line; Crystallography, X-Ray; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Molecular Docking Simulation; Molecular Targeted Therapy; Pyrroles; Structure-Activity Relationship; Thiazoles; Virus Internalization

2017
Structural modifications of diarylpyrimidines (DAPYs) as HIV-1 NNRTIs: Synthesis, anti-HIV activities and SAR.
    Bioorganic & medicinal chemistry, 2017, 04-15, Volume: 25, Issue:8

    Topics: Anti-HIV Agents; Carbon-13 Magnetic Resonance Spectroscopy; HIV-1; Molecular Docking Simulation; Proton Magnetic Resonance Spectroscopy; Pyrimidines; Reverse Transcriptase Inhibitors; Spectrometry, Mass, Electrospray Ionization

2017
Design and synthesis of hybrids of diarylpyrimidines and diketo acids as HIV-1 inhibitors.
    Bioorganic & medicinal chemistry letters, 2017, 04-15, Volume: 27, Issue:8

    Topics: Anti-HIV Agents; Cell Line; Drug Design; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Keto Acids; Molecular Docking Simulation; Pyrimidines; Reverse Transcriptase Inhibitors

2017
An integrated chemical biology approach reveals the mechanism of action of HIV replication inhibitors.
    Bioorganic & medicinal chemistry, 2017, 12-01, Volume: 25, Issue:23

    Topics: Binding Sites; Cells, Cultured; Genotype; Half-Life; HIV Reverse Transcriptase; HIV-1; Humans; Inhibitory Concentration 50; Microfluidics; Microsomes; Molecular Conformation; Molecular Docking Simulation; Pyrimidinones; Reverse Transcriptase Inhibitors; Stereoisomerism; Virus Replication

2017
Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants.
    Journal of medicinal chemistry, 2017, 05-25, Volume: 60, Issue:10

    Topics: Animals; Anti-HIV Agents; Drug Resistance, Viral; HEK293 Cells; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Pyrimidines; Rats, Sprague-Dawley; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiophenes

2017
Potent Inhibitor of Drug-Resistant HIV-1 Strains Identified from the Medicinal Plant Justicia gendarussa.
    Journal of natural products, 2017, 06-23, Volume: 80, Issue:6

    Topics: Anti-HIV Agents; Glycosides; HIV-1; Humans; Justicia; Lignans; Molecular Structure; Plant Roots; Plant Stems; Plants, Medicinal; Reverse Transcriptase Inhibitors; Vietnam; Zidovudine

2017
Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents.
    Journal of medicinal chemistry, 2017, 08-10, Volume: 60, Issue:15

    Topics: Animals; Anti-HIV Agents; Cells, Cultured; Glutamic Acid; HIV-1; Humans; Indoles; Lipopolysaccharides; Mice, Inbred C57BL; Microglia; Molecular Docking Simulation; Mutation; Neurons; Neuroprotective Agents; Reverse Transcriptase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Sulfones

2017
Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives as potent HIV-1 NNRTIs.
    European journal of medicinal chemistry, 2017, Nov-10, Volume: 140

    Topics: Anti-HIV Agents; Carbon-13 Magnetic Resonance Spectroscopy; Cell Line; Drug Design; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Proton Magnetic Resonance Spectroscopy; Reverse Transcriptase Inhibitors; Spectrometry, Mass, Electrospray Ionization

2017
Discovery of Thiophene[3,2-
    ACS medicinal chemistry letters, 2017, Nov-09, Volume: 8, Issue:11

    Topics:

2017
Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1.
    European journal of medicinal chemistry, 2018, Feb-10, Volume: 145

    Topics: Anti-HIV Agents; Biphenyl Compounds; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mutation; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Tumor Cells, Cultured

2018
The discovery of novel diarylpyri(mi)dine derivatives with high level activity against a wide variety of HIV-1 strains as well as against HIV-2.
    Bioorganic & medicinal chemistry, 2018, 05-01, Volume: 26, Issue:8

    Topics: Allosteric Regulation; Binding Sites; Drug Design; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Molecular Docking Simulation; Protein Structure, Tertiary; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

2018
Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus.
    European journal of medicinal chemistry, 2018, May-10, Volume: 151

    Topics: Anti-HIV Agents; Drug Design; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Docking Simulation; Niacinamide; Point Mutation; Structure-Activity Relationship; Triazoles

2018
Discovery of Novel Diarylpyrimidine Derivatives as Potent HIV-1 NNRTIs Targeting the "NNRTI Adjacent" Binding Site.
    ACS medicinal chemistry letters, 2018, Apr-12, Volume: 9, Issue:4

    Topics:

2018
Further Exploring Solvent-Exposed Tolerant Regions of Allosteric Binding Pocket for Novel HIV-1 NNRTIs Discovery.
    ACS medicinal chemistry letters, 2018, Apr-12, Volume: 9, Issue:4

    Topics:

2018
The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic.
    Journal of medicinal chemistry, 2019, 05-23, Volume: 62, Issue:10

    Topics: Animals; Anti-HIV Agents; Clinical Trials as Topic; Drug Discovery; HIV Infections; HIV-1; Humans; Reverse Transcriptase Inhibitors

2019
Synthesis and in-vitro anti-HIV-1 evaluation of novel pyrazolo[4,3-c]pyridin-4-one derivatives.
    European journal of medicinal chemistry, 2019, Dec-01, Volume: 183

    Topics: Anti-HIV Agents; Blood-Brain Barrier; Cell Survival; Drug Design; HeLa Cells; HIV Reverse Transcriptase; Humans; Molecular Docking Simulation; Molecular Structure; Protein Binding; Pyrazoles; Pyridines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

2019
Discovery of 2-isoxazol-3-yl-acetamide analogues as heat shock protein 90 (HSP90) inhibitors with significant anti-HIV activity.
    European journal of medicinal chemistry, 2019, Dec-01, Volume: 183

    Topics: Acetamides; Androstenols; Anti-HIV Agents; Dose-Response Relationship, Drug; Drug Discovery; HIV-1; HSP90 Heat-Shock Proteins; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Virus Replication

2019
Indazolyl-substituted piperidin-4-yl-aminopyrimidines as HIV-1 NNRTIs: Design, synthesis and biological activities.
    European journal of medicinal chemistry, 2020, Jan-15, Volume: 186

    Topics: Anti-HIV Agents; Dose-Response Relationship, Drug; Drug Design; HIV; HIV Reverse Transcriptase; Humans; Indazoles; Microbial Sensitivity Tests; Molecular Structure; Piperidines; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

2020
New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains.
    European journal of medicinal chemistry, 2020, Dec-15, Volume: 208

    Topics: Anti-HIV Agents; Cell Line, Tumor; Drug Design; Drug Synergism; HIV Reverse Transcriptase; HIV-1; Humans; Indoles; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Mutation; Protein Binding; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Sulfones; Zidovudine

2020
Targeting dual tolerant regions of binding pocket: Discovery of novel morpholine-substituted diarylpyrimidines as potent HIV-1 NNRTIs with significantly improved water solubility.
    European journal of medicinal chemistry, 2020, Nov-15, Volume: 206

    Topics: Binding Sites; HIV Reverse Transcriptase; HIV-1; Morpholines; Mutation; Pyrimidines; Reverse Transcriptase Inhibitors; Solubility; Structure-Activity Relationship; Water

2020
Exploiting the tolerant region I of the non-nucleoside reverse transcriptase inhibitor (NNRTI) binding pocket. Part 2: Discovery of diarylpyrimidine derivatives as potent HIV-1 NNRTIs with high Fsp
    European journal of medicinal chemistry, 2021, Mar-05, Volume: 213

    Topics: Anti-HIV Agents; Binding Sites; Drug Design; HIV-1; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Binding; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

2021
Design, synthesis, and evaluation of "dual-site"-binding diarylpyrimidines targeting both NNIBP and the NNRTI adjacent site of the HIV-1 reverse transcriptase.
    European journal of medicinal chemistry, 2021, Feb-05, Volume: 211

    Topics: Anti-HIV Agents; Drug Design; HIV Reverse Transcriptase; Humans; Molecular Dynamics Simulation; Molecular Structure; Pyrimidines; Structure-Activity Relationship

2021
Design, synthesis and anti-HIV evaluation of novel 5-substituted diarylpyrimidine derivatives as potent HIV-1 NNRTIs.
    Bioorganic & medicinal chemistry, 2021, 06-15, Volume: 40

    Topics: Anti-HIV Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Design; HIV; HIV Reverse Transcriptase; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

2021
Exploiting the hydrophobic channel of the NNIBP: Discovery of novel diarylpyrimidines as HIV-1 NNRTIs against wild-type and K103N mutant viruses.
    Bioorganic & medicinal chemistry, 2021, 07-15, Volume: 42

    Topics: Anti-HIV Agents; Dose-Response Relationship, Drug; Drug Discovery; HIV Reverse Transcriptase; HIV-1; Humans; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Molecular Structure; Mutation; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

2021
Design of the naphthyl-diarylpyrimidines as potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) via structure-based extension into the entrance channel.
    European journal of medicinal chemistry, 2021, Dec-15, Volume: 226

    Topics: Anti-HIV Agents; Dose-Response Relationship, Drug; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Structure; Naphthalenes; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

2021
Chemical space exploration around indolylarylsulfone scaffold led to a novel class of highly active HIV-1 NNRTIs with spiro structural features.
    European journal of medicinal chemistry, 2022, Aug-05, Volume: 238

    Topics: Anti-HIV Agents; Drug Design; HIV Reverse Transcriptase; HIV-1; Molecular Structure; Reverse Transcriptase Inhibitors; Space Flight; Structure-Activity Relationship

2022
Expansion of the S-CN-DABO scaffold to exploit the impact on inhibitory activities against the non-nucleoside HIV-1 reverse transcriptase.
    European journal of medicinal chemistry, 2022, Aug-05, Volume: 238

    Topics: Animals; Anti-HIV Agents; HIV Reverse Transcriptase; HIV-1; Mice; Molecular Docking Simulation; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

2022
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
3'-Azido-3'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:12

    Topics: Antiviral Agents; Base Sequence; Benzodiazepines; Cloning, Molecular; Drug Resistance, Microbial; HIV Reverse Transcriptase; HIV-1; Humans; Imidazoles; Molecular Sequence Data; Mutagenesis, Site-Directed; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Zidovudine

1992
In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase.
    Molecular pharmacology, 1992, Volume: 41, Issue:3

    Topics: Antiviral Agents; Base Sequence; Benzodiazepines; CD4-Positive T-Lymphocytes; Cloning, Molecular; Drug Resistance, Microbial; Foscarnet; Gene Expression; HeLa Cells; HIV-1; Humans; Imidazoles; Molecular Sequence Data; Nevirapine; Phosphonoacetic Acid; Polymerase Chain Reaction; Pyridines; Recombinant Proteins; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Zidovudine

1992
HIV-1 reverse transcriptase inhibition by a dipyridodiazepinone derivative: BI-RG-587.
    Biochemical pharmacology, 1992, Mar-17, Volume: 43, Issue:6

    Topics: Antiviral Agents; Foscarnet; HIV-1; Kinetics; Nevirapine; Phosphonoacetic Acid; Pyridines; Reverse Transcriptase Inhibitors; Templates, Genetic; Zidovudine

1992
BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:2

    Topics: Antigens, Viral; Antiviral Agents; Cytopathogenic Effect, Viral; Drug Resistance, Microbial; Drug Synergism; HeLa Cells; HIV-1; HIV-2; Humans; Macrophages; Nevirapine; Picornaviridae; Pyridines; Reverse Transcriptase Inhibitors; T-Lymphocytes; Viral Plaque Assay; Zidovudine

1991
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.
    Journal of virology, 1994, Volume: 68, Issue:3

    Topics: Antiviral Agents; Base Sequence; CD4-Positive T-Lymphocytes; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV Core Protein p24; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Leukocyte Count; Molecular Sequence Data; Mutagenesis; Nevirapine; Phenotype; Pyridines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; RNA, Viral; Selection, Genetic; Time Factors; Zidovudine

1994
Combinative interactions of a human immunodeficiency virus (HIV) Tat antagonist with HIV reverse transcriptase inhibitors and an HIV protease inhibitor.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:2

    Topics: Antiviral Agents; Benzodiazepines; Didanosine; Drug Synergism; Gene Products, tat; HeLa Cells; HIV; HIV Protease Inhibitors; Humans; Isoquinolines; Nevirapine; Pyridines; Pyrroles; Quinolines; Reverse Transcriptase Inhibitors; Saquinavir; tat Gene Products, Human Immunodeficiency Virus; Zalcitabine; Zidovudine

1994
Development of a human immunodeficiency virus-1 in vitro DNA synthesis system to study reverse transcriptase inhibitors.
    Antiviral research, 1994, Volume: 23, Issue:3-4

    Topics: Dideoxynucleotides; DNA, Viral; HIV Reverse Transcriptase; HIV-1; Hydrogen-Ion Concentration; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Thymine Nucleotides; Time Factors; Zidovudine

1994
Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
    AIDS research and human retroviruses, 1994, Volume: 10, Issue:8

    Topics: Amino Acid Sequence; Base Sequence; Binding Sites; Catalysis; Deoxyguanine Nucleotides; Dideoxynucleotides; DNA, Viral; Drug Resistance, Microbial; HIV Reverse Transcriptase; HIV-1; Hot Temperature; Humans; Kinetics; Molecular Sequence Data; Mutation; Nevirapine; Phenanthrolines; Pyridines; Reverse Transcriptase Inhibitors; Ribonuclease H; RNA-Directed DNA Polymerase; Templates, Genetic; Thymine Nucleotides; Tyrosine; Zidovudine

1994
Natural occurrence of drug resistance mutations in the reverse transcriptase of human immunodeficiency virus type 1 isolates.
    AIDS research and human retroviruses, 1994, Volume: 10, Issue:11

    Topics: Amino Acid Sequence; Antiviral Agents; Base Sequence; Cloning, Molecular; DNA, Viral; Drug Resistance, Microbial; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Mutation; Nevirapine; Point Mutation; Polymerase Chain Reaction; Pyridines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Stavudine; Virus Cultivation; Zalcitabine; Zidovudine

1994
Fluorometric measurement of reverse transcriptase activity with 4',6-diamidino-2-phenylindole.
    Analytical biochemistry, 1995, Feb-10, Volume: 225, Issue:1

    Topics: Antiviral Agents; Dideoxynucleotides; Fluorescent Dyes; HIV Reverse Transcriptase; HIV-1; Indicators and Reagents; Indoles; Kinetics; Nevirapine; Phosphorus Radioisotopes; Pyrazines; Pyridines; Radioisotope Dilution Technique; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Spectrometry, Fluorescence; Thiones; Thiophenes; Thymine Nucleotides; Zidovudine

1995
Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptase.
    Virology, 1995, Jun-20, Volume: 210, Issue:1

    Topics: Antiviral Agents; Cell Line; Dose-Response Relationship, Drug; Drug Resistance, Microbial; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Mutagenesis, Site-Directed; Nevirapine; Pyridines; Recombinant Proteins; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Structure-Activity Relationship; Thymine; Uracil; Zidovudine

1995
The inhibition of human immunodeficiency virus type 1 in vitro by a non-nucleoside reverse transcriptase inhibitor MKC-442, alone and in combination with other anti-HIV compounds.
    Antiviral research, 1995, Volume: 26, Issue:2

    Topics: Antiviral Agents; Cells, Cultured; Cytotoxicity Tests, Immunologic; Didanosine; Drug Interactions; HIV Reverse Transcriptase; HIV-1; Humans; Indolizines; Isoquinolines; Leukocytes, Mononuclear; Molecular Structure; Nevirapine; Pyridines; Quinolines; Reverse Transcriptase Inhibitors; Saquinavir; Uracil; Zalcitabine; Zidovudine

1995
In vitro comparison of selected triple-drug combinations for suppression of HIV-1 replication: the Inter-Company Collaboration Protocol.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1995, Volume: 10 Suppl 2

    Topics: Antiviral Agents; Cell Line, Transformed; Cytopathogenic Effect, Viral; Didanosine; Drug Synergism; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Isoquinolines; Lamivudine; Nevirapine; Pyridines; Quinolines; Reverse Transcriptase Inhibitors; Saquinavir; Virus Replication; Zalcitabine; Zidovudine

1995
Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
    Nature, 1993, Feb-18, Volume: 361, Issue:6413

    Topics: Acquired Immunodeficiency Syndrome; Biological Evolution; Didanosine; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Nevirapine; Polymerase Chain Reaction; Pyridines; Pyridones; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Selection, Genetic; Virus Replication; Zidovudine

1993
Triple whammy. Will an AIDS therapy live up to its advance billing?
    Scientific American, 1993, Volume: 268, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Cells, Cultured; Didanosine; Drug Therapy, Combination; HIV; Humans; Nevirapine; Pyridines; Pyridones; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine

1993
AIDS drugs. Harvard group makes a splash--twice.
    Science (New York, N.Y.), 1993, Aug-06, Volume: 261, Issue:5122

    Topics: Antiviral Agents; Didanosine; HIV; Mutation; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine

1993
Resisting the temptation.
    Lancet (London, England), 1993, Aug-21, Volume: 342, Issue:8869

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Didanosine; Drug Combinations; HIV; Humans; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Virus Replication; Zidovudine

1993
Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro.
    Nature, 1993, Sep-30, Volume: 365, Issue:6445

    Topics: Base Sequence; Didanosine; DNA, Viral; Drug Resistance, Microbial; HeLa Cells; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Mutagenesis, Site-Directed; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Zidovudine

1993
Nevirapine synergistically inhibits HIV-1 replication in combination with zidovudine, interferon or CD4 immunoadhesin.
    AIDS (London, England), 1993, Volume: 7, Issue:9

    Topics: Antiviral Agents; CD4 Immunoadhesins; Drug Synergism; Feasibility Studies; HIV Reverse Transcriptase; HIV-1; Humans; In Vitro Techniques; Interferon Type I; Nevirapine; Pyridines; Recombinant Proteins; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine

1993
Alternating nevirapine and zidovudine treatment of human immunodeficiency virus type 1-infected persons does not prolong nevirapine activity.
    The Journal of infectious diseases, 1994, Volume: 169, Issue:6

    Topics: Adolescent; Adult; Antiviral Agents; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Nevirapine; Pyridines; Regression Analysis; Time Factors; Zidovudine

1994
[AIDS: therapeutic changes in the second decade. Triple combination--HIV vaccination].
    Fortschritte der Medizin, 1993, May-30, Volume: 111, Issue:15

    Topics: Acquired Immunodeficiency Syndrome; AIDS Vaccines; Antiviral Agents; Cross-Sectional Studies; Didanosine; Drug Therapy, Combination; Germany; Humans; Incidence; Nevirapine; Pyridines; Zidovudine

1993
Effects of non-nucleoside inhibitors of human immunodeficiency virus type 1 in cell-free recombinant reverse transcriptase assays.
    The Journal of biological chemistry, 1995, Dec-29, Volume: 270, Issue:52

    Topics: Cell-Free System; Delavirdine; Deoxycytosine Nucleotides; Dideoxynucleotides; Drug Antagonism; Drug Synergism; HIV Reverse Transcriptase; HIV-1; Indoles; Nevirapine; Piperazines; Pyridines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Thymine Nucleotides; Zidovudine

1995
Studies of neutralizing monoclonal antibody to human immunodeficiency virus type 1 reverse transcriptase: antagonistic and synergistic effects in reactions performed in the presence of nucleoside and nonnucleoside inhibitors, respectively.
    Journal of virology, 1996, Volume: 70, Issue:4

    Topics: Animals; Antibodies, Monoclonal; Antiviral Agents; Delavirdine; Deoxycytosine Nucleotides; Dideoxynucleotides; DNA; HIV Antibodies; HIV Reverse Transcriptase; Humans; Indoles; Mice; Neutralization Tests; Nevirapine; Peptide Chain Elongation, Translational; Piperazines; Pyridines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Thymine Nucleotides; Zidovudine

1996
Drug combinations and effect parameters of zidovudine, stavudine, and nevirapine in standardized drug-sensitive and resistant HIV type 1 strains.
    AIDS research and human retroviruses, 1996, Apr-10, Volume: 12, Issue:6

    Topics: Antiviral Agents; Cell Line, Transformed; Cytotoxicity, Immunologic; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV-1; Microbial Sensitivity Tests; Nevirapine; Pyridines; Stavudine; T-Lymphocytes; Zidovudine

1996
Complete inhibition of viral breakthrough by combination of MKC-442 with AZT during a long-term culture of HIV-1 infected cells.
    Antiviral research, 1996, Volume: 31, Issue:1-2

    Topics: Acetamides; Acetophenones; Cell Line, Transformed; HIV; HIV Core Protein p24; HIV-1; Humans; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Uracil; Zidovudine

1996
Comparison of virus burden in blood and sequential lymph node biopsy specimens from children infected with human immunodeficiency virus.
    The Journal of pediatrics, 1996, Volume: 129, Issue:3

    Topics: Antiviral Agents; Biopsy; CD4 Lymphocyte Count; Child; Child, Preschool; Didanosine; DNA, Viral; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; In Situ Hybridization; Infant; Lymph Nodes; Male; Nevirapine; Pyridines; Viremia; Zidovudine

1996
Quantitative analysis of the endogenous reverse transcriptase reactions of HIV type 1 variants with decreased susceptibility to azidothymidine and nevirapine.
    AIDS research and human retroviruses, 1996, Jul-20, Volume: 12, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Animals; COS Cells; DNA, Viral; Drug Resistance, Microbial; HIV-1; Nevirapine; Polymerase Chain Reaction; Pyridines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Virus Replication; Zidovudine

1996
Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:3

    Topics: Animals; Antiviral Agents; Didanosine; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Fetal Tissue Transplantation; Flow Cytometry; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Liver Transplantation; Lymphocyte Count; Mice; Mice, SCID; Neutrophils; Nevirapine; Polymerase Chain Reaction; Pyridines; Rats; T-Lymphocytes; Thymus Gland; Transplantation, Heterologous; Zidovudine

1996
[Nevirapine: a new principle of action against HIV].
    Deutsche medizinische Wochenschrift (1946), 1996, Dec-06, Volume: 121, Issue:49

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Child; Clinical Trials as Topic; Didanosine; Double-Blind Method; Drug Therapy, Combination; Female; HIV; HIV Infections; Humans; Infant, Newborn; Male; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pyridines; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Time Factors; Zidovudine

1996
Stavudine selectively induces apoptosis in HIV type 1-infected cells.
    AIDS research and human retroviruses, 1997, Jan-20, Volume: 13, Issue:2

    Topics: Anti-HIV Agents; Apoptosis; Cell Line; Didanosine; DNA Fragmentation; Down-Regulation; HIV Reverse Transcriptase; HIV-1; Humans; Nevirapine; Proto-Oncogene Proteins c-bcl-2; Pyridines; Reverse Transcriptase Inhibitors; Stavudine; T-Lymphocytes; Thymidine; Zalcitabine; Zidovudine

1997
A new reporter cell line to monitor HIV infection and drug susceptibility in vitro.
    Proceedings of the National Academy of Sciences of the United States of America, 1997, Apr-29, Volume: 94, Issue:9

    Topics: Anti-HIV Agents; Cell Line; Genes, Reporter; Green Fluorescent Proteins; HIV Envelope Protein gp120; HIV Long Terminal Repeat; HIV Protease Inhibitors; HIV-1; Luminescent Proteins; Microbial Sensitivity Tests; Nevirapine; Pyridines; Recombinant Proteins; Reverse Transcriptase Inhibitors; Saquinavir; T-Lymphocytes; Zidovudine

1997
Genotypic and phenotypic changes during culture of a multinucleoside-resistant human immunodeficiency virus type 1 strain in the presence and absence of additional reverse transcriptase inhibitors.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:12

    Topics: Antiviral Agents; Cell Line; Cells, Cultured; Didanosine; Drug Interactions; Drug Resistance, Microbial; Drug Resistance, Multiple; Genotype; HIV-1; Humans; Lamivudine; Mutation; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine

1996
Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine. Sydney Primary HIV Infection Study Group.
    The Journal of infectious diseases, 1997, Volume: 175, Issue:6

    Topics: Adolescent; Adult; Anti-HIV Agents; Base Sequence; Codon; DNA Mutational Analysis; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homosexuality, Male; Humans; Male; Molecular Sequence Data; Nevirapine; Pyridines; RNA, Viral; Sexual Partners; Zidovudine

1997
Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe.
    Journal of virology, 1997, Volume: 71, Issue:7

    Topics: Adult; Amino Acid Sequence; Base Sequence; Didanosine; DNA, Viral; Female; Genes, env; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Nevirapine; Nucleic Acid Heteroduplexes; Phylogeny; Pyridines; Reverse Transcriptase Inhibitors; Sequence Homology, Amino Acid; Zidovudine; Zimbabwe

1997
Cure or control of HIV/AIDS?
    Medical hypotheses, 1997, Volume: 48, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Humans; Indinavir; Lamivudine; Models, Biological; Nevirapine; Pyridines; Ritonavir; Saquinavir; Stavudine; Zalcitabine; Zidovudine

1997
Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment.
    AIDS (London, England), 1997, Volume: 11, Issue:11

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Indinavir; Models, Biological; Nevirapine; Pyridines; Risk Factors; RNA, Viral; Substance Withdrawal Syndrome; Viral Load; Viremia; Zidovudine

1997
Drugs for HIV infection.
    The Medical letter on drugs and therapeutics, 1997, Dec-12, Volume: 39, Issue:1015

    Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Delavirdine; Diarrhea; Didanosine; Drug Interactions; Drug Therapy, Combination; HIV Infections; Humans; Indinavir; Lamivudine; Nelfinavir; Nevirapine; Protease Inhibitors; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Virus Replication; Zalcitabine; Zidovudine

1997
Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agents.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1997, Dec-15, Volume: 16, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; HIV-1; Humans; Nevirapine; Ritonavir; RNA, Viral; T-Lymphocytes; Zidovudine

1997
Drug susceptibility of subtypes A,B,C,D, and E human immunodeficiency virus type 1 primary isolates.
    AIDS research and human retroviruses, 1998, Jan-20, Volume: 14, Issue:2

    Topics: Anti-HIV Agents; Cell Line, Transformed; Cells, Cultured; Didanosine; Foscarnet; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Nevirapine; Reverse Transcriptase Inhibitors; Ritonavir; Zidovudine

1998
Retention of marked sensitivity to (S)-4-isopropoxycarbonyl-6-methoxy-3-(methylthiomethyl)-3,4-di hydroquin oxaline-2(1H)-thione (HBY 097) by an azidothymidine (AZT)-resistant human immunodeficiency virus type 1 (HIV-1) strain subcultured in the combined
    Biochemical pharmacology, 1998, Mar-01, Volume: 55, Issue:5

    Topics: Anti-HIV Agents; Antiviral Agents; Benzodiazepines; Cell Line; Delavirdine; Drug Resistance, Microbial; Furans; HIV Reverse Transcriptase; HIV-1; Humans; Imidazoles; Lamivudine; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Mutation; Nevirapine; Quinoxalines; Recombinant Proteins; Reverse Transcriptase Inhibitors; Zidovudine

1998
1,1,3-Trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine (TTD) derivatives: a new class of nonnucleoside human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors with anti-HIV-1 activity.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:3

    Topics: Anti-HIV Agents; Cells, Cultured; Didanosine; Drug Resistance, Microbial; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Nevirapine; Structure-Activity Relationship; Zidovudine

1998
Chimeric HIV-1 and feline immunodeficiency virus reverse transcriptases: critical role of the p51 subunit in the structural integrity of heterodimeric lentiviral DNA polymerases.
    Journal of molecular biology, 1998, May-15, Volume: 278, Issue:4

    Topics: Antiviral Agents; Dideoxynucleotides; Dimerization; DNA, Viral; Drug Resistance, Microbial; HIV Reverse Transcriptase; HIV-1; Immunodeficiency Virus, Feline; Nevirapine; Protein Conformation; Recombinant Fusion Proteins; Reverse Transcriptase Inhibitors; Ribonuclease H; RNA-Directed DNA Polymerase; Thymine Nucleotides; Zidovudine

1998
Induction-maintenance antiretroviral therapy: proof of concept.
    AIDS (London, England), 1998, May-07, Volume: 12, Issue:7

    Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine

1998
Researchers report sustained suppression of HIV with nevirapine--didanosine--zidovudine.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Jun-01, Volume: 55, Issue:11

    Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Zidovudine

1998
Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents.
    Science (New York, N.Y.), 1998, Jul-10, Volume: 281, Issue:5374

    Topics: Anti-HIV Agents; G2 Phase; Gene Products, vpr; Genes, Reporter; Genes, vpr; HeLa Cells; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Leukocytes; Nevirapine; Reverse Transcriptase Inhibitors; Thy-1 Antigens; Virion; vpr Gene Products, Human Immunodeficiency Virus; Zidovudine

1998
Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy.
    AIDS (London, England), 1998, Jul-30, Volume: 12, Issue:11

    Topics: Adult; Anti-HIV Agents; Data Interpretation, Statistical; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Nevirapine; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Virus Replication; Zidovudine

1998
Rebound of plasma HIV viral load following prolonged suppression with combination therapy.
    AIDS (London, England), 1998, Jul-30, Volume: 12, Issue:11

    Topics: Adult; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Male; Nevirapine; Reverse Transcriptase Inhibitors; Time Factors; Viral Load; Zidovudine

1998
High incidence of nevirapine-associated rash in HIV-infected Chinese.
    AIDS (London, England), 1998, Oct-22, Volume: 12, Issue:15

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; China; Didanosine; Drug Eruptions; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine

1998
Estimates of the virological benefit of antiretroviral therapy are both assay- and analysis-dependent.
    AIDS (London, England), 1998, Nov-12, Volume: 12, Issue:16

    Topics: Analysis of Variance; Anti-HIV Agents; Data Interpretation, Statistical; Didanosine; HIV Infections; HIV-1; Humans; Nevirapine; RNA, Viral; Statistics, Nonparametric; Time Factors; Viral Load; Zidovudine

1998
HIV-1 peripheral neuropathy and combination antiretroviral therapy.
    Lancet (London, England), 1998, Dec-12, Volume: 352, Issue:9144

    Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Nelfinavir; Nevirapine; Peripheral Nervous System Diseases; Saquinavir; Zidovudine

1998
Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
    JAMA, 1999, Jan-13, Volume: 281, Issue:2

    Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Randomized Controlled Trials as Topic; Zidovudine

1999
Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
    JAMA, 1999, Jan-13, Volume: 281, Issue:2

    Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Randomized Controlled Trials as Topic; Viral Load; Zidovudine

1999
Molecular basis for the enantioselectivity of HIV-1 reverse transcriptase: role of the 3'-hydroxyl group of the L-(beta)-ribose in chiral discrimination between D- and L-enantiomers of deoxy- and dideoxy-nucleoside triphosphate analogs.
    Nucleic acids research, 1999, Feb-15, Volume: 27, Issue:4

    Topics: Anti-HIV Agents; Carbohydrates; Catalysis; Deoxycytosine Nucleotides; Deoxyribonucleosides; Dideoxynucleosides; Dideoxynucleotides; DNA; Drug Resistance, Microbial; HIV Reverse Transcriptase; Humans; Hydroxyl Radical; Isoleucine; Kinetics; Nevirapine; Recombinant Fusion Proteins; Reverse Transcriptase Inhibitors; Ribose; Templates, Genetic; Thymine Nucleotides; Tyrosine; Zidovudine

1999
Intramolecular chimeras of the p51 subunit between HIV-1 and FIV reverse transcriptases suggest a stabilizing function for the p66 subunit in the heterodimeric enzyme.
    Biochemistry, 1999, Feb-02, Volume: 38, Issue:5

    Topics: Amino Acid Sequence; Animals; Cats; Dideoxynucleotides; Dimerization; DNA, Viral; Enzyme Activation; Enzyme Stability; Genetic Vectors; HIV Reverse Transcriptase; Humans; Immunodeficiency Virus, Feline; Molecular Sequence Data; Nevirapine; Peptide Fragments; Protein Processing, Post-Translational; Recombinant Fusion Proteins; Reverse Transcriptase Inhibitors; Ribonuclease H; RNA-Directed DNA Polymerase; Structure-Activity Relationship; Thymine Nucleotides; Zidovudine

1999
Biochemical characterization of HIV-1 reverse transcriptases encoding mutations at amino acid residues 161 and 208 involved in resistance to phosphonoformate.
    Biochemical pharmacology, 1998, Dec-15, Volume: 56, Issue:12

    Topics: Amino Acids; Diphosphates; Dose-Response Relationship, Drug; Drug Resistance; Enzyme Stability; Foscarnet; HIV Reverse Transcriptase; Kinetics; Mutagenesis, Site-Directed; Nevirapine; Recombinant Proteins; Reverse Transcriptase Inhibitors; Zidovudine

1998
Inhibition of human immunodeficiency virus type 1 replication by combination of transcription inhibitor K-12 and other antiretroviral agents in acutely and chronically infected cells.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:3

    Topics: Alkaloids; Anti-HIV Agents; Anti-Infective Agents; Benzylisoquinolines; Cell Line; Drug Synergism; Fluoroquinolones; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Nelfinavir; Nevirapine; NF-kappa B; Piperazines; Reverse Transcriptase Inhibitors; Tumor Necrosis Factor-alpha; Virus Replication; Zidovudine

1999
Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group.
    AIDS (London, England), 1999, Feb-04, Volume: 13, Issue:2

    Topics: Adult; Aging; Anti-HIV Agents; Didanosine; Follow-Up Studies; HIV Infections; HIV-1; Humans; Immunologic Memory; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Time Factors; Zidovudine

1999
Reverse transcriptase inhibitors can selectively block the synthesis of differently sized viral DNA transcripts in cells acutely infected with human immunodeficiency virus type 1.
    Journal of virology, 1999, Volume: 73, Issue:8

    Topics: Anti-HIV Agents; DNA, Single-Stranded; DNA, Viral; HIV-1; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Time Factors; Transcription, Genetic; Tumor Cells, Cultured; Zidovudine

1999
Changing cost of English HIV service provision 1996-1997. NPMS Steering Group. National Prospective Monitoring System.
    International journal of STD & AIDS, 1999, Volume: 10, Issue:6

    Topics: Adult; Anti-HIV Agents; Didanosine; Drug Costs; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Hospital Costs; Humans; Nevirapine; RNA-Directed DNA Polymerase; United Kingdom; Zalcitabine; Zidovudine

1999
Drug could slash rate of perinatal HIV.
    Nature, 1999, Jul-22, Volume: 400, Issue:6742

    Topics: Anti-HIV Agents; Drug Costs; Drug Therapy, Combination; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Reverse Transcriptase Inhibitors; Uganda; United States; Zidovudine

1999
AIDS drug trials in Thailand and Uganda.
    Nature medicine, 1999, Volume: 5, Issue:11

    Topics: Anti-HIV Agents; Clinical Trials as Topic; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Thailand; Uganda; Zidovudine

1999
HIVNET nevirapine trials.
    Lancet (London, England), 1999, Nov-20, Volume: 354, Issue:9192

    Topics: Anti-HIV Agents; Drug Administration Schedule; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine

1999
Concern at cheap AIDS drug fears.
    Nature, 1999, Nov-25, Volume: 402, Issue:6760

    Topics: Acquired Immunodeficiency Syndrome; Africa, Southern; Anti-HIV Agents; Costs and Cost Analysis; Female; Foundations; Health Policy; Humans; Infant, Newborn; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine

1999
South Africa's health minister downplays AIDS drug concerns.
    Nature, 1999, Dec-02, Volume: 402, Issue:6761

    Topics: Anti-HIV Agents; Drug Resistance, Microbial; Humans; Nevirapine; Reverse Transcriptase Inhibitors; South Africa; Zidovudine

1999
AZT--the saga continues.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1999, Volume: 89, Issue:12

    Topics: Adolescent; Adult; Child; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Zidovudine

1999
Rapid phenotypic drug susceptibility assay for HIV-1 with a CCR5 expressing indicator cell line.
    Journal of virological methods, 2000, Volume: 85, Issue:1-2

    Topics: Anti-HIV Agents; beta-Galactosidase; Cell Line; Drug Resistance, Microbial; Genes, Reporter; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Nevirapine; Phenotype; Receptors, CCR5; Reverse Transcriptase Inhibitors; Ritonavir; Zidovudine

2000
Focus on AIDS.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2000, Volume: 90, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Awareness; Commerce; Humans; Internet; Nevirapine; Politics; Prevalence; Public Health; South Africa; Zidovudine

2000
The efficacy and tolerability of combination antiretroviral therapy in pregnancy: infant and maternal outcome.
    International journal of STD & AIDS, 2000, Volume: 11, Issue:4

    Topics: Adolescent; Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Infant; Lamivudine; Male; Nelfinavir; Nevirapine; Pregnancy; Pregnancy Outcome; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Treatment Outcome; Zidovudine

2000
Flirting with strange ideas. Mbeki reaches out to a controversial AIDS researcher.
    Newsweek, 2000, Apr-17, Volume: 135, Issue:16

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Biochemistry; Clinical Trials as Topic; Famous Persons; Female; History, 20th Century; HIV Seropositivity; Humans; Insecticides; Male; Nevirapine; Organic Chemicals; Pregnancy; Research; Reverse Transcriptase Inhibitors; San Francisco; South Africa; United States; Zidovudine

2000
Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir.
    AIDS (London, England), 2000, Jun-16, Volume: 14, Issue:9

    Topics: Adult; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Disease Reservoirs; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Semen; Stavudine; Viral Load; Zidovudine

2000
The mother of all HIV challenges.
    Science (New York, N.Y.), 2000, Jun-23, Volume: 288, Issue:5474

    Topics: Africa South of the Sahara; AIDS Serodiagnosis; Anti-HIV Agents; Breast Feeding; Clinical Trials as Topic; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Social Conditions; Zidovudine

2000
Mbeki gives AIDS scientists the cold shoulder.
    Nature, 2000, Jul-13, Volume: 406, Issue:6792

    Topics: Acquired Immunodeficiency Syndrome; Adult; Breast Feeding; Enzyme-Linked Immunosorbent Assay; Female; Government; HIV; Humans; Infectious Disease Transmission, Vertical; Male; Middle Aged; Nevirapine; Poverty; Predictive Value of Tests; Pregnancy; Pregnancy Complications, Infectious; South Africa; Zidovudine

2000
Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].
    Antiviral chemistry & chemotherapy, 2000, Volume: 11, Issue:4

    Topics: Anti-HIV Agents; Cells, Cultured; Deoxycytidine; Didanosine; Drug Combinations; Drug Resistance, Microbial; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Molecular Structure; Mutation; Nevirapine; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Stavudine; T-Lymphocytes; Thionucleosides; Zidovudine

2000
AZT blues.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2000, Volume: 90, Issue:7

    Topics: Anti-HIV Agents; Counseling; Female; Foster Home Care; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Reverse Transcriptase Inhibitors; South Africa; Zidovudine

2000
[Cost effectiveness analysis of highly active antiretroviral therapy in HIV asymptomatic patients].
    Medicina clinica, 2000, Volume: 114 Suppl 3

    Topics: Adult; Anti-HIV Agents; Cost-Benefit Analysis; Didanosine; Drug Therapy, Combination; Female; HIV Seropositivity; Humans; Indinavir; Lamivudine; Male; Middle Aged; Nevirapine; Sickness Impact Profile; Spain; Stavudine; Viral Load; Zidovudine

2000
Prevention of mother-child HIV transmission: progress and problems.
    Prescrire international, 2000, Volume: 9, Issue:47

    Topics: Africa; Antiviral Agents; Breast Feeding; Cesarean Section; Clinical Trials as Topic; Cohort Studies; Developing Countries; Drug Therapy, Combination; Europe; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Mitochondrial Myopathies; Nervous System Diseases; Nevirapine; Pregnancy; Pregnancy Trimester, Third; Reverse Transcriptase Inhibitors; Thailand; United States; Zidovudine

2000
Absence of association between individual thymidine analogues or nonnucleoside analogues and lipid abnormalities in HIV-1-infected persons on initial therapy.
    Journal of acquired immune deficiency syndromes (1999), 2000, Aug-01, Volume: 24, Issue:4

    Topics: Adult; Alkynes; Anti-HIV Agents; Arteriosclerosis; Benzoxazines; Cholesterol; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lipids; Male; Nevirapine; Oxazines; Risk Factors; Stavudine; Thymidine; Triglycerides; Zidovudine

2000
[Genotypic resistance to antiretroviral drugs in patients with therapeutic failure to highly active antiretroviral therapy].
    Medicina clinica, 2000, Oct-07, Volume: 115, Issue:11

    Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Microbial; Endopeptidases; Female; Genotype; HIV; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Male; Middle Aged; Mutation; Nevirapine; Protease Inhibitors; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Treatment Failure; Zidovudine

2000
Antiretroviral pharmacology in pregnant women and their newborns.
    Annals of the New York Academy of Sciences, 2000, Volume: 918

    Topics: Administration, Oral; Anti-HIV Agents; Delivery, Obstetric; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Maternal-Fetal Exchange; Nevirapine; Placenta; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Protease Inhibitors; Reverse Transcriptase Inhibitors; Zidovudine

2000
Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures--worldwide, 1997-2000.
    MMWR. Morbidity and mortality weekly report, 2001, Jan-05, Volume: 49, Issue:51-52

    Topics: Adult; Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Drug Eruptions; Female; HIV Infections; Humans; Lamivudine; Liver Failure; Male; Nevirapine; Occupational Exposure; Reverse Transcriptase Inhibitors; Rhabdomyolysis; Zidovudine

2001
Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection.
    Japanese journal of infectious diseases, 2000, Volume: 53, Issue:6

    Topics: Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Didanosine; Drug Therapy, Combination; Fatal Outcome; Granulocyte Colony-Stimulating Factor; HIV Infections; HIV-1; Humans; Leukopenia; Male; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Zidovudine

2000
Further views by the Erice working group on mother-to-child transmission of HIV type 1.
    Acta paediatrica (Oslo, Norway : 1992), 2001, Volume: 90, Issue:1

    Topics: Adult; Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine

2001
Potentiation of inhibition of wild-type and mutant human immunodeficiency virus type 1 reverse transcriptases by combinations of nonnucleoside inhibitors and d- and L-(beta)-dideoxynucleoside triphosphate analogs.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:4

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Dideoxynucleotides; DNA Replication; DNA, Viral; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Synergism; HIV Reverse Transcriptase; Humans; Inhibitory Concentration 50; Mutation; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Stereoisomerism; Thymine Nucleotides; Zidovudine

2001
Triple therapy in previously untreated patients reduces viral load below limit of detection.
    AIDS patient care and STDs, 1996, Volume: 10, Issue:5

    Topics: Adult; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Pyridines; Viral Load; Zidovudine

1996
Two studies suggest nevirapine benefit for children.
    AIDS patient care and STDs, 1997, Volume: 11, Issue:3

    Topics: Anti-HIV Agents; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pyridines; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine

1997
Viramune triple therapy shows suppression of HIV after 1 year, 7 months.
    AIDS patient care and STDs, 1997, Volume: 11, Issue:6

    Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Zidovudine

1997
Nevirapine triple combo results released.
    Common factor (Stoughton, Mass.), 1995, Issue:no 10

    Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; Erythema; HIV Infections; HIV-1; Humans; Nevirapine; Pyridines; Virus Replication; Zidovudine

1995
New combo trial/same old style.
    GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:4

    Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Protocols; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine

1995
Nevirapine: ethical dilemmas and care for HIV-infected mothers.
    Focus (San Francisco, Calif.), 1995, Volume: 10, Issue:7

    Topics: Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Counseling; Ethics, Medical; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pyridines; RNA-Directed DNA Polymerase; United States; Zidovudine

1995
Nevirapine: new drug, new class, new questions.
    Journal of the International Association of Physicians in AIDS Care, 1996, Volume: 2, Issue:7

    Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Child; Didanosine; Drug Approval; Drug Therapy, Combination; HIV; HIV Infections; Humans; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration; Zidovudine

1996
Nevirapine approved by FDA. Food and Drug Administration.
    NIAID AIDS agenda, 1996

    Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Approval; Drug Therapy, Combination; Female; HIV Infections; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pyridines; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration; Viral Load; Zidovudine

1996
NIAID researchers present new findings at retrovirus meeting. National Institute of Allergy and Infectious Diseases.
    NIAID AIDS agenda, 1997

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Chemokines; Clinical Trials as Topic; Clone Cells; Dendritic Cells; Didanosine; Disease Progression; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Interleukin-10; Killer Cells, Natural; Lamivudine; Male; Nevirapine; Pyridines; Receptors, Cytokine; Reverse Transcriptase Inhibitors; Ritonavir; Virus Replication; Zalcitabine; Zidovudine

1997
Scientific basis for PEP rests in animal trials.
    AIDS alert, 1997, Volume: 12, Issue:9

    Topics: Adenine; Animals; Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Health Personnel; HIV; HIV Infections; Humans; Macaca; Nevirapine; Occupational Diseases; Organophosphonates; Organophosphorus Compounds; Pan troglodytes; Pyridines; Reverse Transcriptase Inhibitors; Simian Immunodeficiency Virus; Tenofovir; United States; Zidovudine

1997
Update on nevirapine: quest for a niche.
    Journal of the International Association of Physicians in AIDS Care, 1997, Volume: 3, Issue:9

    Topics: Adult; Anti-HIV Agents; Child; Clinical Trials as Topic; Didanosine; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant; Infant, Newborn; Nevirapine; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine

1997
Preventing HIV infection in infants in developing countries: NIAID's role. National Institute of Allergy and Infectious Diseases.
    NIAID AIDS agenda, 1997

    Topics: Anti-HIV Agents; Child; Child, Preschool; Clinical Trials as Topic; Developing Countries; Ethiopia; Female; Health Planning; HIV Infections; Humans; Immunization, Passive; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; International Cooperation; Male; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Uganda; Zidovudine

1997
Pediatric HIV clinical trials in the United States.
    NIAID AIDS agenda, 1997

    Topics: Adolescent; Anti-HIV Agents; Child; Child, Preschool; Clinical Trials as Topic; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Nevirapine; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; United States; Zidovudine

1997
HIV in the brain: an interview with Dr. Michael Wool, UCLA researcher.
    Positive Directions news : a support and information network of people with HIV/AIDS, their families, friends and providers, 1998, Volume: 10, Issue:1

    Topics: AIDS Dementia Complex; Anti-HIV Agents; Blood-Brain Barrier; Brain; Drug Therapy, Combination; Drugs, Investigational; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Stavudine; Viral Load; Zidovudine

1998
Thai study success affects ongoing placebo trials.
    AIDS alert, 1998, Volume: 13, Issue:4

    Topics: Anti-HIV Agents; Clinical Trials as Topic; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Nevirapine; Placebos; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Thailand; Zidovudine

1998
Viral load--how low is best?
    TreatmentUpdate, 1998, Volume: 10, Issue:10

    Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine

1998
Unequal care sustains vertical transmission rate.
    GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1999, Volume: 13, Issue:2

    Topics: Anti-HIV Agents; Cesarean Section; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Reverse Transcriptase Inhibitors; Zidovudine

1999
Single-dose Nevirapine during pregnancy.
    AIDS clinical care, 1999, Volume: 11, Issue:10

    Topics: Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine

1999
Prevention of perinatal HIV infection: cause for optimism.
    AIDS clinical care, 1999, Volume: 11, Issue:12

    Topics: AIDS Serodiagnosis; Anti-HIV Agents; Cesarean Section; Clinical Trials as Topic; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Risk Factors; Time Factors; Viral Load; Zidovudine

1999
Global strategies for the prevention of HIV transmission from mothers to infants: the second conference.
    Journal of the International Association of Physicians in AIDS Care, 1999, Volume: 5, Issue:12

    Topics: Anti-HIV Agents; Breast Feeding; Cesarean Section; Clinical Trials as Topic; Congresses as Topic; Developing Countries; Drug Therapy, Combination; Female; Global Health; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine

1999
Simpler regimens for preventing mother-to-child HIV transmission.
    Project Inform perspective, 1999, Issue:28

    Topics: Delivery, Obstetric; Developing Countries; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine

1999
Taking HIV to court.
    Lancet (London, England), 2001, Sep-01, Volume: 358, Issue:9283

    Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Jurisprudence; Male; Nevirapine; Politics; Pregnancy; Pregnant Women; South Africa; Zidovudine

2001
Drugs for HIV infection.
    The Medical letter on drugs and therapeutics, 2001, Nov-26, Volume: 43, Issue:1119

    Topics: Alkynes; Benzoxazines; Cyclopropanes; Delavirdine; Didanosine; Dose-Response Relationship, Drug; HIV Infections; HIV Protease Inhibitors; Humans; Nelfinavir; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Saquinavir; Stavudine; Zidovudine

2001
Effect of nevirapine toxicity on choice of perinatal HIV prevention strategies.
    American journal of public health, 2002, Volume: 92, Issue:3

    Topics: Anti-HIV Agents; Cohort Studies; Decision Support Techniques; Female; Fetal Death; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Perinatal Care; Pregnancy; Quality-Adjusted Life Years; Reproducibility of Results; Zidovudine

2002
Stage of the epidemic and viral phenotype should influence recommendations regarding mother-to-child transmission of HIV-1.
    The Lancet. Infectious diseases, 2002, Volume: 2, Issue:2

    Topics: Anti-HIV Agents; Breast Feeding; Disease Outbreaks; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Phenotype; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Virulence; Zidovudine

2002
Feasibility of antenatal and late HIV testing in pregnant women in Phnom Penh Cambodia: the PERIKAM/ANRS1205 study.
    AIDS (London, England), 2002, Apr-12, Volume: 16, Issue:6

    Topics: AIDS Serodiagnosis; Cambodia; Counseling; Feasibility Studies; Female; HIV Infections; HIV Seroprevalence; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine

2002
Improved long-term suppression of HIV-1 replication with a triple-class multidrug regimen compared with standard of care antiretroviral therapy.
    AIDS (London, England), 2002, Mar-29, Volume: 16, Issue:5

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Follow-Up Studies; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Viral Load; Virus Replication; Zidovudine

2002
Paying to waste lives: the affordability of reducing mother-to-child transmission of HIV in South Africa.
    Journal of health economics, 2002, Volume: 21, Issue:3

    Topics: Adult; Anti-HIV Agents; Child Welfare; Child, Preschool; Cost of Illness; Cost-Benefit Analysis; Female; Health Care Costs; Health Policy; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Quality-Adjusted Life Years; South Africa; Zidovudine

2002
Determination of zidovudine/lamivudine/nevirapine in human plasma using ion-pair HPLC.
    Journal of pharmaceutical and biomedical analysis, 2002, Jun-01, Volume: 28, Issue:5

    Topics: Anti-HIV Agents; Calibration; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Lamivudine; Nevirapine; Reference Standards; Reproducibility of Results; Spectrophotometry, Ultraviolet; Zidovudine

2002
Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:7

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Resistance, Viral; Genetic Variation; Genotype; HIV Reverse Transcriptase; HIV-1; Nevirapine; Oxazines; Phylogeny; Reverse Transcriptase Inhibitors; Zidovudine

2002
Simultaneous determination of zidovudine and nevirapine in human plasma by RP-LC.
    Journal of pharmaceutical and biomedical analysis, 2002, Aug-01, Volume: 29, Issue:6

    Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; Humans; Nevirapine; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Zidovudine

2002
Nevirapine reduces perinatal HIV transmission.
    The Hopkins HIV report : a bimonthly newsletter for healthcare providers, 1999, Volume: 11, Issue:5

    Topics: Disease Transmission, Infectious; HIV Infections; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Zidovudine

1999
When will once (-a day) be enough?
    The Hopkins HIV report : a bimonthly newsletter for healthcare providers, 2000, Volume: 12, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Deoxycytidine; Didanosine; Emtricitabine; Humans; Hydroxyurea; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Zidovudine

2000
Antiretroviral therapy.
    The Hopkins HIV report : a bimonthly newsletter for healthcare providers, 2000, Volume: 12, Issue:4

    Topics: Antiretroviral Therapy, Highly Active; Drug Administration Schedule; HIV Protease Inhibitors; Humans; Lopinavir; Nevirapine; Pyrimidinones; Ritonavir; Viral Load; Zidovudine

2000
Antiretroviral treatment in developing countries.
    The Hopkins HIV report : a bimonthly newsletter for healthcare providers, 2002, Volume: 14, Issue:5

    Topics: AIDS Serodiagnosis; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Developing Countries; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Patient Compliance; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Public Sector; Zidovudine

2002
WHO takes major steps to make HIV treatment accessible.
    Journal of advanced nursing, 2002, Volume: 39, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Developing Countries; Drug Therapy, Combination; Health Services Accessibility; HIV Infections; Humans; Nevirapine; Practice Guidelines as Topic; World Health Organization; Zidovudine

2002
Regression of HIV parotid swellings after antiviral therapy: case reports with computed tomographic scan evidence.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2002, Volume: 94, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD8-Positive T-Lymphocytes; HIV Infections; Humans; Lymphocytosis; Lymphoproliferative Disorders; Male; Nevirapine; Parotid Diseases; Parotid Gland; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Viral Load; Zidovudine

2002
Determinations of zidovudine/didanosine/nevirapine and zidovudine/didanosine/ritonavir in human serum by micellar electrokinetic chromatography.
    Journal of pharmaceutical and biomedical analysis, 2002, Nov-07, Volume: 30, Issue:4

    Topics: Anti-HIV Agents; Chromatography, Micellar Electrokinetic Capillary; Didanosine; Humans; Nevirapine; Ritonavir; Zidovudine

2002
Two drugs reduce transmission.
    AIDS patient care and STDs, 2002, Volume: 16, Issue:9

    Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Thailand; Zidovudine

2002
Survival of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012).
    Journal of acquired immune deficiency syndromes (1999), 2002, Nov-01, Volume: 31, Issue:3

    Topics: Cohort Studies; Female; Genotype; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Molecular Sequence Data; Nevirapine; Phylogeny; Pregnancy; Pregnancy Complications, Infectious; Survival Rate; Uganda; Zidovudine

2002
Hope emerges for controlling perinatal HIV transmission.
    Positive living (Los Angeles, Calif.), 1999, Volume: 8, Issue:7

    Topics: Developing Countries; Drug Costs; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine

1999
Multiple relapses of human cytomegalovirus retinitis during HAART in an AIDS patient with reconstitution of CD4+ T cell count in the absence of HCMV-specific CD4+ T cell response.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2003, Volume: 26, Issue:1

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cytomegalovirus Retinitis; Didanosine; Follow-Up Studies; Ganciclovir; HIV Protease Inhibitors; Humans; Lamivudine; Lymphocyte Activation; Male; Nevirapine; Recurrence; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine

2003
Nevirapine resistance mutation at codon 181 of the HIV-1 reverse transcriptase confers stavudine resistance by increasing nucleotide substrate discrimination and phosphorolytic activity.
    The Journal of biological chemistry, 2003, May-02, Volume: 278, Issue:18

    Topics: Codon; Drug Resistance, Viral; HIV Reverse Transcriptase; Mutation; Nevirapine; Nucleotides; Phosphorylation; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine

2003
Preventing HIV transmission.
    Lancet (London, England), 2003, Mar-08, Volume: 361, Issue:9360

    Topics: Anti-HIV Agents; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Zidovudine

2003
Negligence. Liver transplant patient too late to sue Viramune maker.
    AIDS policy & law, 2003, Mar-28, Volume: 18, Issue:6

    Topics: Drug Combinations; Drug Industry; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Liver Failure; Liver Transplantation; Malpractice; Nevirapine; Reverse Transcriptase Inhibitors; Zidovudine

2003
A saga in international HIV policy modeling: preventing mother-to-child HIV transmission.
    Journal of policy analysis and management : [the journal of the Association for Public Policy Analysis and Management], 2002,Summer, Volume: 21, Issue:3

    Topics: Africa; Antiretroviral Therapy, Highly Active; Female; Fetus; Health Policy; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Nevirapine; Policy Making; Pregnancy; United Nations; Zidovudine

2002
Nevirapine-based fixed-dose combination ARVs.
    GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 2003, Volume: 17, Issue:5

    Topics: Dose-Response Relationship, Drug; Drug Eruptions; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Patient Compliance; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine

2003
Cost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a low-prevalence setting.
    Health policy and planning, 2003, Volume: 18, Issue:3

    Topics: AIDS Serodiagnosis; Anti-HIV Agents; Breast Feeding; Cesarean Section; Cost of Illness; Cost-Benefit Analysis; Counseling; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mexico; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Value of Life; Zidovudine

2003
Non-nucleoside inhibitors of HIV-1 reverse transcriptase inhibit phosphorolysis and resensitize the 3'-azido-3'-deoxythymidine (AZT)-resistant polymerase to AZT-5'-triphosphate.
    The Journal of biological chemistry, 2003, Oct-24, Volume: 278, Issue:43

    Topics: Adenosine Triphosphate; Anti-HIV Agents; Dideoxynucleotides; Diphosphates; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; HIV Reverse Transcriptase; Humans; Mutation, Missense; Nevirapine; Phosphorylation; Protein Subunits; Reverse Transcriptase Inhibitors; Thymine Nucleotides; Zidovudine

2003
[Antiviral agents for reduction of mother-to-child transmission of HIV infection].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2003, Aug-14, Volume: 123, Issue:15

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Evidence-Based Medicine; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Zidovudine

2003
Decision analysis to guide choice of interventions to reduce mother-to-child transmission of HIV.
    AIDS (London, England), 2003, Sep-26, Volume: 17, Issue:14

    Topics: Anti-Retroviral Agents; Breast Feeding; Child, Preschool; Decision Support Techniques; Decision Trees; Female; HIV Infections; Humans; Infant; Infant, Newborn; Maternal-Fetal Exchange; Mathematics; Models, Theoretical; Nevirapine; Pregnancy; Weaning; Zidovudine

2003
Nevirapine reduced mother-to-child transmission better than AZT--at 70 times less the cost.
    AIDS treatment news, 2003, Sep-12, Issue:394

    Topics: Drug Costs; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine

2003
HIVNET 012 and Petra.
    Lancet (London, England), 2004, Jan-17, Volume: 363, Issue:9404

    Topics: Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Treatment Outcome; Zidovudine

2004
Preventing mother-to-child transmission: landmark decision by South African court.
    Canadian HIV/AIDS policy & law review, 2002, Volume: 6, Issue:3

    Topics: Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; South Africa; Zidovudine

2002
Mother-to-child transmission. How will AZT and nevirapine use for MTCT affect future treatment? Two studies provide clues.
    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 2004,Winter, Volume: 16, Issue:2

    Topics: CD4 Lymphocyte Count; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine

2004
Immune status and uptake of antiretroviral interventions to prevent mother-to-child transmission of HIV-1 in Africa.
    Journal of acquired immune deficiency syndromes (1999), 2004, Jun-01, Volume: 36, Issue:2

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cote d'Ivoire; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Infectious; Zidovudine

2004
[Antiretroviral therapy of acute HIV-infection].
    Terapevticheskii arkhiv, 2004, Volume: 76, Issue:4

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Combinations; Female; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Lymphocyte Count; Male; Nevirapine; Viral Load; Zidovudine

2004
Antiretroviral agents--how best to protect infants from HIV and save their mothers from AIDS.
    The New England journal of medicine, 2004, Jul-15, Volume: 351, Issue:3

    Topics: Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Developing Countries; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine

2004
Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy.
    American journal of obstetrics and gynecology, 2004, Volume: 191, Issue:3

    Topics: Abnormalities, Drug-Induced; Anti-Retroviral Agents; Female; Gestational Age; Humans; Lamivudine; Maternal-Fetal Exchange; Nelfinavir; Nevirapine; Pregnancy; Pregnancy Outcome; Prospective Studies; Risk Factors; Stavudine; Zidovudine

2004
Perinatal HIV research unit clarifies nevirapine resistance and transmission issues.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2004, Volume: 94, Issue:9

    Topics: Anti-HIV Agents; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Zidovudine

2004
Nevirapine plus zidovudine to prevent mother-to-child transmission of HIV.
    The New England journal of medicine, 2004, Nov-04, Volume: 351, Issue:19

    Topics: Anti-Retroviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine

2004
Meeting report from the XV International AIDS Conference. Perinatal transmission.
    AIDS clinical care, 2004, Volume: 16, Issue:9

    Topics: Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine

2004
Antiretroviral drug pharmacokinetics in hepatitis with hepatic dysfunction.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jan-01, Volume: 40, Issue:1

    Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Therapy, Combination; Hepatitis; HIV Infections; Humans; Indinavir; Liver Function Tests; Lopinavir; Nelfinavir; Nevirapine; Oxazines; Protease Inhibitors; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Zidovudine

2005
Emergence of antiretroviral resistance in HIV-positive women receiving combination antiretroviral therapy in pregnancy.
    AIDS (London, England), 2005, Jan-03, Volume: 19, Issue:1

    Topics: Adolescent; Adult; Anti-HIV Agents; Base Sequence; Cohort Studies; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine

2005
Inhibitory drug levels found in breast milk.
    AIDS patient care and STDs, 2004, Volume: 18, Issue:12

    Topics: Anti-Retroviral Agents; Female; HIV Infections; Humans; Infant; Lamivudine; Milk, Human; Nevirapine; Zidovudine

2004
HIV seroprevalence, uptake of interventions to reduce mother-to-child transmission and birth outcomes in greater Kingston, Jamaica.
    The West Indian medical journal, 2004, Volume: 53, Issue:5

    Topics: Adolescent; Adult; Female; HIV Infections; HIV Seropositivity; HIV Seroprevalence; Humans; Infectious Disease Transmission, Vertical; Jamaica; Nevirapine; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Care; Program Evaluation; Zidovudine

2004
Uptake of interventions, outcomes and challenges in caring for HIV-exposed infants in Kingston, Jamaica.
    The West Indian medical journal, 2004, Volume: 53, Issue:5

    Topics: Antibiotic Prophylaxis; Female; HIV Infections; Humans; Infant; Infant Care; Infant, Newborn; Infectious Disease Transmission, Vertical; Jamaica; Nevirapine; Patient Acceptance of Health Care; Pregnancy; Prenatal Care; Prospective Studies; Retrospective Studies; Treatment Outcome; Zidovudine

2004
Zidovudine monotherapy and the prevention of mother-to-child HIV-1 transmission.
    The Lancet. Infectious diseases, 2005, Volume: 5, Issue:2

    Topics: Anti-HIV Agents; Child; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine

2005
Recent advances in prevention of mother to child (PMTCT) of HIV.
    African health sciences, 2004, Volume: 4, Issue:3

    Topics: Africa; Anti-HIV Agents; Breast Feeding; Disease Outbreaks; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Prenatal Care; Treatment Outcome; Zidovudine

2004
Effectiveness of nevirapine and zidovudine in a pilot program for the prevention of mother-to-child transmission of HIV-1 in Uganda.
    African health sciences, 2004, Volume: 4, Issue:3

    Topics: Anti-HIV Agents; Breast Feeding; Cross-Sectional Studies; Disease Outbreaks; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Logistic Models; Nevirapine; Pilot Projects; Pregnancy; Risk Factors; Socioeconomic Factors; Treatment Outcome; Uganda; Zidovudine

2004
AIDS treatment. A step toward cheaper anti-HIV therapy.
    Science (New York, N.Y.), 2005, Feb-04, Volume: 307, Issue:5710

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Developing Countries; Drug Approval; Drug Combinations; Drug Therapy, Combination; Drugs, Generic; Humans; Lamivudine; Nevirapine; United States; United States Food and Drug Administration; World Health Organization; Zidovudine

2005
Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
    AIDS (London, England), 2005, Feb-18, Volume: 19, Issue:3

    Topics: Adult; Anti-HIV Agents; Cote d'Ivoire; Developing Countries; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine

2005
Inhibition of phosphorolysis catalyzed by HIV-1 reverse transcriptase is responsible for the synergy found in combinations of 3'-azido-3'-deoxythymidine with nonnucleoside inhibitors.
    Biochemistry, 2005, Mar-08, Volume: 44, Issue:9

    Topics: Alkynes; Benzoxazines; Binding Sites; Catalysis; Cyclopropanes; Dideoxynucleotides; DNA Primers; Drug Combinations; Drug Synergism; Enzyme Stability; HIV Reverse Transcriptase; Nevirapine; Oxazines; Phosphoric Acids; Pyridones; Reverse Transcriptase Inhibitors; Templates, Genetic; Thymine Nucleotides; Zidovudine

2005
Averting drug resistance while preventing MTCT.
    The AIDS reader, 2005, Volume: 15, Issue:4

    Topics: Anti-HIV Agents; Drug Administration Schedule; Drug Resistance, Viral; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine

2005
A drug is effective if better than a harmless control.
    Nature, 2005, Apr-28, Volume: 434, Issue:7037

    Topics: Controlled Clinical Trials as Topic; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Nevirapine; Placebos; Pregnancy; Zidovudine

2005
In vitro anti-HIV potency of stampidine alone and in combination with standard anti-HIV drugs.
    Arzneimittel-Forschung, 2005, Volume: 55, Issue:4

    Topics: Anti-HIV Agents; Dideoxynucleotides; Drug Combinations; Drug Interactions; HIV-1; Humans; Lamivudine; Least-Squares Analysis; Models, Theoretical; Nelfinavir; Nevirapine; Phenotype; Stavudine; Thymidine Monophosphate; Virus Replication; Zidovudine

2005
Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates.
    Biostatistics (Oxford, England), 2006, Volume: 7, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Humans; Likelihood Functions; Longitudinal Studies; Models, Statistical; Nevirapine; Proportional Hazards Models; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Zalcitabine; Zidovudine

2006
Addressing the paediatric HIV epidemic: a perspective from the Western Cape Region of South Africa.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 2006, Volume: 100, Issue:1

    Topics: Adolescent; Adult; Anti-HIV Agents; Child; Disease Outbreaks; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Middle Aged; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; South Africa; Zidovudine

2006
Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa.
    Bulletin of the World Health Organization, 2005, Volume: 83, Issue:7

    Topics: Adult; Anti-HIV Agents; Breast Feeding; Cross-Sectional Studies; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Program Development; Program Evaluation; South Africa; Treatment Outcome; Zidovudine

2005
HIV antiretroviral agents inhibit protein synthesis and decrease ribosomal protein S6 and 4EBP1 phosphorylation in C2C12 myocytes.
    AIDS research and human retroviruses, 2005, Volume: 21, Issue:10

    Topics: Animals; Anti-HIV Agents; Cell Line; Mice; Muscle Cells; Nelfinavir; Nevirapine; Phosphorylation; Protein Synthesis Inhibitors; Ribosomal Protein S6; Zidovudine

2005
Triple nucleoside reverse transcriptase inhibitor- vs. nonnucleoside reverse transcriptase inhibitor-containing regimens as first-line therapy: efficacy and durability in a prospective cohort of French HIV-infected patients.
    HIV medicine, 2005, Volume: 6, Issue:6

    Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Cyclopropanes; Dideoxynucleosides; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Oxazines; Prospective Studies; Reverse Transcriptase Inhibitors; Treatment Failure; Treatment Outcome; Viral Load; Zidovudine

2005
[Detection of HIV infection in pregnant women by rapid testing: a successful strategy to reduce its vertical transmission].
    Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2005, Volume: 22, Issue:4

    Topics: Adolescent; Adult; Anti-HIV Agents; Blotting, Western; Enzyme-Linked Immunosorbent Assay; Female; HIV Antibodies; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Middle Aged; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prevalence; Uruguay; Zidovudine

2005
Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1.
    The Journal of infectious diseases, 2006, Feb-15, Volume: 193, Issue:4

    Topics: Anti-Retroviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Risk Factors; Zidovudine

2006
Low risk of nevirapine resistance mutations in the prevention of mother-to-child transmission of HIV-1: Agence Nationale de Recherches sur le SIDA Ditrame Plus, Abidjan, Cote d'Ivoire.
    The Journal of infectious diseases, 2006, Feb-15, Volume: 193, Issue:4

    Topics: Cote d'Ivoire; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Mothers; Mutation; Nevirapine; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine

2006
Concerns regarding a randomized trial of two postexposure prophylaxis regimens.
    AIDS (London, England), 2006, Feb-28, Volume: 20, Issue:4

    Topics: Anti-HIV Agents; Bottle Feeding; Breast Feeding; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Nevirapine; Randomized Controlled Trials as Topic; Zidovudine

2006
The contribution of HIV fitness to the evolution pattern of reverse transcriptase inhibitor resistance.
    Journal of medical virology, 2006, Volume: 78, Issue:4

    Topics: Anti-HIV Agents; Cell Line; Drug Resistance, Viral; Evolution, Molecular; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Nevirapine; Reverse Transcriptase Inhibitors; Thymidine; Zidovudine

2006
Unrecognized near-fatal hyperlactatemia in an HIV-infected infant exposed to nucleoside reverse transcriptase inhibitors.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2007, Volume: 11, Issue:1

    Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Lactates; Lamivudine; Male; Mitochondria; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine

2007
Exposure to HIV and antiretroviral medication as a potential cause of necrotizing enterocolitis in term neonates.
    AIDS (London, England), 2006, Apr-24, Volume: 20, Issue:7

    Topics: Anti-HIV Agents; Enterocolitis, Necrotizing; HIV Seropositivity; Humans; Infant, Newborn; Lamivudine; Male; Nevirapine; Risk Factors; Zidovudine

2006
Cost-effectiveness of HIV rescreening during late pregnancy to prevent mother-to-child HIV transmission in South Africa and other resource-limited settings.
    Journal of acquired immune deficiency syndromes (1999), 2006, Volume: 42, Issue:2

    Topics: Cost-Benefit Analysis; Decision Support Techniques; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mass Screening; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Quality-Adjusted Life Years; South Africa; Zidovudine

2006
A simple and rapid liquid chromatography method for simultaneous determination of zidovudine and nevirapine in plasma.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2006, Nov-07, Volume: 843, Issue:2

    Topics: Adult; Chromatography, High Pressure Liquid; Female; Humans; Male; Nevirapine; Reproducibility of Results; Sensitivity and Specificity; Zidovudine

2006
Inhibition of endogenous reverse transcription of human and nonhuman primate lentiviruses: potential for development of lentivirucides.
    Virology, 2006, Sep-30, Volume: 353, Issue:2

    Topics: Antiviral Agents; Cells, Cultured; Dideoxynucleotides; Disease Transmission, Infectious; HIV-1; Humans; Lentivirus Infections; Nevirapine; Reverse Transcriptase Inhibitors; Simian Immunodeficiency Virus; T-Lymphocytes; Thymine Nucleotides; Transcription, Genetic; Zidovudine

2006
Potent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-Pol.
    PLoS pathogens, 2006, Volume: 2, Issue:11

    Topics: Alkynes; Anti-HIV Agents; Antiviral Agents; Base Sequence; Benzoxazines; Cyclopropanes; Fusion Proteins, gag-pol; HeLa Cells; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Two-Hybrid System Techniques; Virus Replication; Zidovudine

2006
The ethics of placebo-controlled studies on perinatal HIV transmission and its treatment in the developing world.
    Penn bioethics journal, 2006,Spring, Volume: 2, Issue:2

    Topics: Anti-HIV Agents; Breast Feeding; Control Groups; Controlled Clinical Trials as Topic; Developing Countries; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Nevirapine; Placebos; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Zidovudine

2006
Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Jan-15, Volume: 44, Issue:2

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Composition; Body Weight; CD4 Lymphocyte Count; Cohort Studies; Female; HIV Infections; Humans; India; Lamivudine; Male; Nevirapine; Stavudine; Zidovudine

2007
[Vitiligo in a black patient associated with HIV infection and repigmentation under antiretroviral therapy].
    Annales de dermatologie et de venereologie, 2007, Volume: 134, Issue:3 Pt 1

    Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Lamivudine; Nevirapine; Treatment Outcome; Vitiligo; Zidovudine

2007
Nevirapine clearance from plasma in African adults stopping therapy: a pharmacokinetic substudy.
    AIDS (London, England), 2007, Mar-30, Volume: 21, Issue:6

    Topics: Adult; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Stavudine; Uganda; Zidovudine; Zimbabwe

2007
Expanded services for the prevention of mother-to-child HIV transmission: field acceptability of a pilot program in Lusaka, Zambia.
    Journal of acquired immune deficiency syndromes (1999), 2007, May-01, Volume: 45, Issue:1

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Cities; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Nevirapine; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Zambia; Zidovudine

2007
Safety of HIV-1 Perinatal Transmission Prophylaxis With Zidovudine and Nevirapine in Rural South India.
    Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002), 2007, Volume: 6, Issue:2

    Topics: Anti-HIV Agents; Cohort Studies; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Zidovudine

2007
Nodular regenerative hyperplasia: a new serious antiretroviral drugs side effect?
    AIDS (London, England), 2007, Jul-11, Volume: 21, Issue:11

    Topics: Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Chemical and Drug Induced Liver Injury; Didanosine; Female; HIV Infections; HIV-1; Humans; Hyperplasia; Liver; Liver Diseases; Liver Regeneration; Middle Aged; Nevirapine; Zidovudine

2007
NNRTI-selected mutations at codon 190 of human immunodeficiency virus type 1 reverse transcriptase decrease susceptibility to stavudine and zidovudine.
    Antiviral research, 2007, Volume: 76, Issue:2

    Topics: Amino Acid Substitution; Anti-HIV Agents; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Inhibitory Concentration 50; Microbial Sensitivity Tests; Mutation; Nevirapine; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine

2007
Development of a highly efficient extraction technique and specific multiplex assay for measuring antiretroviral drug concentrations in breast milk.
    Therapeutic drug monitoring, 2007, Volume: 29, Issue:4

    Topics: Chromatography, High Pressure Liquid; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Milk, Human; Nevirapine; Postpartum Period; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Stavudine; Zidovudine

2007
Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    PLoS medicine, 2007, Volume: 4, Issue:8

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; CD4 Lymphocyte Count; Cohort Studies; Cote d'Ivoire; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Program Evaluation; Puerperal Disorders; Viral Load; Zidovudine

2007
Human immunodeficiency virus infection in a child presenting as herpes zoster ophthalmicus.
    Journal of the Indian Medical Association, 2007, Volume: 105, Issue:4

    Topics: Acyclovir; Child; Eye Diseases; Herpes Zoster Ophthalmicus; HIV Infections; Humans; Lamivudine; Male; Nevirapine; Zidovudine

2007
Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya.
    Pediatrics, 2007, Volume: 120, Issue:4

    Topics: Adolescent; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Weight; CD4 Lymphocyte Count; Child; Child, Preschool; Drugs, Generic; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Kenya; Lamivudine; Male; Nevirapine; Prospective Studies; RNA, Viral; Viral Load; Zidovudine

2007
N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance.
    PLoS medicine, 2007, Volume: 4, Issue:12

    Topics: Cell Line; Drug Resistance, Multiple, Viral; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Mutation; Nevirapine; Phenotype; Protein Conformation; Protein Structure, Tertiary; Retrospective Studies; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome; Viral Load; Zidovudine

2007
Should we include connection domain mutations of HIV-1 reverse transcriptase in HIV resistance testing.
    PLoS medicine, 2007, Volume: 4, Issue:12

    Topics: Drug Resistance, Multiple, Viral; Genetic Testing; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Nevirapine; Patient Selection; Phenotype; Protein Structure, Tertiary; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome; Viral Load; Zidovudine

2007
Reverse transcriptase mutations in Cambodian CRF01_AE isolates after antiretroviral prophylaxis against HIV Type 1 perinatal transmission.
    AIDS research and human retroviruses, 2007, Volume: 23, Issue:12

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cambodia; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infectious Disease Transmission, Vertical; Molecular Sequence Data; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine

2007
Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Feb-15, Volume: 46, Issue:4

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cote d'Ivoire; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Microbial Sensitivity Tests; Nevirapine; Pregnancy; RNA, Viral; Treatment Outcome; Treatment Refusal; Viral Load; Zidovudine

2008
A radiolabeled oligonucleotide ligation assay demonstrates the high frequency of nevirapine resistance mutations in HIV type 1 quasispecies of NVP-treated and untreated mother-infant pairs from Uganda.
    AIDS research and human retroviruses, 2008, Volume: 24, Issue:2

    Topics: Amino Acid Substitution; Anti-HIV Agents; Cluster Analysis; DNA, Viral; Drug Resistance, Viral; Genetic Techniques; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infant; Infant, Newborn; Leukocytes, Mononuclear; Mothers; Mutation, Missense; Nevirapine; Phylogeny; Polymerase Chain Reaction; Recombination, Genetic; Sequence Analysis, DNA; Uganda; Zidovudine

2008
18-month effectiveness of short-course antiretroviral regimens combined with alternatives to breastfeeding to prevent HIV mother-to-child transmission.
    PloS one, 2008, Feb-20, Volume: 3, Issue:2

    Topics: Africa; Anti-HIV Agents; Breast Feeding; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Proportional Hazards Models; Survival Rate; Treatment Outcome; Zidovudine

2008
Adaptation of antiretroviral therapy in human immunodeficiency virus infection with central nervous system involvement.
    Journal of neurovirology, 2008, Volume: 14, Issue:1

    Topics: Adenine; Adult; AIDS Dementia Complex; Alkynes; Anti-HIV Agents; Anticonvulsants; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Cerebrospinal Fluid; Cyclopropanes; Didanosine; HIV-1; Humans; Indinavir; Lamivudine; Male; Nelfinavir; Nevirapine; Oligopeptides; Organophosphonates; Pyridines; Ritonavir; Seizures; Stavudine; Tenofovir; Viral Load; Virus Replication; Zidovudine

2008
Characteristics of pregnancy with human immuno-deficiency virus (HIV) and perinatal transmission in Nakornping Hospital.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2008, Volume: 91, Issue:2

    Topics: Adolescent; Adult; Anti-Retroviral Agents; Female; HIV Infections; Humans; Incidence; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies; Risk Factors; Thailand; Zidovudine

2008
[HIV-1 genotypic resistance profiles in children failing highly active antiretroviral therapy].
    Zhonghua yi xue za zhi, 2007, Dec-11, Volume: 87, Issue:46

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Child; Child, Preschool; China; Cyclopropanes; Delavirdine; Drug Resistance, Viral; Genotype; HIV-1; Humans; Mutation; Nevirapine; Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Viral Load; Zidovudine

2007
Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants.
    AIDS (London, England), 2008, Apr-23, Volume: 22, Issue:7

    Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cote d'Ivoire; Drug Administration Schedule; Female; Follow-Up Studies; HIV; HIV Infections; HIV-1; HIV-2; Humans; Lamivudine; Male; Nevirapine; Survival Analysis; Treatment Outcome; Zidovudine

2008
Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa.
    Journal of medical virology, 2008, Volume: 80, Issue:6

    Topics: Anti-HIV Agents; Drug Resistance, Viral; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Mutation; Nevirapine; Pregnancy; South Africa; Zidovudine

2008
Breast-feeding, antiretroviral prophylaxis, and HIV.
    The New England journal of medicine, 2008, Jul-10, Volume: 359, Issue:2

    Topics: Anti-HIV Agents; Breast Feeding; Female; HIV; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Nevirapine; Weaning; Zidovudine

2008
[Evaluation of antiretroviral therapy in HIV-infected adults in the Department of Haematology, University Hospital of Brazzavllle, Congo].
    Bulletin de la Societe de pathologie exotique (1990), 2008, Volume: 101, Issue:2

    Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Congo; Cyclopropanes; Didanosine; Drug Evaluation; Drug Therapy, Combination; Female; Hematology; HIV Infections; Hospital Departments; Hospitals, University; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Retrospective Studies; Stavudine; Treatment Outcome; Viral Load; Zidovudine

2008
HIV and obstetric complications and fetal outcomes in Vellore, India.
    Tropical doctor, 2008, Volume: 38, Issue:3

    Topics: Adolescent; Adult; Anti-HIV Agents; Female; HIV Infections; HIV Seronegativity; Humans; India; Infant; Infectious Disease Transmission, Vertical; Medical Audit; Nevirapine; Obstetric Labor Complications; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Care; Zidovudine

2008
A review of the prevention of mother-to-child transmission programme of the Western Cape provincial government, 2003 - 2004.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2008, Volume: 98, Issue:6

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Program Evaluation; Retrospective Studies; Rural Population; South Africa; Urban Population; Zidovudine

2008
Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    AIDS (London, England), 2008, Sep-12, Volume: 22, Issue:14

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cote d'Ivoire; Drug Administration Schedule; Female; HIV Infections; HIV-1; Humans; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Logistic Models; Nevirapine; Perinatal Mortality; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Zidovudine

2008
Antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
    The New England journal of medicine, 2008, Oct-23, Volume: 359, Issue:17

    Topics: Anti-Retroviral Agents; Breast Feeding; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Zidovudine

2008
Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Blood; Breast Feeding; Clinical Trials, Phase II as Topic; Desiccation; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lactation; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Young Adult; Zidovudine

2009
A prospective study evaluating clinical outcomes and costs of three NNRTI-based HAART regimens in Kerala, India.
    Journal of clinical pharmacy and therapeutics, 2009, Volume: 34, Issue:1

    Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Female; HIV Infections; HIV-1; Hospitals, Teaching; Humans; India; Lamivudine; Male; Medication Adherence; Nevirapine; Prospective Studies; Stavudine; Treatment Outcome; Zidovudine

2009
Prevention of mother-to-child HIV transmission using 3-drug combination antiretroviral treatment: observational cohort in clinical practice setting in India.
    Journal of acquired immune deficiency syndromes (1999), 2009, Feb-01, Volume: 50, Issue:2

    Topics: Adolescent; Adult; Anti-HIV Agents; Clinical Trials as Topic; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; India; Infant; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Treatment Outcome; Young Adult; Zidovudine

2009
Higher placental anti-inflammatory IL-10 cytokine expression in HIV-1 infected women receiving longer zidovudine prophylaxis associated with nevirapine.
    Current HIV research, 2009, Volume: 7, Issue:2

    Topics: Adult; Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Interleukin-10; Nevirapine; Placenta; Pregnancy; Pregnancy Complications, Infectious; Time Factors; Young Adult; Zidovudine

2009
The obstetric face and challenge of HIV/AIDS.
    Clinical obstetrics and gynecology, 2009, Volume: 52, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; Developing Countries; Disease Progression; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Maternal Mortality; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Trimethoprim, Sulfamethoxazole Drug Combination; World Health Organization; Zidovudine

2009
Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Jul-15, Volume: 49, Issue:2

    Topics: Adolescent; Adult; Anti-HIV Agents; Blood; Chemoprevention; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Middle Aged; Mothers; Nevirapine; Thailand; Young Adult; Zidovudine

2009
Prevention of human immunodeficiency virus mother-to-child transmission in Israel.
    International journal of STD & AIDS, 2009, Volume: 20, Issue:7

    Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Emigrants and Immigrants; Ethiopia; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Israel; Middle Aged; National Health Programs; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Program Evaluation; Reverse Transcriptase Inhibitors; Viral Load; Young Adult; Zidovudine

2009
[Establishment of pharmacological evaluation system for non-nucleoside reverse-transcriptase inhibitors resistant HIV-1].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2009, Volume: 44, Issue:4

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cell Line; Cyclopropanes; Delavirdine; Drug Evaluation, Preclinical; Drug Resistance, Viral; Genetic Vectors; HIV Reverse Transcriptase; HIV-1; Humans; Membrane Glycoproteins; Nevirapine; Plasmids; Point Mutation; Reverse Transcriptase Inhibitors; Stavudine; Transfection; Viral Envelope Proteins; Virion; Virus Replication; Zidovudine

2009
Adherence to antiretroviral drug therapy in children with HIV/AIDS in Jamaica.
    The West Indian medical journal, 2008, Volume: 57, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; Anti-Retroviral Agents; Biomarkers; CD4 Lymphocyte Count; Child; Child, Preschool; Cross-Sectional Studies; Female; HIV Infections; Humans; Infant; Jamaica; Lamivudine; Male; Medication Adherence; Nevirapine; Surveys and Questionnaires; Young Adult; Zidovudine

2008
Confluent molluscum contagiosum covering the eyelids of an HIV-positive child.
    Clinical & experimental ophthalmology, 2009, Volume: 37, Issue:5

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Child, Preschool; Drug Therapy, Combination; Eye Infections, Viral; Eyelid Diseases; HIV Seropositivity; Humans; Lamivudine; Male; Molluscum Contagiosum; Nevirapine; Trimethoprim, Sulfamethoxazole Drug Combination; Viral Load; Zidovudine

2009
Mother-to-child HIV and HHV-8 transmission in neonates at Saint Camille Medical Centre in Burkina Faso.
    Pakistan journal of biological sciences : PJBS, 2009, Jun-15, Volume: 12, Issue:12

    Topics: Adult; Anti-HIV Agents; Burkina Faso; CD4 Lymphocyte Count; DNA, Viral; Female; Herpesviridae Infections; Herpesvirus 8, Human; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Young Adult; Zidovudine

2009
Frequency of gastroenteritis and gastroenteritis-associated mortality with early weaning in HIV-1-uninfected children born to HIV-infected women in Malawi.
    Journal of acquired immune deficiency syndromes (1999), 2010, Volume: 53, Issue:1

    Topics: Adult; Anti-HIV Agents; Breast Feeding; Developing Countries; Female; Gastroenteritis; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Malawi; Nevirapine; Randomized Controlled Trials as Topic; Risk Factors; Weaning; Zidovudine

2010
Antiretroviral strategies to prevent mother-to-child transmission of HIV: striking a balance between efficacy, feasibility, and resistance.
    PLoS medicine, 2009, Volume: 6, Issue:10

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine

2009
Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy.
    AIDS (London, England), 2010, Jan-02, Volume: 24, Issue:1

    Topics: Adult; Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Nelfinavir; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine

2010
Development of an allele-specific PCR for detection of the K65R resistance mutation in patients infected with subtype C human immunodeficiency virus type 1.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:2

    Topics: Alkynes; Alleles; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutation; Nevirapine; Polymerase Chain Reaction; Zidovudine

2010
Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero.
    AIDS (London, England), 2010, Jan-28, Volume: 24, Issue:3

    Topics: Anti-HIV Agents; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Malawi; Male; Nevirapine; Post-Exposure Prophylaxis; Pregnancy; Viral Load; Zidovudine

2010
Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008.
    Archives of internal medicine, 2010, Jan-11, Volume: 170, Issue:1

    Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Oligopeptides; Organophosphonates; Proportional Hazards Models; Prospective Studies; Pyridines; Pyrimidinones; Risk Factors; Switzerland; Tenofovir; Zidovudine

2010
Detecting and understanding combinatorial mutation patterns responsible for HIV drug resistance.
    Proceedings of the National Academy of Sciences of the United States of America, 2010, Jan-26, Volume: 107, Issue:4

    Topics: Anti-HIV Agents; Drug Resistance, Viral; HIV Infections; HIV Protease; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Models, Molecular; Mutation; Nevirapine; Protein Binding; Protein Structure, Tertiary; Zidovudine

2010
Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Mar-15, Volume: 50, Issue:6

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Ligase Chain Reaction; Mutation, Missense; Nevirapine; Postpartum Period; Pregnancy; RNA, Viral; Sequence Analysis, DNA; Viral Load; Young Adult; Zidovudine

2010
Another milestone in minimizing risks to mothers exposed to single-dose nevirapine for prevention of vertical transmission of HIV-1 to infants: what next?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Mar-15, Volume: 50, Issue:6

    Topics: Anti-HIV Agents; Didanosine; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Mutation, Missense; Nevirapine; Pregnancy; Zidovudine

2010
Analysis of RT sequences of subtype C HIV-type 1 isolates from indian patients at failure of a first-line treatment according to clinical and/or immunological WHO guidelines.
    AIDS research and human retroviruses, 2010, Volume: 26, Issue:3

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; India; Lamivudine; Molecular Sequence Data; Nevirapine; Polymorphism, Single Nucleotide; Stavudine; Treatment Failure; Zidovudine

2010
Positive and negative drug selection pressures on the N348I connection domain mutation: new insights from in vivo data.
    Antiviral therapy, 2010, Volume: 15, Issue:2

    Topics: Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Case-Control Studies; Cyclopropanes; Databases, Genetic; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; HIV Reverse Transcriptase; HIV-1; Humans; Logistic Models; Mutation; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; Stavudine; Tenofovir; Zidovudine

2010
[Durability and tolerability of long-term nevirapine-based HAART].
    Le infezioni in medicina, 2010, Volume: 18, Issue:1

    Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Comorbidity; Dideoxynucleosides; Female; Hepatitis, Viral, Human; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Lipids; Liver Function Tests; Male; Middle Aged; Nevirapine; Retrospective Studies; Stavudine; Viral Load; Young Adult; Zidovudine

2010
Identification, isolation, and characterization of potential degradation products in a triple combination lamivudine, zidovudine, and nevirapine tablet for oral suspension.
    Die Pharmazie, 2010, Volume: 65, Issue:5

    Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; Drug Contamination; Indicators and Reagents; Lamivudine; Magnetic Resonance Spectroscopy; Nevirapine; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Suspensions; Tablets; Zidovudine

2010
Reducing pediatric HIV infection: estimating mother-to-child transmission rates in a program setting in Zambia.
    Journal of acquired immune deficiency syndromes (1999), 2010, Volume: 54, Issue:4

    Topics: Antiretroviral Therapy, Highly Active; Breast Feeding; Child; DNA, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infant Formula; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Mother-Child Relations; Nevirapine; Odds Ratio; Polymerase Chain Reaction; Regression Analysis; Zambia; Zidovudine

2010
Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso.
    AIDS care, 2010, Volume: 22, Issue:7

    Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Burkina Faso; Cohort Studies; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Peripartum Period; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Young Adult; Zidovudine

2010
Addition of 7 days of zidovudine plus lamivudine to peripartum single-dose nevirapine effectively reduces nevirapine resistance postpartum in HIV-infected mothers in Malawi.
    Journal of acquired immune deficiency syndromes (1999), 2010, Volume: 54, Issue:5

    Topics: Adolescent; Adult; Anti-HIV Agents; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Longitudinal Studies; Malawi; Nevirapine; Plasma; Polymerase Chain Reaction; Postpartum Period; Pregnancy; RNA, Viral; Sequence Analysis, DNA; Young Adult; Zidovudine

2010
Immunological response to highly active antiretroviral therapy following treatment for prevention of mother to child transmission of HIV-1: a study in Côte d'Ivoire.
    Journal of the International AIDS Society, 2010, Aug-02, Volume: 13

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cote d'Ivoire; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Treatment Outcome; Zidovudine

2010
Recent FDA approvals and changes.
    AIDS patient care and STDs, 2010, Volume: 24, Issue:8

    Topics: Anti-HIV Agents; Child; Child, Preschool; Drug Approval; Drug Combinations; Drugs, Generic; HIV Antibodies; HIV Core Protein p24; HIV Infections; HIV-1; HIV-2; Humans; Lamivudine; Nevirapine; Reagent Kits, Diagnostic; Reverse Transcriptase Inhibitors; Tablets; United States; United States Food and Drug Administration; Zidovudine

2010
Outcomes and challenges of scaling up comprehensive PMTCT services in rural Swaziland, Southern Africa.
    AIDS care, 2010, Volume: 22, Issue:9

    Topics: Adult; AIDS Serodiagnosis; Anti-HIV Agents; Eswatini; Female; HIV Infections; Humans; Infant; Infant Care; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal Health Services; Neonatal Screening; Nevirapine; Outcome Assessment, Health Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Prevalence; Program Development; Program Evaluation; Rural Health; Zidovudine

2010
Stavudine toxicity in women is the main reason for treatment change in a 3-year prospective cohort of adult patients started on first-line antiretroviral treatment in Uganda.
    Journal of acquired immune deficiency syndromes (1999), 2011, Jan-01, Volume: 56, Issue:1

    Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Female; HIV Infections; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Multivariate Analysis; Nevirapine; Prospective Studies; Risk Factors; Sex Factors; Stavudine; Uganda; Zidovudine

2011
Evaluating patients for second-line antiretroviral therapy in India: the role of targeted viral load testing.
    Journal of acquired immune deficiency syndromes (1999), 2010, Dec-15, Volume: 55, Issue:5

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Female; HIV; HIV Infections; Humans; India; Lamivudine; Male; Middle Aged; Nevirapine; RNA, Viral; Stavudine; Treatment Failure; Viral Load; Zidovudine

2010
Reduced dose of stavudine and lipoatrophy in HIV-infected patients in Cameroon.
    Antiviral therapy, 2010, Volume: 15, Issue:7

    Topics: Adult; Anti-HIV Agents; Cameroon; CD4 Lymphocyte Count; Cross-Sectional Studies; Female; HIV; HIV Infections; Humans; Lamivudine; Lipodystrophy; Male; Middle Aged; Nevirapine; Stavudine; Zidovudine

2010
The impact of maternal highly active antiretroviral therapy and short-course combination antiretrovirals for prevention of mother-to-child transmission on early infant infection rates at the Mulago national referral hospital in Kampala, Uganda, January 20
    Journal of acquired immune deficiency syndromes (1999), 2011, Jan-01, Volume: 56, Issue:1

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Confidence Intervals; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Multivariate Analysis; Nevirapine; Odds Ratio; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Uganda; Young Adult; Zidovudine

2011
Perinatal tuberculosis: two unusual cases.
    Annals of tropical paediatrics, 2011, Volume: 31, Issue:1

    Topics: Anti-HIV Agents; Anti-Inflammatory Agents; Antimalarials; Drug Therapy, Combination; Endometritis; Female; HIV Infections; Humans; Immunocompromised Host; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Nevirapine; Prednisolone; Pregnancy; Pregnancy Complications, Infectious; Radiography; Tuberculosis, Meningeal; Tuberculosis, Pulmonary; Zidovudine

2011
Effectiveness of a PMTCT programme in rural Western Kenya.
    AIDS care, 2011, Volume: 23, Issue:3

    Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Epidemiologic Methods; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Kenya; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Program Evaluation; Rural Health; Treatment Outcome; Young Adult; Zidovudine

2011
Phenotypic characterization of drug resistance-associated mutations in HIV-1 RT connection and RNase H domains and their correlation with thymidine analogue mutations.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:4

    Topics: Amino Acid Substitution; Anti-HIV Agents; Brazil; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Mutant Proteins; Mutation, Missense; Nevirapine; Protein Structure, Tertiary; Thymidine; Zidovudine

2011
Short communication: high prevalence of drug resistance in HIV type 1-infected children born in Honduras and Belize 2001 to 2004.
    AIDS research and human retroviruses, 2011, Volume: 27, Issue:10

    Topics: Anti-HIV Agents; Base Sequence; Belize; Cohort Studies; Drug Resistance, Multiple, Viral; Female; HIV Infections; HIV-1; Honduras; Humans; Infant; Infant, Newborn; Male; Molecular Sequence Data; Mutation; Nevirapine; Phylogeny; pol Gene Products, Human Immunodeficiency Virus; Pregnancy; Prevalence; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine

2011
Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis.
    AIDS (London, England), 2011, Apr-24, Volume: 25, Issue:7

    Topics: Anti-HIV Agents; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Malawi; Male; Nevirapine; Post-Exposure Prophylaxis; Viral Load; Zidovudine

2011
Improving retention in the early infant diagnosis of HIV program in rural Mozambique by better service integration.
    Journal of acquired immune deficiency syndromes (1999), 2011, Sep-01, Volume: 58, Issue:1

    Topics: Adult; Anti-HIV Agents; Delivery of Health Care; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Mozambique; Nevirapine; Pregnancy; Retrospective Studies; Rural Population; Young Adult; Zidovudine

2011
WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers.
    PloS one, 2011, Volume: 6, Issue:6

    Topics: Anti-HIV Agents; Breast Feeding; Child; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; National Health Programs; Nevirapine; Outcome Assessment, Health Care; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Survival Analysis; World Health Organization; Young Adult; Zidovudine; Zimbabwe

2011
Evaluation of saliva as an alternative matrix for monitoring plasma Zidovudine, Lamivudine and nevirapine concentrations in Rwanda.
    Current HIV research, 2011, Volume: 9, Issue:4

    Topics: Adult; Anti-HIV Agents; Cross-Sectional Studies; Drug Monitoring; Feasibility Studies; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Medication Adherence; Middle Aged; Nevirapine; Rwanda; Saliva; Zidovudine

2011
[Comparative study of two anti-antiretroviral protocols used for treatment of a cohort of HIV 1-positive patients followed at the Institute of Public Health and Hygiene in Dakar, Senegal].
    Medecine tropicale : revue du Corps de sante colonial, 2011, Volume: 71, Issue:2

    Topics: Academies and Institutes; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; HIV Seropositivity; HIV-1; Humans; Hygiene; Lamivudine; Nevirapine; Public Health; Quality of Life; Retrospective Studies; Senegal; Survival Analysis; Treatment Outcome; Zidovudine

2011
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach.
    Lancet (London, England), 2011, Jul-16, Volume: 378, Issue:9787

    Topics: Adult; Anti-HIV Agents; Breast Feeding; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Therapy, Combination; Female; Goals; Healthy People Programs; HIV Infections; HIV Seropositivity; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Malawi; Male; Nevirapine; Peripartum Period; Pregnancy; Pregnancy Complications, Infectious; Public Health; United Nations; Zidovudine

2011
Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Volume: 53, Issue:4

    Topics: Adult; Anti-HIV Agents; Breast Feeding; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Malawi; Morbidity; Nevirapine; Poisson Distribution; Post-Exposure Prophylaxis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Weaning; Zidovudine

2011
Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI-based regimens in the Western Cape, South Africa.
    Journal of medical virology, 2011, Volume: 83, Issue:10

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cross-Sectional Studies; Cyclopropanes; Drug Resistance, Viral; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Nevirapine; Nitriles; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; RNA, Viral; South Africa; Treatment Failure; Viral Load; Zidovudine

2011
The effects of RNase H inhibitors and nevirapine on the susceptibility of HIV-1 to AZT and 3TC.
    Virology, 2011, Oct-25, Volume: 419, Issue:2

    Topics: Anti-HIV Agents; Cell Line, Tumor; Drug Resistance, Viral; HEK293 Cells; HIV Reverse Transcriptase; HIV-1; Humans; Inhibitory Concentration 50; Lamivudine; Mutation; Nevirapine; Reverse Transcriptase Inhibitors; Ribonuclease H; Ribonuclease H, Human Immunodeficiency Virus; Zidovudine

2011
Should sponsors and DSMBs share interim results across trials?
    Journal of acquired immune deficiency syndromes (1999), 2011, Dec-15, Volume: 58, Issue:5

    Topics: Anti-HIV Agents; Clinical Trials as Topic; Clinical Trials Data Monitoring Committees; Confidentiality; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Interinstitutional Relations; Nevirapine; Pregnancy; Zidovudine

2011
An autoimmune disease prevented by anti-retroviral drugs.
    Retrovirology, 2011, Nov-08, Volume: 8

    Topics: Animals; Autoimmune Diseases; Autoimmune Diseases of the Nervous System; Deoxycytidine; Drug Combinations; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Exodeoxyribonucleases; Green Fluorescent Proteins; Lupus Erythematosus, Systemic; Mice; Mice, Knockout; Myocarditis; Nervous System Malformations; Nevirapine; Organophosphorus Compounds; Phosphoproteins; Retroelements; Reverse Transcriptase Inhibitors; Zidovudine

2011
Costs and benefits of multidrug, multidose antiretroviral therapy for prevention of mother-to-child transmission of HIV in the Dominican Republic.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2012, Volume: 116, Issue:3

    Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cost-Benefit Analysis; Cyclopropanes; Dominican Republic; Drug Administration Schedule; Drug Costs; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Zidovudine

2012
Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirin.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Acyclovir; Anti-HIV Agents; Cell Line; Drug Resistance, Viral; Drug Synergism; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Lamivudine; Nevirapine; Palatine Tonsil; Protease Inhibitors; Ribavirin; T-Lymphocytes; Tissue Culture Techniques; Zidovudine

2012
Recombination between variants from genital tract and plasma: evolution of multidrug-resistant HIV type 1.
    AIDS research and human retroviruses, 2012, Volume: 28, Issue:12

    Topics: Adult; Anti-HIV Agents; Female; Genitalia, Female; HIV Infections; HIV-1; Humans; Lamivudine; Molecular Sequence Data; Nevirapine; Plasma; Recombination, Genetic; RNA, Viral; Sequence Analysis, DNA; Zidovudine

2012
Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria.
    BMC clinical pharmacology, 2012, Feb-27, Volume: 12

    Topics: Adenine; Adolescent; Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cohort Studies; Cyclopropanes; Drug-Related Side Effects and Adverse Reactions; Exanthema; Female; HIV Infections; Humans; Incidence; Lamivudine; Male; Middle Aged; Nevirapine; Nigeria; Organophosphonates; Pain; Retrospective Studies; Risk Factors; Stavudine; Tenofovir; Zidovudine

2012
Development and validation of an HPLC-UV method for simultaneous determination of zidovudine, lamivudine, and nevirapine in human plasma and its application to pharmacokinetic study in human volunteers.
    Drug testing and analysis, 2013, Volume: 5, Issue:6

    Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; Humans; Lamivudine; Limit of Detection; Liquid-Liquid Extraction; Nevirapine; Zidovudine

2013
Emergence of minor drug-resistant HIV-1 variants after triple antiretroviral prophylaxis for prevention of vertical HIV-1 transmission.
    PloS one, 2012, Volume: 7, Issue:2

    Topics: Adult; Alleles; Anti-Retroviral Agents; Drug Resistance, Viral; Female; Genetic Variation; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Nevirapine; Oligonucleotides; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Tanzania; Zidovudine

2012
Effects of short-course zidovudine on the selection of nevirapine-resistant HIV-1 in women taking single-dose nevirapine.
    The Journal of infectious diseases, 2012, Jun-15, Volume: 205, Issue:12

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Mutation, Missense; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Viral Proteins; Young Adult; Zidovudine

2012
Lignosulfonic acid exhibits broadly anti-HIV-1 activity--potential as a microbicide candidate for the prevention of HIV-1 sexual transmission.
    PloS one, 2012, Volume: 7, Issue:4

    Topics: Anti-HIV Agents; Anti-Infective Agents; Antibodies, Monoclonal; Antibodies, Viral; Antibody Specificity; Binding Sites; CD4 Antigens; Cell Death; Cell Line; Drug Synergism; Epithelium; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Interleukin-8; Lignin; Models, Molecular; Nevirapine; NF-kappa B; Protein Structure, Secondary; Receptors, CCR5; Receptors, CXCR4; Virus Internalization; Zidovudine

2012
N348I in HIV-1 reverse transcriptase counteracts the synergy between zidovudine and nevirapine.
    Journal of acquired immune deficiency syndromes (1999), 2012, Oct-01, Volume: 61, Issue:2

    Topics: Anti-HIV Agents; Drug Resistance, Viral; Drug Synergism; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutant Proteins; Mutation, Missense; Nevirapine; Selection, Genetic; Zidovudine

2012
In vitro and ex vivo inhibition of human telomerase by anti-HIV nucleoside reverse transcriptase inhibitors (NRTIs) but not by non-NRTIs.
    PloS one, 2012, Volume: 7, Issue:11

    Topics: Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Cell Line; Cyclopropanes; Didanosine; Dideoxynucleosides; DNA Primers; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; Stavudine; Telomerase; Tenofovir; Zidovudine

2012
Impact of hepatitis C virus on HIV response to antiretroviral therapy in Nigeria.
    Journal of acquired immune deficiency syndromes (1999), 2013, Feb-01, Volume: 62, Issue:2

    Topics: Adult; Alanine Transaminase; Alkynes; Anti-Retroviral Agents; Benzoxazines; Chemical and Drug Induced Liver Injury; Coinfection; Cyclopropanes; Deoxycytidine; Drug Combinations; Drug Therapy, Combination; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Lamivudine; Logistic Models; Male; Nevirapine; Nigeria; Organophosphorus Compounds; RNA, Viral; Stavudine; Zidovudine

2013
Risk adapted transmission prophylaxis to prevent vertical HIV-1 transmission: effectiveness and safety of an abbreviated regimen of postnatal oral zidovudine.
    BMC pregnancy and childbirth, 2013, Jan-24, Volume: 13

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Risk Factors; Treatment Outcome; Zidovudine

2013
Toxicology and carcinogenesis studies of mixtures of 3'-azido-3'-deoxythymidine (AZT), lamivudine (3TC), nevirapine (NVP), and nelfinavir mesylate (NFV) (Cas Nos. 30516-87-1, 134678-17-4, 129618-40-2, 159989-65-8) in B6C3F1 Mice (transplacental exposure s
    National Toxicology Program technical report series, 2013, Issue:569

    Topics: Administration, Oral; Animals; Anti-Retroviral Agents; DNA; Drug Therapy, Combination; Escherichia coli; Female; Lamivudine; Longevity; Male; Maternal Exposure; Mice; Mice, Inbred Strains; Nelfinavir; Nevirapine; Pregnancy; Prenatal Exposure Delayed Effects; Salmonella typhimurium; Skin Neoplasms; Zidovudine

2013
Nevirapine inhibits the anti-HIV activity of CD8+ cells.
    Journal of acquired immune deficiency syndromes (1999), 2013, Jun-01, Volume: 63, Issue:2

    Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Coculture Techniques; HIV Infections; HIV Seropositivity; HIV-1; Humans; Nevirapine; RNA, Viral; Zidovudine

2013
High throughput LC-MS/MS method for simultaneous determination of zidovudine, lamivudine and nevirapine in human plasma.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2013, Mar-15, Volume: 921-922

    Topics: Anti-HIV Agents; Chromatography, Liquid; Humans; Lamivudine; Male; Nevirapine; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Zidovudine

2013
Effect of highly active antiretroviral treatment (HAART) during pregnancy on pregnancy outcomes: experiences from a PMTCT program in western India.
    AIDS patient care and STDs, 2013, Volume: 27, Issue:3

    Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; Gestational Age; HIV Infections; Humans; India; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Logistic Models; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Program Evaluation; Prospective Studies; Socioeconomic Factors; Viral Load; Young Adult; Zidovudine

2013
Cardiometabolic risk factors among HIV patients on antiretroviral therapy.
    Lipids in health and disease, 2013, Apr-10, Volume: 12

    Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cyclopropanes; Female; HIV; HIV Infections; Humans; Insulin Resistance; Lamivudine; Male; Middle Aged; Nevirapine; Organophosphonates; Risk Factors; Stavudine; Tenofovir; Triglycerides; Zambia; Zidovudine

2013
Talk of HIV cure goes viral.
    The Lancet. Infectious diseases, 2013, Volume: 13, Issue:4

    Topics: Adult; Anti-HIV Agents; CD4-Positive T-Lymphocytes; Child, Preschool; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Male; Nevirapine; Primary Prevention; Ritonavir; Secondary Prevention; Time Factors; Zidovudine

2013
Left ventricular hypertrophy detected by echocardiography in HIV-infected patients.
    European journal of internal medicine, 2013, Volume: 24, Issue:6

    Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Carbamates; Comorbidity; Cross-Sectional Studies; Cyclopropanes; Diabetes Mellitus; Drug Combinations; Dyslipidemias; Echocardiography; Female; Furans; HIV Infections; Humans; Hypertension; Hypertrophy, Left Ventricular; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Organophosphates; Organophosphonates; Risk Factors; Ritonavir; Smoking; Spain; Sulfonamides; Tenofovir; Zidovudine

2013
Antiretroviral drugs in Africa: a public health versus a market approach.
    Journal of acquired immune deficiency syndromes (1999), 2013, Jun-01, Volume: 63, Issue:2

    Topics: Africa; Anti-HIV Agents; Drug Packaging; Health Resources; Health Services Accessibility; HIV Infections; Humans; Lamivudine; Nevirapine; Public Health; Zidovudine

2013
Characterization of antiviral activity of benzamide derivative AH0109 against HIV-1 infection.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:8

    Topics: Active Transport, Cell Nucleus; CD4-Positive T-Lymphocytes; DNA, Viral; Drug Evaluation, Preclinical; HEK293 Cells; HIV Integrase Inhibitors; HIV-1; Humans; Lamivudine; Microbial Sensitivity Tests; Morphinans; Nevirapine; Reverse Transcriptase Inhibitors; Reverse Transcription; Virus Replication; Zidovudine

2013
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.
    The Journal of infectious diseases, 2013, Jun-15, Volume: 207 Suppl 2

    Topics: Adenine; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cyclopropanes; Databases, Factual; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; HIV Infections; HIV-1; Humans; Mutation, Missense; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Tenofovir; Zidovudine

2013
Baseline CD4 cell counts and outcomes among adult treatment naive HIV patients after taking fixed dose combination GPO-VIR-S and GPO-VIR-Z in Thailand.
    The Southeast Asian journal of tropical medicine and public health, 2013, Volume: 44, Issue:2

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Female; Hematologic Tests; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Kaplan-Meier Estimate; Lamivudine; Male; Middle Aged; Nevirapine; Retrospective Studies; Stavudine; Thailand; Treatment Outcome; Viral Load; Zidovudine

2013
Economic evaluation of 3-drug antiretroviral regimens for the prevention of mother-to-child HIV transmission in Thailand.
    Asia-Pacific journal of public health, 2015, Volume: 27, Issue:2

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cost-Benefit Analysis; Cyclopropanes; Drug Therapy, Combination; Female; Health Services; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Models, Econometric; Mothers; Nevirapine; Pregnancy; Thailand; Zidovudine

2015
Anti-HIV host factor SAMHD1 regulates viral sensitivity to nucleoside reverse transcriptase inhibitors via modulation of cellular deoxyribonucleoside triphosphate (dNTP) levels.
    The Journal of biological chemistry, 2013, Jul-12, Volume: 288, Issue:28

    Topics: Blotting, Western; CD4-Positive T-Lymphocytes; Cell Line; Cells, Cultured; Deoxyribonucleosides; Dose-Response Relationship, Drug; HIV-1; Host-Pathogen Interactions; Humans; Macrophages; Monomeric GTP-Binding Proteins; Nevirapine; Reverse Transcriptase Inhibitors; RNA Interference; SAM Domain and HD Domain-Containing Protein 1; Viral Regulatory and Accessory Proteins; Virion; Virus Replication; Zidovudine

2013
Adherence to antiretroviral therapy among HIV infected children measured by caretaker report, medication return, and drug level in Dar Es Salaam, Tanzania.
    BMC pediatrics, 2013, Jun-15, Volume: 13

    Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Caregivers; CD4 Lymphocyte Count; Child; Child, Preschool; Cross-Sectional Studies; Drug Administration Schedule; Drug Combinations; Female; HIV Infections; Humans; Lamivudine; Logistic Models; Male; Medication Adherence; Middle Aged; Nevirapine; Odds Ratio; Stavudine; Surveys and Questionnaires; Tanzania; Young Adult; Zidovudine

2013
HIV-1 drug-resistance surveillance among treatment-experienced and -naïve patients after the implementation of antiretroviral therapy in Ghana.
    PloS one, 2013, Volume: 8, Issue:8

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Child; Child, Preschool; Cyclopropanes; Drug Resistance, Viral; Epidemiological Monitoring; Female; Ghana; HIV Infections; HIV Protease; HIV-1; Humans; Infant; Lamivudine; Male; Middle Aged; Molecular Epidemiology; Molecular Typing; Mutation, Missense; Nevirapine; Prevalence; Sequence Analysis, DNA; Stavudine; Zidovudine

2013
Anemia and risk factors in HAART naïve and HAART experienced HIV positive persons in south west Ethiopia: a comparative study.
    PloS one, 2013, Volume: 8, Issue:8

    Topics: Adolescent; Adult; Anemia; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Child; Child, Preschool; Cross-Sectional Studies; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Lamivudine; Longitudinal Studies; Male; Middle Aged; Nevirapine; Risk Factors; Social Class; Surveys and Questionnaires; Zidovudine

2013
High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa.
    PloS one, 2013, Volume: 8, Issue:8

    Topics: Adolescent; Adult; Alkynes; Analysis of Variance; Anti-HIV Agents; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Mutation; Nevirapine; Outcome Assessment, Health Care; Prevalence; South Africa; Stavudine; Young Adult; Zidovudine

2013
Child cured of HIV: can this be repeated?
    Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:17

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Infant, Newborn; Lamivudine; Nevirapine; Reverse Transcriptase Inhibitors; Zidovudine

2013
[Evaluation of tolerance of zidovudine-lamivudine-nevirapine combination in HIV 1 patients in Fann Teaching Hospital in Dakar].
    Bulletin de la Societe de pathologie exotique (1990), 2013, Volume: 106, Issue:4

    Topics: Adult; Anti-HIV Agents; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; HIV-1; Hospitals, Teaching; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Retrospective Studies; Senegal; Zidovudine

2013
Trends in clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Shanghai from 2006 to 2011.
    International journal of STD & AIDS, 2014, Volume: 25, Issue:7

    Topics: Adolescent; Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; China; Cross-Sectional Studies; Female; HIV Infections; Humans; Immune Tolerance; Lamivudine; Male; Middle Aged; Nevirapine; Retrospective Studies; Stavudine; Viral Load; Zidovudine

2014
Preliminary study of quinine pharmacokinetics in pregnant women with malaria-HIV co-infection.
    The American journal of tropical medicine and hygiene, 2014, Volume: 90, Issue:3

    Topics: Adult; Anti-HIV Agents; Antimalarials; Antiretroviral Therapy, Highly Active; Coinfection; Drug Interactions; Female; HIV Infections; Humans; Lamivudine; Malaria, Falciparum; Nevirapine; Parasite Load; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Quinidine; Quinine; Stavudine; Treatment Outcome; Young Adult; Zidovudine

2014
Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:5

    Topics: Adolescent; Adult; Amodiaquine; Anti-Retroviral Agents; Antimalarials; Antiretroviral Therapy, Highly Active; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Drug Interactions; Female; HIV Infections; Humans; Lamivudine; Malaria; Male; Middle Aged; Nevirapine; Nigeria; Plasma; Young Adult; Zidovudine

2014
Clinical profile and response to first-line ARV in HIV patients from Eastern UP and Bihar: a retrospective study.
    The Journal of the Association of Physicians of India, 2013, Volume: 61, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; Humans; India; Lamivudine; Male; Middle Aged; Nevirapine; Retrospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Treatment Outcome; Young Adult; Zidovudine

2013
Toxicology and Carcinogenesis Studies of Mixtures of 3'-Azido-3'-Deoxythymidine (AZT), Lamivudine (3TC), and Nevirapine (NVP) (CAS Nos. 30516-87-1, 134678-17-4, 129618-40-2) in Genetically Modified C3B6.129F1-Trp53(tm1Brd) N12 Haploinsufficient Mice (in u
    National Toxicology Program genetically modified model report, 2013, Issue:16

    Topics: Animals; Animals, Genetically Modified; Animals, Newborn; Anti-HIV Agents; Body Weight; Chemistry, Pharmaceutical; Drug Combinations; Female; Haploinsufficiency; Intubation, Gastrointestinal; Lamivudine; Litter Size; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mutagens; Nevirapine; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Reproduction; Reverse Transcriptase Inhibitors; Survival; Zidovudine

2013
Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cambodia; CD4 Lymphocyte Count; Coinfection; Cyclopropanes; Female; Hepatitis B; Hepatitis C; HIV Infections; Humans; Kaplan-Meier Estimate; Lamivudine; Liver; Logistic Models; Male; Middle Aged; Nevirapine; Proportional Hazards Models; Retrospective Studies; Stavudine; Treatment Outcome; Zidovudine

2014
Birth prevalence of congenital cytomegalovirus among infants of HIV-infected women on prenatal antiretroviral prophylaxis in South Africa.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Volume: 58, Issue:10

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cytomegalovirus; Cytomegalovirus Infections; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Prevalence; South Africa; Viral Load; Zidovudine

2014
Exposure of Allium cepa root cells to zidovudine or nevirapine induces cytogenotoxic changes.
    PloS one, 2014, Volume: 9, Issue:3

    Topics: Anti-HIV Agents; DNA Damage; Drug Evaluation, Preclinical; Inhibitory Concentration 50; Mitosis; Mitotic Index; Mutagens; Nevirapine; Onions; Plant Roots; Zidovudine

2014
Challenges of antiretroviral treatment monitoring in rural and remote-access regions in Africa.
    AIDS research and human retroviruses, 2014, Volume: 30, Issue:7

    Topics: Acquired Immunodeficiency Syndrome; Adult; Africa; Alkynes; Anti-HIV Agents; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Drug Monitoring; Drug Resistance, Viral; Female; HIV-1; Hospitals, Rural; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Rural Health Services; Rural Population; Stavudine; Treatment Outcome; Zidovudine

2014
Presence of HIV drug resistance in antiretroviral therapy-naive and -experienced patients from Papua New Guinea.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:8

    Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Dried Blood Spot Testing; Drug Resistance, Viral; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Papua New Guinea; Reverse Transcriptase Inhibitors; Stavudine; Treatment Failure; Viral Load; Young Adult; Zidovudine

2014
Clinical manifestations and treatment outcomes in HIV-1-infected children receiving antiretroviral therapy in Karachi, Pakistan.
    Journal of infection in developing countries, 2014, Apr-15, Volume: 8, Issue:4

    Topics: Anti-HIV Agents; Body Height; Body Weight; CD4 Lymphocyte Count; Child, Preschool; Drug Resistance, Viral; Female; Genotype; HIV; HIV Infections; Humans; Infant; Lamivudine; Male; Nevirapine; Pakistan; Retrospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load; Zidovudine

2014
MicroRNA-150 is a potential biomarker of HIV/AIDS disease progression and therapy.
    PloS one, 2014, Volume: 9, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Biomarkers; CD4 Lymphocyte Count; Cyclopropanes; Disease Progression; Drug Resistance, Viral; Female; Gene Expression Regulation; HIV; Humans; Lamivudine; Leukocytes, Mononuclear; Male; MicroRNAs; Nevirapine; Stavudine; Treatment Outcome; Viral Load; Zidovudine

2014
Impact of Y181C and/or H221Y mutation patterns of HIV-1 reverse transcriptase on phenotypic resistance to available non-nucleoside and nucleoside inhibitors in China.
    BMC infectious diseases, 2014, May-05, Volume: 14

    Topics: Alkynes; Benzoxazines; China; Cyclopropanes; Drug Resistance, Multiple, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutation; Nevirapine; Phenotype; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine

2014
Foetal loss and enhanced fertility observed in mice treated with Zidovudine or Nevirapine.
    PloS one, 2014, Volume: 9, Issue:9

    Topics: Animals; Anti-HIV Agents; Female; Fertility; Fetal Death; Male; Mice; Nevirapine; Pregnancy; Sex Ratio; Zidovudine

2014
[Analysis on HIV suppression effect after initiating antiretroviral treatment and related factors among AIDS patients in Henan province during 2008 and 2013].
    Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine], 2015, Volume: 49, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Female; Health Facilities; HIV Infections; Humans; Lamivudine; Male; Nevirapine; Stavudine; Time-to-Treatment; Treatment Outcome; Zidovudine

2015
Time trends of baseline demographics and clinical characteristics of HIV infected children enrolled in care and treatment service in Dar es Salaam, Tanzania.
    BMC infectious diseases, 2015, Mar-26, Volume: 15

    Topics: Adolescent; Age Distribution; Alkynes; Ambulatory Care Facilities; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Child; Child, Preschool; Comorbidity; Cyclopropanes; Female; HIV Infections; Humans; Infant; Lamivudine; Linear Models; Male; Nevirapine; Severity of Illness Index; Tanzania; Tuberculosis; Zidovudine

2015
A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.
    Journal of medical virology, 2015, Volume: 87, Issue:10

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Deoxycytidine; Drug Administration Schedule; Drug Resistance, Viral; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Mothers; Mutation; Nevirapine; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Sequence Analysis, DNA; South Africa; Tenofovir; Viral Load; Zidovudine

2015
Serious adverse events are uncommon with combination neonatal antiretroviral prophylaxis: a retrospective case review.
    PloS one, 2015, Volume: 10, Issue:5

    Topics: Anemia; Anti-HIV Agents; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Neutropenia; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Thrombocytopenia; Zidovudine

2015
Lower Preprandial Insulin and Altered Fuel Use in HIV/Antiretroviral-Exposed Infants in Cameroon.
    The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:9

    Topics: Amino Acids, Branched-Chain; Anti-Retroviral Agents; Cameroon; Energy Metabolism; Female; HIV Infections; Humans; Infant; Insulin; Male; Nevirapine; Pregnancy; Prospective Studies; Zidovudine

2015
Missed Opportunities along the Prevention of Mother-to-Child Transmission Services Cascade in South Africa: Uptake, Determinants, and Attributable Risk (the SAPMTCTE).
    PloS one, 2015, Volume: 10, Issue:7

    Topics: Adolescent; Adult; AIDS Serodiagnosis; Anti-HIV Agents; CD4 Lymphocyte Count; Cross-Sectional Studies; Developing Countries; Female; HIV Infections; Home Childbirth; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal Age; Maternal Health Services; Nevirapine; Parity; Patient Dropouts; Pregnancy; Pregnancy Complications, Infectious; Pregnancy in Adolescence; Prenatal Care; Risk Factors; Socioeconomic Factors; South Africa; Zidovudine

2015
Longitudinal Analysis of Adherence to First-Line Antiretroviral Therapy: Evidence of Treatment Sustainability from an Indian HIV Cohort.
    Current HIV research, 2016, Volume: 14, Issue:1

    Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Administration Schedule; Female; HIV Infections; Humans; India; Lamivudine; Longitudinal Studies; Male; Medication Adherence; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine

2016
Longitudinal adherence to antiretroviral drugs for preventing mother-to-child transmission of HIV in Zambia.
    BMC pregnancy and childbirth, 2015, Oct-12, Volume: 15

    Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Medication Adherence; Nevirapine; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Probability; Prospective Studies; Referral and Consultation; Risk Factors; Rural Health Services; Self Report; Time Factors; Young Adult; Zambia; Zidovudine

2015
Antiretrovirals, Methamphetamine, and HIV-1 Envelope Protein gp120 Compromise Neuronal Energy Homeostasis in Association with Various Degrees of Synaptic and Neuritic Damage.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Autophagy; Cell Culture Techniques; Cerebral Cortex; Drug Combinations; Embryo, Mammalian; HIV Envelope Protein gp120; HIV Integrase Inhibitors; Homeostasis; Methamphetamine; Neuroglia; Neurons; Nevirapine; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Saquinavir; Sirolimus; Zidovudine

2016
Testing anti-HIV activity of antiretroviral agents in vitro using flow cytometry analysis of CEM-GFP cells infected with transfection-derived HIV-1 NL4-3.
    Journal of medical virology, 2016, Volume: 88, Issue:6

    Topics: Anti-HIV Agents; Cell Line, Tumor; Cell Survival; Flow Cytometry; HEK293 Cells; HIV Core Protein p24; HIV-1; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Nevirapine; Transfection; Zidovudine

2016
Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian Cohort.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, Feb-15, Volume: 62, Issue:4

    Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cohort Studies; Female; HIV Infections; Humans; Male; Nevirapine; Retrospective Studies; Tenofovir; Treatment Outcome; Viral Load; Young Adult; Zidovudine

2016
The last and first frontier--emerging challenges for HIV treatment and prevention in the first week of life with emphasis on premature and low birth weight infants.
    Journal of the International AIDS Society, 2015, Volume: 18, Issue:Suppl 6

    Topics: Female; HIV Infections; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Zidovudine

2015
FRET-based assay to screen inhibitors of HIV-1 reverse transcriptase and nucleocapsid protein.
    Nucleic acids research, 2016, 05-05, Volume: 44, Issue:8

    Topics: Anti-HIV Agents; DNA, Viral; Drug Evaluation, Preclinical; Fluorescence Resonance Energy Transfer; gag Gene Products, Human Immunodeficiency Virus; High-Throughput Screening Assays; HIV Reverse Transcriptase; HIV-1; Humans; Nevirapine; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine

2016
Improved pregnancy outcomes with increasing antiretroviral coverage in South Africa.
    BMC pregnancy and childbirth, 2016, Feb-11, Volume: 16

    Topics: Adolescent; Adult; Anti-Retroviral Agents; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Care; South Africa; Stavudine; Young Adult; Zidovudine

2016
[Survival analysis of AIDS patients of 15 years or above years old after initiation antiretroviral treatment in Henan province during 2005 to 2014].
    Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine], 2015, Volume: 49, Issue:12

    Topics: Acquired Immunodeficiency Syndrome; Anti-Retroviral Agents; China; Drug Therapy, Combination; Female; Humans; Lymphocyte Count; Male; Nevirapine; Proportional Hazards Models; Retrospective Studies; Risk Factors; Stavudine; Survival Analysis; Survival Rate; Zidovudine

2015
Prevention of perinatal transmission of zidovudine- and nevirapine-resistant HIV.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2016, Apr-01, Volume: 73, Issue:7

    Topics: Adolescent; Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Viral Load; Zidovudine

2016
Treatment of vitiligo with antiretroviral therapy in a child with HIV infection.
    AIDS (London, England), 2016, 05-15, Volume: 30, Issue:8

    Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Drug Therapy, Combination; Follow-Up Studies; HIV-1; Humans; Lamivudine; Male; Nevirapine; Treatment Outcome; Vitiligo; Zidovudine

2016
HIV-1 Drug Resistance by Ultra-Deep Sequencing Following Short Course Zidovudine, Single-Dose Nevirapine, and Single-Dose Tenofovir with Emtricitabine for Prevention of Mother-to-Child Transmission.
    Journal of acquired immune deficiency syndromes (1999), 2016, Dec-01, Volume: 73, Issue:4

    Topics: Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load; Zidovudine

2016
Early infant diagnosis of HIV infection using DNA-PCR at a referral center: an 8 years retrospective analysis.
    AIDS research and therapy, 2016, Volume: 13, Issue:1

    Topics: Anti-HIV Agents; DNA, Viral; Early Diagnosis; Ethiopia; Female; HIV; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Nevirapine; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Risk Factors; Zidovudine

2016
Adverse drug reactions associated with antiretroviral therapy in South Africa.
    African journal of AIDS research : AJAR, 2016, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dizziness; Exanthema; Female; Gynecomastia; HIV Infections; Humans; Lipodystrophy; Male; Middle Aged; Nevirapine; Peripheral Nervous System Diseases; Renal Insufficiency; Retrospective Studies; South Africa; Stavudine; Tenofovir; Zidovudine

2016
Improved Adherence to Antiretroviral Therapy Observed Among HIV-Infected Children Whose Caregivers had Positive Beliefs in Medicine in Sub-Saharan Africa.
    AIDS and behavior, 2017, Volume: 21, Issue:2

    Topics: Africa South of the Sahara; Alkynes; Anti-HIV Agents; Attitude to Health; Benzoxazines; Caregivers; Child; Child, Preschool; Cyclopropanes; Dideoxynucleosides; Female; HIV Infections; Humans; Infant; Lamivudine; Linear Models; Logistic Models; Male; Medication Adherence; Multivariate Analysis; Nevirapine; Randomized Controlled Trials as Topic; Stavudine; Surveys and Questionnaires; Uganda; Zambia; Zidovudine

2017
Early antiretroviral treatment (eART) limits viral diversity over time in a long-term HIV viral suppressed perinatally infected child.
    BMC infectious diseases, 2016, Dec-09, Volume: 16, Issue:1

    Topics: Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Lamivudine; Lopinavir; Male; Nevirapine; Phylogeny; Ritonavir; Zidovudine

2016
Antiretrovirals causing severe pre-eclampsia.
    Pregnancy hypertension, 2016, Volume: 6, Issue:4

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Delivery, Obstetric; Female; HIV Infections; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Lamivudine; Nevirapine; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Zidovudine

2016
Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa.
    The Journal of antimicrobial chemotherapy, 2017, 05-01, Volume: 72, Issue:5

    Topics: Adult; Africa South of the Sahara; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Mutation; Nevirapine; Polymerase Chain Reaction; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Thymidine; Treatment Failure; Viral Load; Zidovudine

2017
Multi-state models for the analysis of time-to-treatment modification among HIV patients under highly active antiretroviral therapy in Southwest Ethiopia.
    BMC infectious diseases, 2017, 06-27, Volume: 17, Issue:1

    Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Ethiopia; Female; HIV Infections; Humans; Lamivudine; Male; Models, Theoretical; Nevirapine; Pregnancy; Retrospective Studies; Stavudine; Tenofovir; Time-to-Treatment; Treatment Failure; Zidovudine

2017
Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: implications for the activity of next-line regimens from a longitudinal study in Mozambique.
    BMC infectious diseases, 2017, 09-05, Volume: 17, Issue:1

    Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Lamivudine; Longitudinal Studies; Male; Mozambique; Mutation; Nevirapine; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure; Viral Load; Zidovudine

2017
Central nervous system-penetrating antiretrovirals impair energetic reserve in striatal nerve terminals.
    Journal of neurovirology, 2017, Volume: 23, Issue:6

    Topics: Adenosine Triphosphate; Alkynes; Animals; Anti-HIV Agents; Benzoxazines; Cerebral Cortex; Corpus Striatum; Cyclohexanes; Cyclopropanes; Darunavir; Dideoxynucleosides; Dose-Response Relationship, Drug; Emtricitabine; Lopinavir; Male; Maraviroc; Mitochondria; Neurons; Nevirapine; Oxidative Phosphorylation; Permeability; Presynaptic Terminals; Raltegravir Potassium; Rats; Rats, Long-Evans; Triazoles; Zidovudine

2017
Lower mitochondrial DNA and altered mitochondrial fuel metabolism in HIV-exposed uninfected infants in Cameroon.
    AIDS (London, England), 2017, 11-28, Volume: 31, Issue:18

    Topics: Amino Acids, Branched-Chain; Anti-Retroviral Agents; Cameroon; Carnitine; DNA, Mitochondrial; Energy Metabolism; HIV Infections; Humans; Infant; Mitochondria; Nevirapine; Real-Time Polymerase Chain Reaction; Tandem Mass Spectrometry; Zidovudine

2017
HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
    Journal of medical virology, 2018, Volume: 90, Issue:3

    Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Cohort Studies; Coinfection; Cyclopropanes; Female; Hepatitis B; Hepatitis C; HIV; HIV Infections; Humans; Male; Middle Aged; Nevirapine; Retrospective Studies; Treatment Outcome; Viral Load; Zidovudine

2018
Motives for change of first-line antiretroviral therapy regimens in an unselected cohort of HIV/AIDS patients at a major referral centre in South-west Cameroon.
    BMC research notes, 2017, Nov-28, Volume: 10, Issue:1

    Topics: Adult; Anti-HIV Agents; Cameroon; Cohort Studies; Cross-Sectional Studies; Drug Combinations; Drug Substitution; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Referral and Consultation; Stavudine; Zidovudine

2017
Long-term viral suppression and immune recovery during first-line antiretroviral therapy: a study of an HIV-infected adult cohort in Hanoi, Vietnam.
    Journal of the International AIDS Society, 2017, Volume: 20, Issue:4

    Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Cyclopropanes; Female; HIV Infections; Humans; Longitudinal Studies; Male; Middle Aged; Nevirapine; Stavudine; Time Factors; Vietnam; Viral Load; Young Adult; Zidovudine

2017
A prospective study of adverse events to antiretroviral therapy in HIV- infected adults in Ekiti State, Nigeria.
    African journal of medicine and medical sciences, 2016, Volume: 45, Issue:2

    Topics: Abdominal Pain; Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Substitution; Drug Therapy, Combination; Female; HIV Infections; Humans; Incidence; Lamivudine; Male; Middle Aged; Nausea; Nevirapine; Nigeria; Prospective Studies; Sleep Initiation and Maintenance Disorders; Tenofovir; Young Adult; Zidovudine

2016
Antiretroviral treatment Long-Term (ALT) cohort: a prospective cohort of 10 years of ART-experienced patients in Uganda.
    BMJ open, 2018, 02-21, Volume: 8, Issue:2

    Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Combinations; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Lamivudine; Male; Nevirapine; Prospective Studies; RNA, Viral; Time; Uganda; Viral Load; Zidovudine

2018
Short Communication: Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy.
    AIDS research and human retroviruses, 2018, Volume: 34, Issue:11

    Topics: Adult; Anti-HIV Agents; Antimalarials; Cross-Sectional Studies; Drug Interactions; Female; Fetal Blood; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Kenya; Lamivudine; Malaria; Mefloquine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Zidovudine

2018
Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria.
    Pharmacology research & perspectives, 2018, Volume: 6, Issue:5

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Anti-HIV Agents; Child; Child, Preschool; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Infant; Lamivudine; Male; Middle Aged; Nevirapine; Nigeria; Pharmacovigilance; Sex Factors; Young Adult; Zidovudine

2018
Rates of HBV, HCV, HDV and HIV type 1 among pregnant women and HIV type 1 drug resistance-associated mutations in breastfeeding women on antiretroviral therapy.
    BMC pregnancy and childbirth, 2018, Dec-22, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Anti-HIV Agents; Breast Feeding; Cameroon; Coinfection; Drug Resistance, Viral; Female; Health Knowledge, Attitudes, Practice; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Vaccines; Hepatitis C; Hepatitis C Antibodies; Hepatitis D; HIV Seroprevalence; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Vaccination; Young Adult; Zidovudine

2018
Rate of viral load change and adherence of HIV adult patients treated with Efavirenz or Nevirapine antiretroviral regimens at 24 and 48 weeks in Yaoundé, Cameroon: a longitudinal cohort study.
    BMC infectious diseases, 2019, Feb-26, Volume: 19, Issue:1

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cameroon; Cohort Studies; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Longitudinal Studies; Male; Middle Aged; Nevirapine; Patient Compliance; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Viral Load; Zidovudine

2019
Incidence and types of HIV-1 drug resistance mutation among patients failing first-line antiretroviral therapy.
    Journal of pharmacological sciences, 2019, Volume: 139, Issue:4

    Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Antiviral Agents; Benzoxazines; Cyclopropanes; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Incidence; Lamivudine; Male; Middle Aged; Mutation; Nevirapine; Stavudine; Tenofovir; Treatment Failure; Viral Load; Zidovudine

2019
Rates of HIV-1 virological suppression and patterns of acquired drug resistance among fisherfolk on first-line antiretroviral therapy in Uganda.
    The Journal of antimicrobial chemotherapy, 2019, 10-01, Volume: 74, Issue:10

    Topics: Adult; Anti-HIV Agents; Drug Resistance, Viral; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Male; Mutation; Nevirapine; Reverse Transcriptase Inhibitors; Treatment Failure; Treatment Outcome; Uganda; Viral Load; Zidovudine

2019
Safety of 6-week Neonatal Triple-combination Antiretroviral Postexposure Prophylaxis in High-risk HIV-exposed Infants.
    The Pediatric infectious disease journal, 2019, Volume: 38, Issue:10

    Topics: Anti-Retroviral Agents; Chemoprevention; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Nevirapine; Post-Exposure Prophylaxis; Prospective Studies; Thailand; Treatment Outcome; Zidovudine

2019
Trend of HIV transmitted drug resistance before and after implementation of HAART regimen restriction in the treatment of HIV-1 infected patients in southern Taiwan.
    BMC infectious diseases, 2019, Aug-23, Volume: 19, Issue:1

    Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Combinations; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Mutation; Nevirapine; Prevalence; Reverse Transcriptase Inhibitors; Taiwan; Zidovudine

2019
Formulation, Development and Scale-Up of Fixed-Dose Combination Tablets Containing Zidovudine, Lamivudine and Nevirapine.
    Current HIV research, 2019, Volume: 17, Issue:5

    Topics: Anti-HIV Agents; Drug Combinations; Drug Compounding; Drug Development; Drug Stability; Lamivudine; Nevirapine; Tablets; Technology, Pharmaceutical; Zidovudine

2019
Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of Life.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 02-01, Volume: 72, Issue:3

    Topics: Anti-HIV Agents; Botswana; Child; Child, Preschool; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Zidovudine

2021
Incidence and predictors of loss to follow up among adult HIV patients on antiretroviral therapy in University of Gondar Comprehensive Specialized Hospital: A competing risk regression modeling.
    PloS one, 2020, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Ambulatory Care; Anti-Retroviral Agents; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Hospitals, Special; Humans; Incidence; Lamivudine; Lost to Follow-Up; Male; Nevirapine; Regression Analysis; Retrospective Studies; Risk Factors; Young Adult; Zidovudine

2020
Perinatal Antiretroviral Intensification to Prevent Intrapartum HIV Transmission When Antenatal Antiretroviral Therapy Is Initiated Less Than 8 Weeks Before Delivery.
    Journal of acquired immune deficiency syndromes (1999), 2020, 07-01, Volume: 84, Issue:3

    Topics: Adult; Anti-HIV Agents; Bayes Theorem; Drug Combinations; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Mothers; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Thailand; Viral Load; Young Adult; Zidovudine

2020
Risk factors for delayed viral suppression on first-line antiretroviral therapy among persons living with HIV in Haiti, 2013-2017.
    PloS one, 2020, Volume: 15, Issue:10

    Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Female; Haiti; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Risk Factors; Viral Load; Young Adult; Zidovudine

2020
Mother-to-Child HIV Transmission among Pregnant Women in a City with the Highest Rates of HIV in Brazil.
    American journal of perinatology, 2022, Volume: 39, Issue:13

    Topics: Brazil; Child; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Retrospective Studies; Syphilis; Zidovudine

2022
Adverse Reactions to Antiretrovirals in Cuban Patients Living with HIV/AIDS.
    MEDICC review, 2021, Volume: 23, Issue:2

    Topics: Adolescent; Adult; Anti-HIV Agents; Child; Child, Preschool; Cuba; Female; HIV Infections; Humans; Infant; Infant, Newborn; Male; Middle Aged; Nevirapine; Young Adult; Zidovudine

2021
Improved Hematologic Outcomes in HIV1-Exposed Infants Receiving Nevirapine Compared With Zidovudine for Postnatal Prophylaxis in a High Resource Setting.
    The Pediatric infectious disease journal, 2022, 05-01, Volume: 41, Issue:5

    Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine

2022
Nevirapine hair and plasma concentrations and HIV-1 viral suppression among HIV infected ante-partum and post-partum women attended in a mother and child prevention program in Maputo city, Mozambique.
    PloS one, 2022, Volume: 17, Issue:2

    Topics: Adolescent; Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Drug Combinations; Female; Hair; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Logistic Models; Medication Adherence; Mozambique; Nevirapine; Postpartum Period; Pregnancy; Prospective Studies; Viral Load; Young Adult; Zidovudine

2022
Serum Interleukin-6 and Weight Loss in Antiretroviral-naïve and Antiretroviral-treated Patients with HIV/AIDS: Relationships and Predictors.
    Current HIV research, 2022, Volume: 20, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; Emtricitabine; HIV Infections; Humans; Interleukin-6; Lamivudine; Middle Aged; Nevirapine; Tenofovir; Weight Loss; Zidovudine

2022
Antiretroviral therapy resistance mutations among HIV infected people in Kazakhstan.
    Scientific reports, 2022, 10-13, Volume: 12, Issue:1

    Topics: Anti-HIV Agents; Darunavir; Drug Resistance, Viral; Emtricitabine; HIV Infections; HIV-1; Humans; Kazakhstan; Mutation; Nevirapine; Viral Load; Zidovudine

2022
Rate of virological failure and HIV-1 drug resistance among HIV-infected adolescents in routine follow-up on health facilities in Cameroon.
    PloS one, 2022, Volume: 17, Issue:10

    Topics: Adolescent; Anti-HIV Agents; Cameroon; Drug Resistance, Viral; Follow-Up Studies; Health Facilities; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Nevirapine; Retrospective Studies; Viral Load; Zidovudine

2022